<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/210415-indolinones-of-general-formula-i by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 04:04:55 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 210415:INDOLINONES OF GENERAL FORMULA I</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">INDOLINONES OF GENERAL FORMULA I</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention relates to indolinones of general formula substituted in the 6 position, wherein R1 to R5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof which have valubale pharmacological properties esecially an inhibitory effect on receptor tyrosine kinases, and cyclin/CDK complexes, as well as on the proliferation of endothelial cells and various tumour cells, pharmaecutical compositions containing these compounds their use and processes for preparing them.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM 2<br>
THE PATENTS ACT 1970<br>
[39 OF 1970]<br>
&amp;<br>
THE PATENTS RULES, 2006<br>
COMPLETE SPECIFICATION [See Section 10; rule 13]<br>
"INDOLINONES OF GENERAL FORMULA I"<br>
BOEHRINGER  INGELHEIM   PHARMA  GMBH   &amp;  CO.   KG.,   a  German company of 55216 Ingelheim am Rhein, Germany,<br>
GRANTED<br>
25-06-2007<br>
The following specification particularly describes the invention and the manner in which it is to be performed:<br><br><br><br>
The present invention relates to new indolinones of general formula<br><br><br>
(I),<br><br>
substituted in the 6 position, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable properties.<br>
The above compounds of general formula I wherein R^ denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, in particular an inhibiting effect on various kinases, especially receptor tyrosine kinases such as VEGFR2, PDGFRa, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as complexes of CDK"s (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins (A, Bl, B2, C, Dl, D2, D3, E, F, Gl, G2, H, I" and K) and to viral cyclin (cf. L. Mengtao in J. Virology .71(3), 1984-1991 (1997)), and on the proliferation of cultivated human cells, in particular endothelial cells, e.g. in angiogenesis, but also on the proliferation of other cells, in particular tumour cells.<br><br>
The other compounds of the above general formula I wherein Rx does not denote a hydrogen atom or a prodrug group are valuable intermediate products for preparing the abovementioned compounds.<br>
The present invention thus relates to the above compounds of general formula I, whereby those compounds wherein Rj_  denotes a hydrogen atom or ,k  prodrug group have valuable pharmacological properties, pharmaceutical compositions containing the pharmacologically active compounds, the use thereof and processes for preparing them.<br>
In the above general formula I<br>
X denotes an oxygen or sulphur atom,<br>
Rx denotes a hydrogen atom or a prodrug group such as a Cx.4-alkoxycarbonyl or C2.4-alkanoyl group,<br>
R2 denotes a carboxy group, a straight-chain or branched C^g-alkoxy-carbonyl group, a C4_7-cycloalkoxy-carbonyl or an aryloxycarbonyl group,<br>
a straight-chain or branched C^-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C^-alkoxy-carbonyl, aminocarbonyl, C-L.-j-alkylamino-carbonyl or di-(C^3-alkyl)-aminocarbonyl group,<br>
a straight-chain or branched C2.6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C1.3-alkoxy, amino, C^-alkylamino or di-(Cx„3-alkyl)-amino group,<br><br><br><br>
an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C-^-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N- (C^s-alkyl) -Cj.-j-alkylaminocarbonyl-phenyl group, it may also denote a di- (Cx.2-alkyl) -aminocarbonyl group,<br>
R3 denotes a hydrogen atom, a C^-alkyl, C3_7-cycloalkyl, trifluoromethyl or heteroaryl group,<br>
a phenyl or naphthyl group, a phenyl or naphthyl group mono-or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C^-alkyl or C^-alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted<br>
by a hydroxy, hydroxy-C1_3-alkyl or C^-alkoxy-C^-alkyl group,<br>
by a cyano, carboxy, carboxy-C-^-alkyl,<br>
C^-alkoxycarbonyl, aminocarbonyl, C1.3-alkylamino-carbonyl or di- (C^j-alkyl)-aminocarbonyl group,<br>
by a nitro group,<br>
by an amino, C^-alkylamino, di- (C^-alkyl) -amino or amino-C^.-,-alky 1 group,<br>
by a C^-alkylcarbonylamino, N~ (C1_3-alkyl) -C^-alkyl-<br>
carbonylamino, C1_3-alkylcarbonylamino-C1_3-alkyl,<br>
N- (C1.3-alkyl) -C1.3-alkylcarbonylamino-C1.3-alkyl, C^-alkyl-<br>
sulphonylamino, C^-alkylsulphonylamino-Ci.-j-alkyl,<br>
N- (C^-alkyl) -C^-alkylsulphonylamino-C^-alkyl or<br>
aryl-C^-alkylsulphonylamino group,<br><br><br>
by a cycloalkylamino, cycloalkyleneimino, cyclo-alkyleneiminocarbonyl, cycloalkyleneimino-C^-alkyl, cycloalkyleneiminocarbonyl-C^^^-alkyl or<br>
cycloalkyleneiminosulphonyl-C^-alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -NCC^-alkyl) group,<br>
or by a heteroaryl or heteroaryl-C^-alky 1 group,<br>
R4 denotes a C3.7-cycloalkyl group,<br>
whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C^-alkylamino or di- (C^-alkyl) -amino group or replaced by an -NH or -NCC^-alkyl) group,<br>
or a phenyl group substituted by the group R6, which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by Cx.5-alkyl, trifluoromethyl, hydroxy, C1.3-alkoxy, carboxy, C1.3-alkoxycarbonyl, amino, acetylamino, C^-alkyl-sulphonylamino, aminocarbonyl, C^-alkyl-aminocarbonyl, di- (C^-alkyl)-aminocarbonyl, aminosulphonyl, C1.3 - alkyl - aminosulphonyl,<br>
di- (C^-alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein<br>
R6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom,<br>
a cyano, nitro, amino, C^-alkyl, C3_7-cycloalkyl,<br>
trifluoromethyl, phenyl, tetrazolyl or heteroaryl group,<br><br><br>
the group of formula<br><br>
wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a C^-alkyl group,<br>
a C1.3-alkoxy group, a C^-alkoxy-C^-alkoxy, phenyl-C10-alkoxy, amino-C2„3-alkoxy, C1_3-alkylamino-C2_3-alkoxy, di- (C^-alkyl) -amino-C2.3-alkoxy, phenyl-C^-alkylamino-C2.3-alkoxy, N- (C^-alkyl) -phenyl-C^-alkylamino-Cj.-j-alkoxy, C5_7-cycloalkyleneimino-C2_3-alkoxy or C-L.-j-alkylmercapto group,<br>
a carboxy, C1.4-alkoxycarbonyl, aminocarbonyl, C1.3-alkyl-amino-carbonyl, N- (C^g-alkyl) -C^-j-alkylaminocarbonyl, phenyl- C^3 -alkylamino-carbonyl, N- (C^-alkyl) -phenyl-C1.3-alkylamino-carbonyl, piperazinocarbonyl or N- (C1.3-alkyl) -piperazinocarbonyl group,<br>
a C^-alkylaminocarbonyl or N- (C^-alkyl) -C1.3-alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C^-alkoxycarbonyl group or in the 2 or 3 position by a di- (C^-alkyl) -amino, piperazino, N- (C^-alkyl) -piperazino or a 4- to 7-membered cycloalkyleneimino group,<br>
a C3.7 - eye loalkyl-carbonyl group,<br>
wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be substituted by an amino, C1.3-alkylamino or di- (C^3-alkyl) -amino group or replaced by an -NH or -NCC^-alkyl) group,<br><br><br><br>
a 4- to 7-membered cycloalkyleneimino group wherein<br>
a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or<br>
the cycloalkylene moiety may be fused to a phenyl ring or<br>
one or two hydrogen atoms may each be replaced by a C1_2-alkyl group and/or<br>
in each case the methylene group in the 4 position of a 6-or 7-membered cycloalkyleneimino group may be substituted by a carboxy, Cj._3-alk0xycarb0n.yl, aminocarbonyl, Cj._3-alkylamir.0carb0r.yl, di- (C^j-alkyl) -aminocarbonyl, phenyl-C1_3-alkylatnino or N-(C1.3-alkyl)-phenyl-Cj._3-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1_3-alkyl) , -N(phenyl), -N (C^-alkyl-carbonyl) or -N.(benzoyl) group,<br>
a C1_4-alkyl group substituted by the group R7, wherein<br>
R7 denotes a C3.7-cycloalkyl group,<br>
whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, Cj,_3-alkylamino or di- (C1_3-alkyl) -amino group or replaced by an -NH or -N (C1_3-alkyl) group or<br>
in a 5- to 7-membered cycloalkyl group a -(CH2)2 group may be replaced by a -CO-NH group, a -(CH2)3 group may be replaced by a -NH-CO-NH or -CO-NH-CO group or a -(CH2)4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C1_3-alkyl group,<br><br>
an aryl or heteroaryl group,<br>
a hydroxy or C1.3-alkoxy group,<br>
an amino, C^-alkylamino, di-(C1.7-alkyl)-amino, phenylamino, N-phenyl-C^-alkyl-amino, phenyl-C^.-j-alkyl-amino, N- (C^-alkyl) -phenyl-C^-alkylamino or di-(phenyl-C1.3-alkyl) -amino group,<br>
an co-hydroxy-C2_3-alkyl-amino, N- (C^-alkyl) -co-hydroxy-C2_3-alkyl-amino, di- (co~ hydroxy-C2_3-alkyl) -amino, di- (co- (C^-alkoxy) -C2,3-alkyl) -amino or N~ (dioxolan-2-yl) -C1.3-alkyl-amino group,<br>
a C1^3-alkylcarbonylamino-C2_3-alkyl-amino or C^-alkylcarbonylamino-Cj.-j-alkyl-N- (Cx..3-alkyl) -amino group,<br>
a C1.3-alkylsulphonylamino, N-(C^-alky!)-C^.-j-alkyl-sulphonylamino, C^-alkylsulphonylamino-C^-alkyl-amino or C-^-alkylsulphonylamino-C^-alkyl-N- (C^-alkyl) -amino group,<br>
a hydroxycarbonyl-C1.3-alkylamino or N- (C^-alkyl) -hydroxycarbonyl-Cj^.3-alkyl-amino group,<br>
a guanidino group wherein one or two hydrogen atoms may each be replaced by a C^-alky! group,<br>
a group of formula<br>
-N(R8) -CO- (CH2)n-R9     (ID,<br>
wherein<br><br>
R8 denotes a hydrogen atom or a C^-alkyl group,<br>
n denotes one of the numbers 0, 1, 2 or 3 and<br>
R9 denotes an amino, C1.4-alkylamino,<br>
di- (C^-alkyl)-amino, phenylamino,<br>
N- (C^-alkyl)-phenylamino, benzylamino,<br>
N-(C^-alkyl)-benzylamino or C^-alkoxy group, a 4- to<br>
7-membered cycloalkyleneimino group, whilst in each<br>
case the methylene group in the 4 position of a 6- or<br>
7-membered cycloalkyleneimino group may be replaced by<br>
an oxygen or sulphur atom, by a sulphinyl, sulphonyl,<br>
-NH, -NCC^-alkyl) , -N(phenyl), -N (C^-alkyl-carbonyl)<br>
or -N(benzoyl) group, or, if n denotes one of the<br>
numbers 1, 2 or 3, it may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R10)-(CH2)m-(C0)o-R11     (III),<br>
wherein<br>
R10 denotes a hydrogen atom, a C1.3-alkyl group, a C1_3-alkylcarbonyl, arylcarbonyl, phenyl-^.3-alkyl-carbonyl, C^j-alkylsulphonyl, arylsulphonyl or phenyl-C1^-alkylsulphonyl group,<br>
m denotes one of the numbers 1, 2, 3 or 4,<br>
o denotes the number 1 or, if m denotes one of the numbers 2, 3 or 4, o may also denote the number 0 and<br>
RX1 denotes an amino, C^-alkylamino, di- (C^-alkyl)-amino, phenylamino, N- (C-^-alkyl) -phenylamino, benzylamino, N-(C2.4-alkyl)-benzylamino, C^-alkoxy or<br><br><br>
C^-alkoxy-C-^-alkoxy group, a di- (C^-alkyl) -amino-C^-alkylamino group optionally substituted in the 1 position by a C^-alkyl group or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1.3-alkyl) , -N(phenyl) , -N(Cl.3-alkyl-carbonyl) or -N(benzoyl) group,<br>
a C4_7-cycloalkylamino, C4_7-cycloalkyl-C1_3-alkylamino or C4.7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C5.7-cycloalkyl, C2.4-alkenyl or C^-alkyl group,<br>
a 4- to 7-membered cycloalkyleneimino group, wherein<br>
the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C^-alkyl, C^-alkoxy or amino group, and/or<br>
one or two hydrogen atoms may each be replaced by a C^-alkyl, Cs.7-cycloalkyl or phenyl group and/or<br>
the methylene group in the 3 position of a 5-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C^-alkyl, C1_3-alkoxy or Cj.j-alkoxy-C^-alkyl group,<br>
the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may in each case be<br><br><br>
substituted by a hydroxy, hydroxy-C^3 -alkyl, C^-alkoxy, C1,3-alkoxy-C1.:3-alkyl, carboxy, C1_4 - alkoxycarbonyl, aminocarbonyl,<br>
C^-alkylaminocarbonyl, di- (C^-alkyl) -aminocarbonyl, phenyl-Cj.3-alkylamino or N- (C^-alkyl) -phenyl-C^-alkyl-amino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1.3-alkyl-) , -N (phenyl) , -N(phenyl-C^-alkyl-) , -N(C1^3-alkyl-carbonyl-) , -N(C1.4-hydroxy-carbonyl-) , -N (C^-alkoxy-carbonyl- ) , -N(benzoyl-) or -N(phenyl-C^.3-alkyl-carbonyl-) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a 5-to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino-nitrogen atom may each be replaced by a carbonyl group,<br>
or R6 denotes a C^-alkyl group which is substituted by a carboxy, Cx.3-alkoxycarbonyl, aminocarbonyl,<br>
C^-alkylaminocarbonyl or di- (C^-alkyl) -aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group,<br>
an N- (Cj^-alkyl) -C2_4-alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or Cx.3-alkoxycarbonyl group,<br>
a group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br><br><br>
wherein<br>
R12  denotes   a  hydrogen  atom,   a  C^-alkyl  or  C3.7-cycloalkyl<br>
*<br>
group or a C^-alkyl group terminally substituted by a phenyl, heteroaryl, trifluoromethyl, hydroxy, C^-alkoxy, aminocarbonyl, C^-alkylamino-carbonyl, di-(C^4-alkyl)-amino-carbonyl, C-^-alkyl-carbonyl, C^-alkyl-sulphonyl-amino, N- (C1.3-alkyl) -C^,.,--alkyl-sulphonylamino, C1.3-alkyl-amino^ulphonyl or di-(C.^-alkyl)-aminosulphonyl group and<br>
p denotes one of the numbers 0, 1, 2 or 3 and<br>
R13  assumes the meanings of the abovementioned group R7, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom,<br>
     a group of formula<br>
-N(R14)-(CH2)q-(CO)r-R15     (V),<br>
    wherein<br>
R14 denotes a hydrogen atom, a C^-alkyl group, a<br>
C^-alkylcarbonyl, arylcarbonyl, phenyl-C^-alkylcarbonyl,<br>
heteroarylcarbonyl, heteroaryl-C^-alkylcarbonyl,<br>
Ci.4-alkylsulphonyl, arylsulphonyl,<br>
phenyl- Cx.3 -alkylsulphonyl, heteroaryl sulphonyl or<br>
heteroaryl -Cx_3 -alkyl -sulphonyl group,<br>
q denotes one of the numbers 1, 2, 3 or 4,<br>
r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and<br>
R15  assumes the meanings of the abovementioned group R7,<br><br><br>
a group of formula<br>
-N(R16)-S02-Ri7     (VI), wherein<br>
R16 denotes a hydrogen atom or a C^-alkyl group optionally<br>
terminally substituted by a cyano,<br>
trifluoromethyl-carbonylamino or<br>
N- (C^-alkyl)-trifluoromethyl-carbonyl-amino group and<br>
R17 denotes a Cx_2-alkyl group,<br>
an amino group substituted by a di- (C^-alkyl) -amino-Cx.3-alkyl-carbonyl or di- (G^-alkyl) -amino-Cx_3-alkyl-sulphonyl group and a di- (C^-alkyl) -aminocarbonyl-C1.3-alkyl group,<br>
or an N-(C^-alkyl)-C-^-alkylsulphonylamino or N- (C1.3-alkyl) -phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group,<br>
wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R6 may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C1_5-alkyl, trifluoromethyl, hydroxy, C^3-alkoxy, carboxy, C1.3-alkoxycarbonyl, aminocarbonyl, C^-alkylamino-carbonyl, di- (C^-alkyl)-amino-carbonyl, aminosulphonyl, Cx.3 -alkyl -aminosulphonyl, di- (Ci.j-alkyl) -aminosulphonyl, C^-alkyl-sulphonylamino, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group,<br><br><br>
and<br>
Rs denotes a hydrogen atom or a C^-alkyl group,<br>
wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a cyano, trifluoromethyl, nitro, carboxy, aminocarbohyl, C^-alkyl or C^-alkoxy group and<br>
by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C^-alkyl group in the carbon skeleton, wherein<br>
the 6-membered heteroaryl group contains one, two or three nitrogen atoms and<br>
the 5-membered heteroaryl group contains an imino group optionally substituted by a C^-alkyl or phenyl-C1.3i-alkyl group, an oxygen or sulphur atom or<br>
an imino group optionally substituted by a C1.3-alkyl or phenyl-^.3-alkyl group or an oxygen or sulphur atom and additionally a nitrogen atom or<br>
an imino group optionally substituted by a C1_3-alkyl or phenyl-Ci.3-alkyl group and two nitrogen atoms,<br>
and moreover a phenyl ring may be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms and the bonding takes place via a nitrogen atom or via a carbon atom of the heterocyclic moiety or a fused phenyl ring,<br>
some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the<br><br><br>
above-defined groups of formula I optionally being replaced by fluorine atoms,<br>
the saturated alkyl and alkoxy moieties with more than 2 carbon atoms which are present in the groups defined hereinbefore also include the branched isomers thereof, such as for example the isopropyl, tert.butyl, isobutyl group, unless otherwise stated, and<br>
additionally the hydrogen atom of any carboxy group present or a hydrogen atom bound to a nitrogen atom, e.g. a hydrogen atom of an amino, alkylamino or imino group or a saturated N-heterocycle such as the piperidinyl group, may each be replaced by a group which can be cleaved in  vivo.<br>
By a group which can be cleaved in  vivo  from an imino or amino<br>
group is meant, for example, a hydroxy group, an acyl group such as the benzoyl or pyridinoyl group or a C^^-alkanoyl group such as the formyl, acetyl, propionyl, butanoyl, pentanoyl or hexanoyl group, an allyloxycarbonyl group, a C^^-alkoxycarbonyl group such as the methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, tert.butoxycarbonyl, pentoxycarbonyl, hexyloxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyloxycarbonyl or hexadecyloxycarbonyl group, a phenyl-C.^-alkoxycarbonyl group such as the benzyloxycarbonyl, phenylethoxycarbonyl or phenylpropoxycarbonyl group, a C^-alkylsulphonyl-C2_4 - alkoxycarbonyl, C^ - alkoxy- C2.4 - alkoxy- C2_4 - alkoxycarbonyl or ReCO-0- (RfCRg) -0-C0 group wherein<br>
Re denotes a C^g-alkyl, C5,7-cycloalkyl, phenyl or phenyl-CJ.J-alkyl group,<br><br><br>
R£ denotes a hydrogen atom, a C10-alkyl, C5.7-cycloalkyl or phenyl group and<br>
Rg denotes a hydrogen atom, a C^-alkyl or ReCO-0- (RECRg) -0 group wherein Re to Rg are as hereinbefore defined,<br>
wherein additionally the amino group may be a phthalimido group, whilst the abovementioned ester groups may also be used as a group which cari be converted in  vivo  into a carboxy<br>
group.<br>
One sub-group of compounds of general formula I which deserves special mention comprises those wherein<br>
X, R1 and R3 to R5 are as hereinbefore defined and<br>
R2 denotes a straight-chain or branched C^.g-alkoxy-carbonyl group, a C4_7-cycloalkoxycarbonyl or a aryloxycarbonyl group,<br>
a straight-chain or branched C^g-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C^-alkoxycarbonyl, aminocarbonyl, C^-alkylaminocarbonyl or di- (C^-alkyl)-aminocarbonyl group,<br>
a straight-chain or branched C2„6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C^-alkoxy, amino, C^-alkylamino or di- (C1_3-alkyl) -amino group,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
A second sub-group of compounds of general formula I which deserves special mention comprises those wherein<br><br><br><br>
X, R-L and R3 to R5 are as hereinbefore defined and<br>
R2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1.3-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N- (Ci.s-alkyl) -C^-alkylaminocarbonyl-phenyl group, R2 may also denote a di- (C^-alkyl)-aminocarbonyl group,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
A third sub-group of compounds of general formula I which deserves special mention comprises those wherein<br>
X, Rx to R3 and R5 are as hereinbefore defined and<br>
R4 denotes an R7-(C^-alkyl)-phenyl group, wherein<br>
R7 denotes an amino, C^-alkylamino, di- (C^-alkyl) -amino, phenylamino, N-phenyl-C^3-alkyl-amino, phenyl-C^-alkyl-amino, N- (C^-alkyl) -phenyl-C1.3-alkylamino or di- (phenyl-0^3-alkyl) -amino group,<br>
or a phenyl group substituted by the group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein R12, p and R13 are as hereinbefore defined,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
Preferred compounds of general formula I are those wherein<br><br><br>
Rx and R3 are as hereinbefore defined and<br>
X denotes an oxygen atom,<br>
R2 denotes a carboxy group, a straight-chain or branched C^.g-alkoxy-carbonyl group, a C5_7-cycloalkoxycarbonyl or a phenoxycarbonyl group,<br>
a straight-chain or branched C^-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C-^-alkoxycarbonyl, aminocarbonyl, C^j-alkylaminocarbonyl or di- (C^-alkyl)-aminocarbonyl group,<br>
a straight-chain or branched C2^3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C^-alkoxy, amino, C^-alkylamino or di- (C^.j-alkyl) -amino group,<br>
an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C^-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N~ (C^-alkyl) -C-L.3-alkylaminocarbonyl-phenyl group, it may also denote a di-(C^-alkyl)-aminocarbonyl group,<br>
R4 denotes a C3.7-cycloalkyl group,<br>
whilst the methylene group in the 4 position of a 6- or 7-membered oycloalkyl group may be substituted by an amino, C^j-alkylamino or di- (C^-alkyl)-amino group or replaced by an -NH or -N(C1_3-alkyl) group,<br>
or a phenyl group substituted by the group R6, which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C^-alkyl, trifluoromethyl, hydroxy,<br><br><br>
C^-alkoxy, carboxy, C^-alkoxycarbonyl, amino, acetylamino, aminocarbonyl, C1_3 - alkyl - aminocarbonyl,<br>
di-(C^j-alkyl)-aminocarbonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein<br>
R6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom,<br>
a cyano, nitro, amino, C^.j-alkyl, C3_7-cycloalkyl,<br>
trifluoromethyl, phenyl, tetrazolyl or heteroaryl group,<br>
the group of formula<br><br>
wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C^-alkyl group,<br>
a C^-alkoxy group, an amino-C2_3-alkoxy, C^-alkylamino-C2.3-alkoxy, di- (C1.3-alkyl) -amino-C2_3-alkoxy, phenyl-C1_3-alkylamino-C2_3-alkoxy, N- (C^-alkyl) -phenyl-C1.3-alkylamino-C2_3-alkoxy, pyrrol idino-C2_3-alkoxy, piperidino-C2_3-alkoxy or C^-alkylmercapto group,<br>
a carboxy, Cw-alkoxycarbonyl, aminocarbonyl, C^.,-alkyl -amino-carbonyl, phenyl -C-^-alkylamino-carbonyl or N- (C-^-alkyl) -phenyl-C1.3-alkylamino-carbonyl group,<br>
a C3_7-cycloalkyl-carbonyl group,<br>
wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an -NH or -N (Cx.3 - alkyl) group,<br><br><br><br><br>
a 4- to 7-membered cycloalkyleneimino group, wherein<br>
a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or<br>
one or two hydrogen atoms may each be replaced by a C^.j-alkyl group and/or<br>
in each case th^ methylene group in the 4 position of a 6-or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C^-alkoxycarbonyl, aminocarbonyl, Cx.3-alkylaminocarbonyl, di- (Cx_3-alkyl) -aminocarbonyl, phenyl-C^-alkylamino or N- (C^-alkyl) -phenyl-Cx_3-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N (C^-alkyl) group,<br>
a Cx.4-alkyl group terminally substituted by the group R7, wherein<br>
R7 denotes a C5.7-cycloalkyl group,<br>
whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an -NH or -NlC^j-alkyl) group or<br>
in a 5- to 7-membered cycloalkyl group a -(CH2)2 group may be replaced by a -CO-NH group, a -(CH3)3 group may be replaced by a -NH-CO-NH- or a -(CH2)4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C^-alkyl group,<br>
a phenyl or heteroaryl group,<br><br><br>
a hydroxy or C^-alkoxy group,<br>
an amino, C^-alkylamino, di-(C-^-alkyl)-amino, phenylamino, N-phenyl-C^-alkyl-amino,<br>
phenyl-C^-alkylamino, N- (C1_3-alkyl) -phenyl-C^-alkylamino or di- (phenyl-Q.1_3-alkyl) -amino group,<br>
a co-hydroxy-C2^3-alkyl-amino, N- (C^-alkyl) -©-hydroxy--C2_3-alkyl-amino, di- (co-hydroxy-C2.3-alkyl) -amino, di- (00- (C^j-alkoxy) -C2.3-alkyl) -amino or N-(dioxolan-2-yl)-C^-alkyl-amino group,<br>
a C10-alkylcarbonylamino-C2_3-alkyl-amino or C1_3-alkylcarbonylamino-C2_3-alkyl-N- (G^-alkyl) -amino group,<br>
a C^-alkylsulphonylamino, N- (C^-alkyl) -C^-alkylsulphonylamino, Cj^^-alkylsulphonylamino--C2_3-alkyl-amino or C1_3-alkylsulphonylamino-C2_3-alkyl--N- (Ci.j-alkyl) -amino group,<br>
a hydroxycarbonyl-C1.3-alkylamino or<br>
N- (C^.-j-alkyl) -hydroxycarbonyl-Ci^-alkyl-amino group<br>
a guanidino group wherein a hydrogen atom may be replaced by a C3..3-alkyl group,<br>
a group of formula<br>
-N(R8)-CO-(CH2)n-R9     (II),<br>
wherein<br>
R8 denotes a hydrogen atom or a C^-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and<br><br><br>
R9 denotes an amino, C-^-alkylamino, di- (C^-alkyl) -amino, phenylamino, benzylamino or Cx.4-alkoxy group, a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C1_3-alkyl) , -N(phenyl), -N (C^-alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2"or 3, it may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R10)-(CH2)m-(CO)0-R11     (III),<br>
wherein<br>
R10 denotes a hydrogen atom, a C^-alkyl group, a C1.3-alkylcarbonyl or C^j-alkylsulphonyl group,<br>
m denotes one of the numbers 1, 2 or 3,<br>
o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and<br>
Rxl denotes an amino, C1.3-alkylamino, di- (C-^-alkyl) -amino, C^4-alkoxy or C1.3-alkoxy-C1.3-alkoxy group or a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an   -NH, -N (C^-alkyl), -N(phenyl), -NCC^-alkyl-carbonyl) or -N(benzoyl) group,<br>
a C4.7-cycloalkylamino or C4_7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond,<br><br><br><br>
a 4- to 7-membered cycloalkyleneimino group, wherein<br>
the cycloalkylene moiety may be fused to a phenyl group or<br>
one or two hydrogen atoms may each be replaced by a C^-alkyl group and/or<br>
the methylene group in position 3 of the pyrrolidine group may be substituted by a hydroxy or C^-alkoxy group,<br>
in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C^-alkyl, C^-alkoxy, carboxy, C1.3-alkoxycarbonyl, aminocarbonyl, C1.3-alkylaminocarbonyl, di- (C^-alkyl) -aminocarbonyl, phenyl-C^-alkylamino or N- (C1.3-alkyl) -phenyl-C1.3-alkyl-amino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N (C^-alkyl) , -N(phenyl), -N (phenyl -C^-alkyl) , -N (Cx_3-alkyl-carbonyl) , -N(C1.4-alkoxy-carbonyl) , -N(benzoyl) or - N (phenyl - C^-j - alkyl - carbonyl) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a 5-to 6-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino-nitrogen atom may each be replaced by a carbonyl group,<br><br><br>
or  R6  denotes  a  C^--alkyl  group  which  is   terminally substituted by  a  carboxy,   C^-alkoxycarbonyl,   aminocarbonyl, C^.j-alkylaminocarbonyl  or  di- (C^-alkyl) -aminocarbonyl   group or by a  4-   to  7-membered  cycloalkyleneiminocarbonyl   group,<br>
a  group  of   formula<br>
-N(R12)-CO-(CH2)p-Ri3	(IV),<br>
wherein<br>
R12 denotes a hydrogen atom, a C1.3-alkyl, Cs.7-cycloalkyl, phenyl-C1_3-alkyl or heteroaryl-Q^-alkyl group and<br>
p denotes one of the numbers 0, 1, 2 or 3 and<br>
R13 assumes the meanings of the abovementioned group R7, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom,<br>
a group of formula<br>
-N(Ri4)-(CH2)q-(CO)r-Rxs     (V),<br>
wherein<br>
R14 denotes a hydrogen atom, a C^-alkyl group, a C^-alkylcarbonyl, phenylcarbonyl, phenyl-C^3-alkyl-carbonyl, heteroarylcarbonyl,<br>
heteroaryl - C^ - alkylcarbonyl, Cx.4 -alkylsulphonyl, phenyl sulphonyl, phenyl -C^- alkyl sulphonyl -heteroarylsulphonyl or heteroaryl-Cx_3-alkyl-sulphonyl group,<br>
g denotes one of the numbers 1, 2, 3 or 4,<br><br><br>
r denotes the number 1 or if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and<br>
R15 assumes the meanings of the abovementioned group R7,<br>
a group of formula<br>
-N(R16)-S02-Ri7     (VI), wherein<br>
R16 denotes a hydrogen atom or a C^-alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or N- (C1.3-alkyl) -trifluoromethyl--carbonyl-amino group and<br>
R17 denotes a C^-alkyl group,<br>
an amino group substituted by a di- (C^-alkyl) -amino-^.3-alkyl-carbonyl or di- (C1.3-alkyl) -amino-C^-alkyl-sulphonyl group and a di- (C^-alkyl) -aminocarbonyl-C^.j-alkyl group,<br>
wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under RG may be mono-or disubstituted by fluorine, chlorine or bromine atoms, by C^-alkyl, trifluoromethyl, hydroxy, C^-alkoxy, carboxy, C^j-alkoxycarbonyl, aminocarbonyl, C^-alkyl-aminocarbonyl, aminosulphonyl, C^-alkyl-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and<br>
Rs denotes a hydrogen atom or a C^-alkyl group,<br><br><br>
whilst by a heteroaryl group as mentioned above is meant a pyridinyl, pyrazinyl, pytimidinyl, pyridazinyl, pyrrolyl, furyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, imidazolyl or triazolyl group optionally substituted in the carbon skeleton by a C^-alkyl group wherein a hydrogen atom bound to a nitrogen atom may be replaced by a C1.3-alkyl or phenyl-C,^,-alkyl group and wherein the 5-membered heteroaryl groups containing at least one imino group are bound via a carbon or nitrogen Atom,<br>
a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by a group which can be cleaved in<br>
vivo,   particularly by an acetyl or tert.butoxycarbonyl group,<br>
the carboxy groups contained in the abovementioned groups may each be substituted by a group which can be cleaved in  vivo<br>
and may occur, for example, in the form of the tert.butoxycarbonyl group,<br>
some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the above-defined groups of formula I optionally being replaced by fluorine atoms and<br>
the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
One subgroup of preferred compounds of general formula I deserving- special  mention comprises  those  wherein<br>
X, Rx  and R3 to R5 are as hereinbefore defined and •<br><br>
R2 denotes a straight-chain or branched C^-alkoxy-carbonyl group, a Cs_7-cycloalkoxycarbonyl or a phenoxycarbonyl group,<br>
a straight-chain or branched C^-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl-carboxy, C^-alkoxycarbonyl, aminocarbonyl, C^-alkylaminocarbonyl or di- (C^-alkyl)-aminocarbonyl group,<br>
a straight-chain or branched C2.3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy, C^.j-alkoxy, amino, C^-alkylamino or di- (C^-alkyl) -amino group,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
A second sub-group of preferred compounds of general formula I deserving special mention comprises those wherein<br>
X, Rx and R3 to R5 are as hereinbefore defined and<br>
R2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C^-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N-(C^-alkyl)-C^-alkylaminocarbonyl-phenyl group, R2 may  also denote a di- (C1.2-alkyl) -aminocarbonyl group,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
A third sub-group of preferred compounds of general formula I deserving special mention comprises those wherein<br>
X, Rx to R3 and R5 are as hereinbefore defined and<br><br><br>
R„ denotes an R7- (n-C^-alkyl) -phenyl group, wherein<br>
R7 denotes an amino, C^.g-alkylamino, di- (C^.g-alkyl) -amino, phenylamino, N-phenyl-C1.3-alkyl-amino, phenyl -C1_2- alkyl -amino, N- (C^-alkyl) -phenyl-C1.3-alkylamino or di-(phenyl-Ca.3-alkyl) -amino group,<br>
or a phenyl group substituted by the group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein R12, p and R13 are as hereinbefore defined,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
Particularly preferred compounds of general formula I are those wherein<br>
X denotes an oxygen atom,<br>
R-L denotes a hydrogen atom,<br>
R2 denotes a carboxy group, a straight-chain or branched C1.4-alkoxycarbonyl  group or a phenoxycarbonyl   group,<br>
a straight-chain or branched C^-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C1.3-alkoxycarbonyl, aminocarbonyl, C1.3-alkylaminocarbonyl or di- (C^-alkyl) -aminocarbonyl group,<br>
a straight-chain or branched C2.3-alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy,<br><br><br>
C10-alkoxy, amino, C^-alkylamino or di- (C1.3-alkyl) -amino group,<br>
an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C^-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N- (Ci^-alkyl) -CVj-alkylaminocarbonyl-phenyl group, it may also denote a di- (C^-alkyl)-aminocarbonyl group,<br>
R3 denotes a C^-alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C1_3-alkyl, hydroxy or C1_3-alkoxy group,<br>
R4 denotes a Cs_6-cycloalkyl group,<br>
wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino, C^-alkylamino or di- (C^-alkyl)-amino group or replaced by an -NH or -N(C1.3-alkyl) group,<br>
a phenyl group, a phenyl group disubstituted by C^-alkyl, C1_3-alkoxy or nitro groups, wherein the substituents may be identical or different, or<br>
a phenyl group substituted by the group R6, which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein R6 denotes a fluorine, chlorine or bromine atom,<br>
a C^-alkyl, C1.3-alkoxy, nitro, amino or C5.6-cycloalkyl group,<br>
a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be<br><br><br>
substituted by a C1.3-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C^-alkyl or phenyl-Cj.-j-alkyl group,<br>
the group of formula<br><br>
a  carboxy,   C^-alkoxycarbonyl,   phenyl-C^-alkylamino-carbonyl or  C5.7-cycloalkyl-carbonyl  group,<br>
a 5 or 6-membered cycloalkyleneimino group, wherein<br>
the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH or -N (C^-alkyl) group,<br>
an unbranched C^-alkyl group terminally substituted by the group R7, wherein<br>
R7 denotes a C5.7-cycloalkyl group,<br>
wherein in a 5 or 6-membered cycloalkyl group a -(CH2)2 group may be replaced by a -CO-NH group, a -(CH2)3 group may be replaced by an -NH-CO-NH- or a -(CH2)4 group may be replaced by an -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C^-alkyl group,<br>
a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a<br><br><br>
C^-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C^-alkyl group,<br>
a hydroxy or C^-alkoxy group,<br>
an amino, C^g-alkylamino, di- (C^g-alkyl) -amino, phenylamino, N-phenyl-C^-alkylamino, phenyl-G^-alkylamino or N- (C^-alkyl) -phenyl-C1_3-alkylamino group,<br>
a co-hydroxy-C2_3-alkyl-amino,<br>
N- (C^-j-alkyl) -co-hydroxy~C2_3-alkylamino,<br>
di- (co-hydroxy-C2.3-alkyl) -amino or<br>
di- (co- (C^-alkoxy) -C2_3-alkyl) -amino group,<br>
a  C1.3-alkylcarbonylamino-C2.3-alkyl-amino  or C1.3-alkylcarbonylamino-C2.3-alkyl-N- (C^-alkyl) -amino  group,<br>
a  C^-alkylsulphonylamino,   N- (C^-alky!) -C1.3-alkylsulphonylamino,   C-^-alkylsulphonylamino--C2.3-alkylamino or C^-alkylsulphonylamino--C2_3-alkyl-N- (C1.3-alkyl) -amino  group,<br>
a hydroxycarbonyl-C1_3-alkylamino or<br>
N- (C-^-alkyl) -hydroxycarbonyl-C-L.-j-alkyl-amino  group,<br>
a guanidino group wherein a hydrogen atom may be replaced by a C^-alkyl group,<br>
a group of formula<br>
-N(R8)-CO-(CH2)n-R9     (ID, wherein<br><br><br>
R8 denotes a hydrogen atom or a C^-alkyl group,<br>
n denotes one of the numbers 0, 1, 2 or 3 and<br>
R9 denotes an amino, C^-alkylamino,<br>
di- (C^3-alkyl) -amino or C^-alkoxy group, a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N (C^-alkyl) or -N(C1.3-alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R9 may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R10)-(CH2)m-(CO)0-R11     (III),<br>
wherein<br>
R10 denotes a hydrogen atom or a C^-alkyl group,<br>
m denotes one of the numbers 1, 2 or 3,<br>
o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and<br>
RX1 denotes an amino, C1.3-alkylamino,<br>
di- (C^-alkyl) -amino, C^-alkoxy or methoxy-C1.3-alkoxy group or a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C1.3-alkyl) or -N (C1.3-alkyl-carbonyl) group,<br>
an azetidino, pyrrolidino, piperidino,<br>
2, 6-dimethyl-piperidino, 3,5-dimethyl-piperidino or<br>
azepino group, wherein<br><br>
the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy group,<br>
the methylene group in position 4 of the piperidino group may be substituted by a hydroxy, hydroxy-C^3-alkyl or C^-alkoxy group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N (C^-alkyl) , -N (C^-alkyl-carbonyl), -N(benzoyl) or -Ntphenyl-C^-alkyl-carbonyl) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the pyrrolidino, piperidino or piperazino group may be replaced by a carbonyl group,<br>
or R6 denotes a straight-chain C^-alkyl group which is terminally substituted by a carboxy or C^-alkoxy-carbonyl group,<br>
a group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein<br>
R12 denotes a hydrogen atom, a C^-alkyl or phenyl-Cx.3-alkyl group,<br>
p denotes one of the numbers 0, 1 or 2 and<br>
R13 denotes an amino, C^-alkylamino, di-(C1.4-alkyl)-amino, benzylamino, N-(C^-alkyl)-benzylamino, (^..j-alkoxy-C^-alkylamino, N- (C^-alkyl) -<br><br><br>
C1_3-alkoxy-C1.3-alkylamino/ di- (2-methoxy-ethyl) -amino, di- {co-hydroxy-C2_3-alkyl) -amino or aminocarbonyl-methyl-N-(methyl)-amino group,<br>
a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and optionally substituted by a C^-alkyl group,<br>
a pyrrolidino, piperidino, morpholino, thiomorpholino or a piperazino group optionally substituted in the 4 position by a C^-alkyl, phenyl - C^ - alkyl, C^-alkylcarbonyl or C^-alkoxycarbonyl group or, if n denotes the number 1 or 2, it may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R14)-(CH2)q-(CO)r-R15     (V),<br>
wherein<br>
R14 denotes a hydrogen atom, a C^-alkyl, C^-alkyl-carbonyl, phenylcarbonyl, phenyl-C^-alkylcarbonyl, furyl-carbonyl, pyridinyl-carbonyl, furyl-C^-alkylcarbonyl, pyridinyl-C^j-alkylcarbonyl, C^-alkylsulphonyl, phenyl sulphonyl or phenyl -Cx_3- alkyl sulphonyl group,<br>
q denotes one of the numbers 1, 2 or 3,<br>
r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and<br>
R15 denotes an amino, C^-alkylamino, di- (C^-alkyl) -amino, phenylamino, N- (C^-alkyl) -phenylamino, benzylamino or N-(C^-alkyl)-benzylamino group,or a group of formula<br><br><br>
-N(R16)-S02-Ri7     (VI), wherein<br>
R1S denotes a hydrogen atom or a C^-alkyl group optionally<br>
terminally substituted by a cyano,<br>
trifluoromethyl-carbonylamino or<br>
N- (C^-alkyl) -trifluoromethyl-carbonyl-amino group and<br>
R17 denotes a C^-alkyl group,<br>
wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R6 may be substituted by a fluorine, chlorine or bromine atom, by a methyl," trifluoromethyl, methoxy, nitro or cyano group and<br>
R5 denotes a hydrogen atom,<br>
wherein a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by an acetyl or tert.butoxycarbonyl group,<br>
the carboxy groups contained in the abovementioned groups may also be present in the form of the tert.butoxycarbonyl precursor group and<br>
the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated,<br>
the tautomers, the diastereomers, the enantiomers,  the mixtures thereof and the salts thereof.<br><br><br>
One subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein<br>
X, Rx, R3 and R5 are as hereinbefore defined,<br>
R2 denotes a straight-chain or branched C^-alkoxycarbonyl group or a phenoxycarbonyl group,<br>
a straight-chain or"branched C^-alkoxycarbonyl group, which is terminally substituted in the alkyl moiety by a phenyl-carboxy, C1.3-alkoxycarbonyl, aminocarbonyl,<br>
C^-alkylaminocarbonyl or di- (C^-alkyl)-aminocarbonyl group, or<br>
a straight-chain or branched C2_3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy, C^-alkoxy, amino, C-^-alkylamino or di- (C^-alkyl) -amino group, and<br>
R4 denotes an R7- (n-C^-alkyl) -phenyl group, wherein<br>
R7 denotes an amino, C^.j-alkylamino, di- (C^-alkyl) -amino,<br>
co - hydroxy- C2_3- alkyl -amino,<br>
N- (C1„3-alkyl) -co-hydroxy-C2_3-alkyl-amino,<br>
di- (co-hydroxy-C2.3-alkyl) -amino or<br>
di- (co- (C1.3-alkoxy) -C2.3-alkyl) -amino group,<br>
or a phenyl group substituted by the group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein R12, p and R13 are as hereinbefore defined,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br><br><br>
A second subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein<br>
X, R1 R3 and Rs are as hereinbefore defined,<br>
R2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1-3-alkoxy group or, if R4 does not denote an aminosulphonyl-phenyl or N- (C1-3-alkyl) -C1-3-alkylaminocarbonyl-phenyl group, R2 may also denote a di- (C1-3-alkyl)-aminocarbonyl group and<br>
R4 denotes a R7- (n-C1-3-alkyl) -phenyl group, wherein<br>
R7 denotes an amino, C1-3-alkylamino, di- (C1-4-alkyl) -amino, co-hydroxy-C2-3-alkyl-amino, N- (C1-3-alkyl) -co-hydroxy--C2-3-alkyl-amino, di- (to-hydroxy-C2-3-alkyl) -amino or di- (03- (C1-3-alkoxy) -C2-3-alkyl) -amino group,<br>
or a phenyl group substituted by the group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein R12, p and R13 are as hereinbefore defined,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
Most particularly preferred compounds of general formula I are those wherein<br>
X denotes an oxygen atom,<br><br>
R.x and R5 each denote a hydrogen atom,<br>
R2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group,<br>
R3 denotes a phenyl group and<br>
R4 denotes a phenyl group monosubstituted by the group R6, wherein<br>
R6 denotes an N-methyl-imidazol-2-yl group,<br>
an unbranched C^-alkyl group which is terminally substituted by a C^-alkylamino, di-(C^-alkyl)-amino, piperidino or 2,6-dimethyl-piperidino group,<br>
a group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV),<br>
wherein<br>
R12  denotes  a  C-^-alkyl  group,<br>
p denotes one of the numbers 1 or 2 and<br>
R13 denotes a di- (C^-alkyl) -amino group,<br>
or a group of formula<br>
-N(R14)-(CH2)q-(CO)r-R15      (V),<br>
wherein<br>
R14  denotes  a  C1.3-alkyl-carbonyl  or  C^-alkylsulphonyl group,<br><br>
q denotes one of the numbers 1, 2 or 3,<br>
r denotes the number 1 or, if q is one of the numbers 2 or 3, r may also denote the number 0 and<br>
R1S denotes a di- (C^-alkyl) -amino group,<br>
wherein the saturated alkyl moieties contained in the abovementioned groups which contain more than 2 carbon atoms may be straight-chain or branched, unless otherwise stated,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
A subgroup of most particularly preferred compounds of general formula I deserving special mention comprises those wherein<br>
X, R^ R3 and R5 are as hereinbefore defined, R2 denotes a methoxycarbonyl or ethoxycarbonyl group and R4 denotes a di-(C^-alkyl) - amino-C^-alkylphenyl group or a phenyl group substituted by the group of formula<br>
-N(R12)-CO-(CH2)p-Ri3     (IV)  wherein R12l   p and R13 are as hereinbefore defined,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.<br>
The following are mentioned as examples of particularly preferred compounds:<br><br>
(a)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2 -indolinone,<br>
(b)	3-Z-[(1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone,<br>
(c)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone,<br>
(d)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2 -indolinone,<br><br>
(e)	3-Z-[l-(4-((2,6-dimethyl-piperidin-1-yl)-methyl)-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2 -indolinone,<br>
(f)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani¬lino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(g)	3-Z- [1- (4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-ani-lino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(h) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(i) 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(j) 3-Z-[1-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(k) 3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone,<br>
(1) 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone, <br>
(m) 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(n) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(o) 3-Z-[l-(4-(N-(3*dimethylamino-propyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(p) 3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone,<br>
(q) 3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(r) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani¬lino) -1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and<br>
(s) 3-Z-[1-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
the tautomers, the mixtures and the salts thereof.<br>
Another subgroup of compounds of general formula I comprises<br>
those wherein<br>
X denotes an oxygen or sulphur atom,<br>
RL denotes a hydrogen atom or a prodrug group such as a C^-alkoxycarbonyl or C2.4-alkanoyl group,<br><br><br>
R2 denotes a carboxy group, a straight-chain or branched C^g-alkoxycarbonyl group, a C5_7-cycloalkoxycarbonyl or phenyl-C1.3-alkoxycarbonyl group, an aminocarbonyl or C^-alkylamihocarbonyl group or, if R4 does not denote an aminosulphonyl-phenyl or N- (C^-alkyl) -Cj^.j-alkylaminocarbonyl-phenyl group, a di- (C^-alkyl)-aminocarbonyl group,<br>
R3 denotes a hydrogen atom, a C^-alkyl, C3.7-cycloalkyl, trifluoromethyl or heteroaryl group,<br>
a phenyl or naphthyl group, a phenyl or naphthyl group mono-or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trif luoromethyl, C^-alkyl or C^-alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted<br>
by a hydroxy, hydroxy-C^-alkyl or C^-alkoxy-C^-alkyl group,<br>
by a cyano, carboxy, carboxy-C^-alkyl,<br>
C-^-alkoxycarbonyl, aminocarbonyl, C^-alkylamino-carbonyl or di- (C^-alkyl)-aminocarbonyl group,<br>
by a nitro group,<br>
by an amino, C1_3-alkylamino, di- (C^-alkyl) -amino or amino-C^-alky 1 group,<br>
by a Cj^-alkylcarbonylamino, N- (C^-alkyl) -C^-alkyl-<br>
carbonyl amino, C1.3-alkylcarbonylamino-C1.3-alkyl,<br>
N- (C^-alkyl) -C-L.-j-alkylcarbonylamino-C^-alkyl, Cx.3-alkyl-<br>
sulphonylamino,   C1.3-alkylsulphonylamino-C1.3-alkyl,<br>
N- (C1.3-alkyl) -C1.3-alkylsulphonylamino-C1.3-alkyl  or<br>
aryl-C^-alkylsulphonylamino group,<br><br><br>
by a cycloalkylamino, cycloalkyleneimino, cyclo-alkyleneiminocarbonyl, cycloalkyleneimino-C1-3-alkyl, cycloalkyleneiminocairbonyl-C1-3-alkyl or<br>
cycloalkyleneiminosulphonyl-C1-3-alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C1.3-alkyl) group,<br>
or by a heteroaryl or heteroaryl-C1.3-alkyl group,<br>
R4 denotes a C3.7-cycloalkyl group,<br>
whilst the methylene group in the 4 position of a 6- or 7 membered cycloalkyl group may be substituted by an amino, C^.j-alkylamino or di- (C^-alkyl) -amino group or replaced by an -NH or -N (C1.3-alkyl) group,<br>
or a phenyl group substituted by the group Rfi, which may additionally be substituted by a fluorine, chlorine, bromine or iodine atom, by a Cx.5-alkyl, trif luoromethyl, C^-j-alkoxy, carboxy, C1.3-alkoxycarbonyl, aminosulphonyl, nitro or cyano group, wherein<br>
R6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom,<br>
a cyano, nitro, C^-alkyl, C3_7-cycloalkyl, trif luoromethyl, phenyl, tetrazolyl or heteroaryl group,<br>
a C1.3-alkoxy group optionally sunstituted by 1 to 3 fluorine<br>
atoms, a C1.3-alkoxy-C1.3-alkoxy, phenyl-C1.3-alkoxy,<br>
amino-C2.3-alkoxy, C1_3-alkylamino-C2_3-alkoxy,<br>
di- (C^-alkyl) -amino-C2.3-alkoxy, phenyl-C^-alkylamino-<br><br><br><br>
C2-3-alkoxy, N- (C1-3-alkyl) -phenyl-C1-3-alkylamino-C1-3-alkoxy, C5-7-cycloalkyleneimino-C2-3-alkoxy or C1-3-alkylmercapto group,<br>
a carboxy, C1-4-alkoxycarbonyl, aminocarbonyl, C1-3-alkyl-amino-carbonyl, N- (C1-3-alkyl) -C1-3-alkylaminocarbonyl, phenyl-C1-3-alkylamino-carbonyl, N- (C1-3-alkyl) -phenyl-C1-3-alkylamino-carbonyl, piperazinocarbonyl or N- (C1-3-alkyl)-piperazinocarbonyl group,<br>
a C1-3-alkylaminocarbonyl or N- (C1-3-alkyl) -C1-3-alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C1-3-alkoxycarbonyl group or is substituted in the 2 or 3 position by a di- (C1-3-alkyl)-amino, piperazino, N- (C1-3-alkyl)-piperazino or a 4- to 7-membered cycloalkyleneimino group,<br>
a 4- to 7-membered cycloalkyleneimino group, wherein<br>
a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or<br>
the cycloalkylene moiety may be fused to a phenyl ring or<br>
one or two hydrogen atoms may each be replaced by a C1-3-alkyl group and/or<br>
in each case the methylene group in the 4 position of a 6-or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C1-3-alkoxycarbonyl, aminocarbonyl, C1-3-alkylaminocarbonyl, di- (C1-3-alkyl) -aminocarbonyl, phenyl-C1-3-alkylamino or N-(C1-3-alkyl)-phenyl-C^-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1-3-alkyl), -N(phenyl), -N(C1-3-alkyl-carbonyl) or -N (benzoyl) group,<br>
a C1-4-alkyl group which may be substituted<br>
by a hydroxy or C1-3-alkoxy group,<br>
by an amino, C1-3-alkylamino, di- (C1-7-alkyl) -amino, di-N- (C1-3-alkyl) -amino-C2-3-alkylamino,<br>
tri-N,N,N" - (C1-3-alkyl) -amino-C2-3-alkylamino, phenylamino, N-phenyl-C1-3-alkyl-amino, phenyl-C1-3-alkylamino, N- (C1-3-alkyl) -phenyl-C1-3-alkylamino or di-(phenyl-C1-3-alkyl)-amino group,<br>
by a C1-3-alkylcarbonylamino, N-(C1-3-alkyl)-C1-3-alkylcarbonylamino, C1-3-alkoxycarbonyl-C1-3-alkyl amino or N- (C1-3-alkyl) -C1-3-alkoxycarbonyl-C1-3-alkylamino group,<br>
by a C4-7-cycloalkylamino, C1-3-cycloalkyl-C1-3-alkylamino or C4-7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C1-3-alkyl group wherein some or all of the hydrogen atoms are replaced by fluorine atoms, by a C5-7-cycloalkyl, C2-4-alkenyl or Cl-4-alkyl group,<br>
by a 4- to 7-membered cycloalkyleneimino group, wherein<br>
a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or<br>
the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C1-3-alkyl, C1-3-alkoxy or amino group or<br><br><br>
one or two hydrogen atoms may each be replaced by a C1-3-alkyl, C5-7-cycloalkyl or phenyl group and/or<br>
in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, carboxy, C1-4-alkoxycarbonyl, aminocarbonyl, C1-3-alkylaminocarbonyl,<br>
di- (C1-3-alkyl) -aminocarbonyl, phenyl-C1-3-alkylamino or N- (C1-3-alkyD"-phenyl-C1-3-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N (C1-3-alkyl), -N(phenyl), -N(C1-3-alkyl-carbonyl) or -N(benzoyl) group,<br>
by a carboxy, C1-3-alkoxycarbonyl, aminocarbonyl, C1-3-alkylaminocarbonyl or di- (C1-3-alkyl) -aminocarbonyl group or<br>
by a 4- to 7-membered cycloalkyleneiminocarbonyl group,<br>
an amino, pyrrolidino, piperidino, morpholino, benzoylamino or N- (C1-3-alkyl)-benzoylamino group,<br>
an N- (C1-3-alkyl) -C2-4-alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or C1-3-alkoxycarbonyl group,<br>
a group of formula<br>
-N(R8)-CO-(CH2)n-R9     (II), wherein<br>
R8 denotes a hydrogen atom or a C1-3-alkyl group,<br>
n denotes one of the numbers 0, 1, 2 or 3 and<br><br><br>
R9 denotes an amino, C1-4-alkylamino, phenylamino,<br>
N- (C1-4-alkyl) -phenylamino, benzylamino,<br>
N~ (C1-4-alkyl) -benzylamino or di- (C1-4-alkyl) -amino group, a<br>
4- to 7-membered cycloalkyleneimino group, whilst in each<br>
case the methylene group in the 4 position of a 6- or 7-<br>
membered cycloalkyleneimino group may be replaced by an<br>
oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,<br>
-N(C1-3-alkyl) , -N (phenyl) , -N(C1-3-alkyl-carbonyl) or<br>
-N(benzoyl) group, or, if n denotes one of the numbers 1,<br>
2 or 3, it may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R10)-(CH2)m-(C0)o-R11     (III),<br>
wherein<br>
R10 denotes a hydrogen atom, a C1-3-alkyl group, a C1-3-alkylcarbonyl, arylcarbonyl, phenyl - C^ - alkylcarbonyl, C1-3-alkylsulphonyl, arylsulphonyl or phenyl-C1-3-alkylsulphonyl group,<br>
m denotes one of the numbers 1, 2, 3 or 4,<br>
o denotes one of the numbers 0 or 1 and<br>
R11 denotes an amino, C1-3-alkylamino, phenylamino, N- (C1-3-alkyl)-phenylamino, benzylamino,<br>
N- (C1-4-alkyl) -benzylamino or di- (C1-4-alkyl) -amino group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1-3-alkyl) , -N(phenyl) , -N (C1-3-alkyl-carbonyl) or<br><br><br><br>
-N(benzoyl) group, a C1-3-alkoxy group or a<br>
di- (C1-4-alkyl) -amino-C1-3-alkylamino group optionally<br>
substituted in the 1 position by a C1-3-alkyl group,<br>
or an N-(C1-3-alkyl)-C1-3-alkylsulphonylamino or N- (C1-3-alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group,<br>
wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R6 may be mono- or disubstituted by fluorine, chlorine, bromine or iodine " atoms, by C1-5-alkyl, trifluoromethyl, C1-3-alkoxy, carboxy, C1-3-alkoxycarbonyl, aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group,<br>
and<br>
R5 denotes a hydrogen atom or a C1-3-alkyl group,<br>
wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C1-3-alkyl or C1-3-alkoxy group and<br>
by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C1-3-alkyl group, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C1-3-alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a C1-3-alkyl group and an oxygen or sulphur -atom or one or two nitrogen atoms, and moreover a phenyl ring may<br><br>
be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms,<br>
the saturated alkyl and alkoxy moieties present in the groups defined above which contain more than 2 carbon atoms also include the branched isomers thereof such as, for example, the isopropyl, tert.butyl or isobutyl group, unless otherwise stated, and<br>
additionally any carboxy, amino or imino group present may be substituted by a group which can be cleaved in  vivo,<br>
the isomers and the salts thereof.<br>
According to the invention the new compounds are obtained, for example, by the following methods known in principle from the literature:<br>
a. reacting a compound of general formula<br><br>
(VII),<br>
wherein<br>
X and R3 are as hereinbefore defined,<br>
R2" has the meanings given for R2 hereinbefore,<br>
Rie denotes a hydrogen atom or a protecting group for the<br>
nitrogen atom of the lactam group, wherein one of the groups<br>
R2" and R18 may also denote a bond to a solid phase optionally<br>
formed via a spacer and the other one of the groups R2"   and R18 <br><br><br><br>
has the abovementioned meanings, and Z1  denotes a halogen atom, a hydroxy, alkoxy or aryl-alkoxy group, e.g. a chlorine or bromine atom, a methoxy, ethoxy or benzyloxy group,<br>
with an amine of general formula<br><br>
wherein<br>
R4 and R5 are as hereinbefore defined,<br>
and if necessary subsequently cleaving any protecting group<br>
used for the nitrogen atom of the lactam group or cleaving<br>
from a solid phase.<br>
The protecting group for the nitrogen atom of the lactam group may be, for example, an acetyl, benzoyl, ethoxycarbonyl, tert.butyloxycarbonyl or benzyloxycarbonyl group and<br>
the solid phase may be a resin such as a<br>
4-(2",4"-dimethoxyphenylaminomethyl)-phenoxy resin, the bond preferably being formed via the amino group, or a p-benzyloxybenzyl alcohol resin, wherein the bond is conveniently formed via an intermediate member such as a 2,5-dimethoxy-4-hydroxy-benzyl derivative.<br>
The reaction is conveniently carried out in a solvent such as dimethylformamide, toluene, acetonitrile, tetrahydrofuran, dimethylsulphoxide, methylene chloride or mixtures thereof, optionally in the presence of an inert base such as triethylamine, N-ethyl-diisopropylamine or sodium hydrogen carbonate at temperatures between 20 and 175°C, whilst any protecting group used can be cleaved at the same time by transamidation.<br><br><br><br>
If 21 in a compound of general formula VII denotes a halogen atom, the reaction is preferably carried out in the presence of an inert base at temperatures of between 20 and 120°C.<br>
If Zx   in a compound of general formula VII denotes a hydroxy, alkoxy or arylalkoxy group, the reaction is preferably carried out at temperatures between 2 0 and 200°C.<br>
If a protecting group used subsequently has to be cleaved, this is conveniently done either hydrolytically in an aqueous or alcoholic solvent, e.g. in methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water, dioxan/water, dimethylformamide/water, methanol or ethanol in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C,<br>
or advantageously by transamidation with an organic base such as ammonia, butylamine, dimethylamine or piperidine in a solvent such as methanol, ethanol, dimethylformamide and the mixtures thereof or in an excess of the amine used, at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C.<br>
Cleaving from any solid phase used is preferably carried out using trifluoroacetic acid and water at temperatures between 0 and 35°C, preferably at ambient temperature.<br>
b. In order to prepare a compound of general formula I wherein R2  has the meanings given hereinbefore, with the exception of the carboxy group:<br>
reacting a compound of general formula<br><br><br>
(IX)<br><br>
wherein<br>
R±  and R3 to R5 are as hereinbefore defined, or the reactive<br>
derivatives thereof, with a compound of general formula<br>
  (X) ,<br>
wherein<br>
R19 denotes a C^-alkanol, a C4.7-cycloalkanol or an aromatic<br>
alcohol,<br>
a C^.g-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C^-alkoxy-carbonyl, aminocarbonyl, C^-alkylamino-carbonyl or di- (C^-alkyl) -aminocarbonyl group,<br>
a C2_6-alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, Cx^3-alkoxy, amino, C1_3-alkylamino or di- (C^-alkyl) -amino group,<br>
an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1_3-alkoxy group or a di- (C^-alkyl) -amino group.<br>
The esterification or amidation is preferably carried out in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide, optionally in the presence of an inorganic or a tertiary organic base,<br><br><br>
preferably at temperatures between 20°C and the boiling temperature of the solvent used. The reaction with a corresponding acid is preferably carried out in the presence of a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionylchloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N"-dicyclohexylcarbodiimide, N,N"-dicyclohexyl-carbodiimide/N-hydroxysuccinimide, N,N"-dicyclohexyl-carbodiimide/l-hydroxy-benzotriazole, 2-(lH-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-tetrafluoroborate, 2-(1H-benzotriazol-l-yl)-1,1,3,3-tetramethyluronium-tetraf luoroborate/l-hydroxy-benzotriazole, N,N"-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylaminopyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 150°C, preferably at temperatures between 0 and 100°C, and the acylation with a corresponding reactive compound such as an anhydride, ester, imidazolide or halide thereof, is optionally carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine or N-methyl-morpholine at temperatures between 0 and 150°C, preferably at temperatures between 50 and 100°C.<br>
c. In order to prepare a compound of general formula I, wherein R4 denotes a C1-4-alkyl group substituted by the group R7, wherein<br>
R7 denotes an amino, C1-7-alkylamino, di-(C1-7-alkyl)-amino, phenylamino, N-phenyl-C1-3-alkyl-amino, phenyl-C1-3-alkyl-amino, N- (C1-3-alkyl) -phenyl-C1-3-alkylamino or di- (phenyl-C1-3-alkyl) -amino group,<br><br>
a  co-hydroxy-C2_3-alkyl-amino,<br>
N- (C1-3-alkyl) -co-hydroxy-C2-3-alkyl-amino,<br>
di- (co~ hydroxy-C2-3-alkyl) -amino,<br>
di- (co- (C1-3-alkoxy) -C2-3-alkyl) -amino or<br>
N-(dioxolan-2-yl)-C^-alkyl-amino  group,<br>
a  C1.3-alkylcarbonylamino-C2_3-alkyl-amino  or C1.3-alkylcarbonylamino-C2.3-alkyl-N- (C1.3-alkyl) -amino  group,<br>
a C1.3-alkylsulphonylamino,   N- (C1.3-alkyl) -<br>
C^-alkyl sulphonylamino,<br>
C^3 -alkyl sulphonyl amino -C2.3-alkyl- amino or<br>
C1_3-alkylsulphonylamino-C2.3-alkyl-N- (C^-alkyl) -amino<br>
group,<br>
a group of formula<br>
-N(R10) - (CH2)ra- (C0)o-Rn     (III) ,<br>
wherein<br>
R10 denotes a hydrogen atom, a C^-alky! group, a C^-alkylcarbonyl, arylcarbonyl, phenyl-C^-alkyl-carbonyl, C^- alkyl sulphonyl, arylsulphonyl or phenyl-C1.3-alkylsulphonyl group,<br>
m denotes one of the numbers 1, 2, 3 or 4,<br>
o denotes the number 1 and<br>
R1X  denotes  an  amino,   C^-alkylamino,<br>
di- (C^-alkyl)-amino, phenylamino,<br>
N-(C^-alkyl)-phenylamino, benzylamino,<br>
N- (C^-alkyl) -benzylamino, C^-alkoxy or<br>
C^-alkoxy-C^-alkoxy group, a di- (Cx.4-alkyl) -amino-C^-<br><br>
alkylamino group optionally substituted in the 1 position by a C1-3-alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1-3-alkyl) , -N(phenyl), -N (C1-3-alkyl-carbonyl) or -N(benzoyl) group,<br>
a C4-7-cycloalkylamino, C4-7-cycloalkyl-C1-3-alkylamino or C4_7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs_7-cycloalkyl, C2_4-alkenyl or C^-alkyl group,<br>
or a 4- to 7-membered cycloalkyleneimino group, wherein<br>
the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridine pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C1-3-alkyl, C1-3-alkoxy or amino group, and/or<br>
one or two hydrogen atoms may each be replaced by a C1-3-alkyl, C1-3-cycloalkyl or phenyl group and/or<br>
the methylene group in the 3 position of a 5-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C1-3-alkyl, C1-3-alkoxy or C1-3-alkoxy-C1-3-alkyl group,<br>
in each case the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C1-3-alkyl,<br><br><br><br>
C1-3-alkoxy, C1-3-alkoxy-C1-3-alkyl, C1-3-alkoxycarbonyl, aminocarbonyl, C1-3-alkylaminocarbonyl, di- (C1-3-alkyl)-aminocarbonyl, phenyl-C1-3-alkylamino or N- (C1-3-alkyl)-phenyl-C1-3-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1-3-alkyl-) , -N(phenyl), -N(phenyl-C1-3-alkyl-) , -N(C1-3-alkyl-carbonyl-) , -N(C1-3-alkoxy-carbonyl-), -N(benzoyl-) or -N (phenyl - C1-3 - alkyl - carbonyl - ) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a 5-to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino-nitrogen atom may each be replaced by a carbonyl group:<br>
reacting a compound of general formula<br><br><br>
(XI),<br><br>
wherein<br>
R3, R5 and X are as hereinbefore defined,<br><br>
R,<br>
has the meanings given for R2 hereinbefore,<br>
R1B denotes a hydrogen atom or a protecting group for-the nitrogen atom of the lactam group, wherein one of the groups R2" and R18 may also denote a bond to a solid phase optionallyformed via a spacer and the other one of the groups R2" and R18<br>
has the abovementioned meanings, A denotes a C1-4-alkyl group<br>
and Z2 denotes a leaving group, for example an alkyl or<br>
arylsulphonyloxy group such as the methylsulphonyloxy,<br>
ethylsulphonyloxy, p-toluenesulphonyloxy or<br>
trifluoromethanesulphonyloxy group, with an amine of general<br>
formula<br>
H	R7      (XII) ,<br>
wherein<br>
R7, has the meanings given for R7 hereinbefore, and subsequently, if necessary, cleaving any protecting group used for the nitrogen atom of the lactam group, or cleaving from a solid phase.<br>
The reaction is conveniently carried out in a solvent such as methylene chloride, tetrahydrofuran, 1,4-dioxan, toluene, acetonitrile, dimethylsulphoxide, dimethylformamide, dimethyl-acetamide, N-methylpyrrolidone or the mixtures thereof, optionally with the addition of water as a co-solvent and/or with the addition of an inert auxiliary base, e.g. sodium hydrogen carbonate, pyridine, 2,4,6-trimethylpyridine, quinoline, triethylamine, N-ethyldiisopropylamine, N-ethyl-dicyclohexylamine, 1,4-diazabicyclo[2,2,2]octane or 1,8-diazabicyclo[5,4,0]undec-7-ene, at temperatures between -50°C and +100°C, preferably between -10°C and +50°C, while any protecting group, used may be cleaved at the same time by transamidation.<br>
If any protecting group used for the nitrogen atom of the lactam group has to be removed or if the compound has to be cleaved from a solid phase this is carried out as described under method (a) above.If according to the invention a compound of general formula I is obtained which contains an alkoxycarbonyl group, this may be converted by hydrolysis into a corresponding carboxy compound, or<br>
if a compound of  general formula I is  obtained  which  contains an amino or alkylamino group, this may be converted by reductive alkylation into a corresponding alkylamino or dialkylamino compound, or<br>
if a compound of general formula I is obtained which contains an amino or alkylamino group, this may be converted by acylation or sulphonation into a corresponding acyl or sulphonyl compound, or<br>
if a compound of general formula I is obtained which contains a carboxy group, this may be converted by esterification or amidation into a corresponding ester or aminocarbonyl compound, or<br>
if a compound of general formula I is obtained which contains a cycloalkyleneimino group wherein a methylene group is replaced by a sulphur atom, this may be converted by oxidation into a corresponding sulphinyl or sulphonyl compound, or<br>
if a compound of general formula I is obtained which contains a nitro group, this may be converted by reduction into a corresponding amino compound, or<br>
if a compound of general formula I is obtained wherein R4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding cyanate, iso-cyanate or carbamoyl halide, into a corresponding urea compound of general formula I, or<br><br>
if a compound of general formula I is obtained wherein R4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I.<br>
The subsequent hydrolysis is preferably carried out in an aqueous solvent, e.g. in water, methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in . the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50QC.<br>
The subsequent reductive alkylation is preferably carried out in a suitable solvent such as methanol, methanol/water, methanol/water/ammonia, ethanol, ether, tetrahydrofuran, dioxan or dimethylformamide, optionally with the addition of an acid such as hydrochloric acid in the presence of catalytically activated hydrogen, e.g. hydrogen in the presence of Raney nickel, platinum or palladium/charcoal, or in the presence of a metal hydride such as sodium borohydride, lithium borohydride, sodium cyanoborohydride or lithium aluminium hydride at temperatures between 0 and 100°C, preferably at temperatures between 20 and 80°C.<br>
The subsequent acylation or sulphonylation is preferably carried out with the corresponding free acid or a corresponding reactive compound such as the anhydride, ester, imidazolide or halide thereof, preferably in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide,<br>
optionally in the presence of an inorganic or tertiary organic base at temperatures between -20 and 200°C, preferably at temperatures between 20°C and boiling temperature of the solvent used.   The reaction with the free acid may optionally be carried out in the presence of an acid-activating agent or a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionyl chloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N"-dicyclohexyl-carbodiimide,<br>
N,N"-dicyclohexylcarbodiimide/N-hydroxysuccinimide, N,N"-dicyclohexylcarbodiimide/1-hydroxy-benzotriazole, 2-(lH-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-tetrafluoroborate, 2-(lH-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-tetrafluoroborate/1-hydroxy-benzotriazole, N,N"-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylamino-pyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 150°C, preferably at temperatures between 0 and 100°C. The reaction with a corresponding reactive compound may optionally be carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine, N-methyl-morpholine or pyridine or by using an anhydride in the presence of the corresponding acid at temperatures between 0 and 150°C, preferably at temperatures between 50 and 100°C.<br>
The subsequent esterification or amidation is conveniently carried out by reacting a corresponding reactive carboxylic acid derivative with a corresponding alcohol or amine as described hereinbefore.<br>
The subsequent oxidation of the sulphur atom is preferably carried out in a solvent or mixture of solvents, e.g. in water, water/pyridine, acetone, methylene chloride, acetic<br><br><br><br><br><br><br><br><br><br>
sodium periodate or potassium permanganate in acetic acid, water/sulphuric acid or in acetone at 0 to 20°C.<br>
The subsequent reduction of a nitro group is preferably carried out by hydrogenolysis, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal or Raney nickel in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures of between 0 and 50°C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar.<br>
The subsequent preparation of a corresponding urea compound of general formula I is conveniently carried out with an inorganic cyanate or a corresponding isocyanate or carbamoylchloride, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures between 0 and 50°C, preferably at ambient.<br>
The subsequent preparation of a corresponding guanidino compound of general formula I is conveniently carried out by reacting with a compound which transfers the amidino group such as 3,5-dimethylpyrazole-l-carboxylic acid amidine, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures of between 0 and 50°C, preferably at ambient temperature.<br>
In the reactions described hereinbefore, any reactive groups present such as carboxy, hydroxy, amino, alkylamino or imino groups may be protected during the reaction by conventional protecting groups which are cleaved again after the reaction.<br><br>
For example, a protecting group for a carboxyl group may be a trimethylsilyl, methyl, ethyl, tert.butyl, benzyl or tetrahydropyranyl group and<br>
protecting groups for a hydroxy, amino, alkylamino or imino group may be an acetyl, trifluoroacetyl, benzoyl, ethoxycarbonyl, tert.butoxycarbonyl, benzyloxycarbonyl, benzyl, methoxybenzyl or 2,4-dimethoxybenzyl group and additionally, for the amino group, a phthalyl group.<br>
Any protecting group used is optionally subsequently cleaved for example by hydrolysis in an aqueous solvent, e.g. in water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in the presence of a acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide, at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C.<br>
However, a benzyl, methoxybenzyl or benzyloxycarbonyl group is cleaved, for example, hydrogenolytically, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures between 0 and 50°C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar.<br>
A methoxybenzyl group may also be cleaved in the presence of an oxidising agent such as cerium(IV)ammonium nitrate in a solvent such as methylene chloride, acetonitrile or<br><br>
acetonitrile/water at temperatures of between 0 and 50°C, but preferably at ambient temperature.<br>
A 2,4-dimethoxybenzyl group, however, is preferably cleaved in trifluoroacetic acid in the presence of anisole.<br>
A tert.butyl or tert.butyloxycarbonyl group is preferably cleaved by treating with an acid such as trifluoroacetic acid or hydrochloric aci£, optionally using a solvent such as methylene chloride, dioxan, ethyl acetate or ether.<br>
A phthalyl group is preferably cleaved in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene/water or dioxan at temperatures between 2 0 and 5 0°C.<br>
Moreover, chiral compounds of general formula I obtained may be resolved into their enantiomers and/or diastereomers.<br>
Thus, for example, the compounds of general formula I obtained which occur as racemates may be separated by methods known per<br>
se   (cf. Allinger N. L. and Eliel E. L. in "Topics in<br>
Stereochemistry", Vol. 6, Wiley Interscience, 1971) into their optical antipodes and compounds of general formula I with at least 2 asymmetric carbon atoms may be resolved into their diastereomers on the basis of their physical-chemical differences using methods known per se,   e.g. by chromatography<br>
and/or fractional crystallisation, and, if these compounds are obtained in racemic form, they may subsequently be resolved into the enantiomers as mentioned above.<br>
The enantiomers are preferably separated by column separation on chiral phases or by recrystallisation from an optically active solvent or by reacting with an optically active<br><br><br><br><br>
be obtained by methods known from the literature or may be obtained by the methods described hereinbefore and in the Examples.  For example, the compounds of general formula VI are described in German Patent Application 198 24 922.5. Moreover, the compounds of general formula XI may be obtained from the compounds of general formula I wherein R4 denotes a C^-alkyl-phenyl group substituted in the alkyl moiety by a hydroxy group, for example, by reacting with alkyl- or arylsulphonyl chlorides.<br>
As already mentioned, the new compounds of general formula I wherein Rj_  denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, particularly inhibitory effects on various kinases, especially on receptor-tyrosine kinases such as VEGFR2, PDGFRa, PDGFRp, FGFR1, FGFR3, EGFR, HER2, IGFIR and HGFR, as well as on complexes of CDK"s (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins (A, Bl, B2, C, Dl, D2, D3, E, F, Gl, G2, H, I and K) and on viral cyclin, on the proliferation of cultivated human cells, particularly endothelial cells, e.g. in angiogenesis, but also on the proliferation of other cells, particularly tumour cells.<br>
The biological properties of the new compounds were tested by the following standard procedure, as follows:<br>
Human umbilical endothelial cells (HUVEC) were cultivated in IMDM (Gibco BRL)," supplemented with 10 % foetal calf serum (FBS) (Sigma) , 50 pcM of fi-mercaptoethanol (Fluka) , standard antibiotics, 15 ^g/ml of endothelial cell growth factor (ECGS, Collaborative Biomedical Products) and 10 0 /xg/ml of heparin (Sigma) on gelatine-coated culture dishes (0.2 % gelatine, Sigma) at 37°C, under 5 % CO2 in a water-saturated atmosphere.<br><br>
In order to investigate the inhibitory activity of the compounds according to the invention the cells were starved for 16 hours, i.e. kept in culture medium without growth factors (ECGS + heparin). The cells were detached from the culture dishes using trypsin/EDTA and washed once in serum-containing medium. Then they were seeded out in amounts of 2.5 x 103 cells per well.<br>
The proliferation of the cells was stimulated with 5 ng/ml of VEGFi65 (vascular endothelial growth factor; H. Weich, GBF Braunschweig) and 10 /ig/ml of heparin. As a control, 6 wells in each dish were not stimulated.<br>
The compounds according to the invention were dissolved in 100% dimethylsulphoxide and added to the cultures in various dilutions in triplicate, the maximum dimethyl sulphoxide concentration being 0.3 %.<br>
The cells were incubated for 76 hours at 37°C, then for a further 16 hours 3H-thymidine (0.1 // Ci/well, Amersham) was added in order to determine the DNA synthesis. Then the radioactively labelled cells were immobilised on filter mats and the radioactivity incorporated was measured in a 6-counter. In order to determine the inhibitory activity of the compounds according to the invention the mean value of the non-stimulated cells was subtracted from the mean value of the factor-stimulated cells (in the presence or absence of the compounds according to the invention).<br>
The relative cell proliferation was calculated as a percentage of the control (HUVEC without inhibitor) and the concentration of active substance which inhibits the proliferation of the cells by 50 % (IC50) was determined.<br><br><br><br>
xhe test results of the following compounds (a) to (s) of general formula I are given by way of example:<br>
(a)	3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone,<br>
(b)	3-Z- [ (1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]- 6 -carbamoyl-2 -indolinone,<br>
(c)	3-Z- [1-(4-(piperidin-l-yl-methyl) -anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone,<br>
(d)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone,<br><br>
(e)	3-Z- [1-(4- ( (2,6-dimethyl-piperidin-1-yl)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(f)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(g)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone,<br>
(h) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone,<br>
(i) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone,<br>
(j) 3-Z-[l-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(k) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone,<br><br>
(1) 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(m) 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(n) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(o) 3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(p) 3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone,<br>
(q) 3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(r) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl) -N-acetyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and<br>
(s) 3-Z-[1-(4-methylaminomethyl-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone.<br><br><br>
The following Table contains the results found:<br><br>
Compound	IC50    [//m]<br>
(a)	0.04<br>
(b)	0.35<br>
(c)	0.01<br>
(d)	0.02<br>
(e)	0.05<br>
(f)	0.01<br>
(g)	0.003<br>
(h)	0.01<br>
(i)	0.03<br>
(J)	0.02<br>
(k)	0.03<br>
(1)	0.1<br>
(m)	0.02<br>
(n)	0.02<br>
(o)	0.01<br>
(P)	0.02<br>
(q)	0.02<br>
(r)	0.01<br>
(s)	0.04<br>
In view of their inhibitory effect on the proliferation of cells, particularly endothelial cells and tumour cells, the compounds of general formula I are suitable for treating diseases in which the proliferation of cells, particularly endothelial cells, plays a part.<br>
Thus, for example, the proliferation of endothelial cells and the concomitant neovascularisation constitute a crucial stage in tumour progression (Folkman J. et al., Nature 339, 58-61, (1989); Hanahan D. and Folkman J., Cell 86,   353-365, (1996)). Furthermore, the proliferation of endothelial cells is also<br><br>
important in haemangiomas, in metastasisation, rheumatoid arthritis, psoriasis and ocular neovascularisation (Folkman J., Nature Med. 1, 27-31, (1995)). The therapeutic usefulness of inhibitors of endothelial cell proliferation was demonstrated in the animal model for example by O"Reilly et al. and Parangi et al. (O"Reilly M.S. et al. , Cell 8J., 277-285, (1997); Parangi S. et al. , Proc Natl Acad Sci USA .93., 2002-2007, (1996) ) .<br>
The compounds of general formula I, their tautomers, their stereoisomers or the physiologically acceptable salts thereof are thus suitable, for example, for treating tumours (e.g. plate epithelial carcinoma, astrocytoma, Kaposi"s sarcoma, glioblastoma, lung cancer, bladder cancer, carcinoma of the neck, melanoma, ovarian cancer, prostate cancer, breast cancer, small-cell lung cancer, glioma, colorectal carcinoma, urogenital cancer and gastrointestinal carcinoma as well as haematological cancers, such as multiple myeloma), psoriasis, arthritis (e.g. rheumatoid arthritis), haemangioma, angiofibroma, eye diseases (e.g. diabetic retinopathy), neovascular glaucoma, kidney diseases (e.g. glomerulonephritis), diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy, fibrotic diseases (e.g. cirrhosis of the liver), mesangial cell proliferative diseases, arteriosclerosis and damage to the nerve tissue and also for inhibiting the reocclusion of blood vessels after treatment with a balloon catheter, in vascular prosthetics or after the insertion of mechanical devices for keeping blood vessels open (e.g. stents), or other diseases in which cell proliferation or angiogenesis are involved.<br>
By reason of their biological properties the compounds according to the invention may be used on their own or in conjunction with other pharmacologically active compounds, for example in tumour therapy, in monotherapy or in conjunction<br><br>
with other anti-tumour therapeutic agents, for example in combination with topoisomerase inhibitors (e.g. etoposide), mitosis inhibitors (e.g. vinblastin, taxol), compounds which interact with nucleic acids (e.g. cis-platin, cyclophosphamide, adriamycin), hormone antagonists (e.g. tamoxifen), inhibitors of metabolic processes (e.g. 5-FU etc.), cytokines (e.g. interferons), kinase inhibitors, antibodies, or in conjunction with radiotherapy, etc. These combinations may be"administered either simultaneously or sequentially.<br>
For pharmaceutical use the compounds according to the invention are generally used for warm-blooded vertebrates, particularly humans, in doses of 0.01-100 mg/kg of body weight, preferably 0.1-20 mg/kg. For administration they are formulated with one or more conventional inert carriers and/or diluents, e.g. with corn starch, lactose, glucose, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethylene glycol, propylene glycol, stearyl alcohol, carboxymethylcellulose or fatty substances such as hard fat or suitable mixtures thereof in conventional galenic preparations such as plain or coated tablets, capsules, powders, injectable solutions, ampoules,  suspensions, solutions, sprays or suppositories.The Examples which follow are intended to illustrate the invention:<br>
Abbreviations used:<br>
FMOC =   9-fluorenylmethoxycarbonyl<br>
HOBt =   1-hydroxy^lH-benzotriazole<br>
TBTU =   0-benzotriazol-l-yl-N,N,N" ,N" -tetramethyluronium-tetrafluoroborate<br>
DBU =    1,8-diazabicyclo[5.4.0]undec-7-ene<br>
Preparation of the starting compounds:<br>
Solid phase Example I<br>
2.0 g of Rink resin (MBHA resin, made by Messrs Novabiochem) are left to swell in 30 ml of dimethylformamide. Then 40 ml of 30% piperidine in dimethylformamide are added and the mixture is shaken for 7 minutes to cleave the FMOC protecting group. The resin is then washed repeatedly with dimethylformamide. Then 0.4 g of 2-indolinone-6-carboxylic acid (prepared analogously to Langenbeck"et al., Justus Liebigs Ann. Chem. 4 99, 201-208 (1932)), 297 mg HOBt, 706 mg TBTU and 0.9 ml of N-ethyl-diisopropylamine in 30 ml of dimethylformamide are added and the mixture is shaken for 1 hour. Then the solution is suction filtered and the resin is washed five times with 3 0 ml of dimethylformamide and three times with 3 0 ml of methylene chloride. To dry it, nitrogen is blown through the resin. Yield: 1.9 g of charged resinSolid phase example II<br>
1.9 g of the resin obtained in Example I are stirred with 6 ml of acetic anhydride and 6 ml of triethyl orthobenzoate for 3 hours at 110°C. Then the mixture is left to cool and the resin is washed with dimethylformamide and subsequently with methylene chloride. Yield: 1.9 g of moist resin<br>
The following charged resins are prepared analogously to Example II:<br>
(1)	resin charged with 3-Z-(1-ethoxy-methylene)-6-carbamoyl-2-<br>
indolinone<br>
Prepared by reacting the resin obtained according to Example I with triethyl orthoformate<br>
(2)	resin charged with 3-Z-(1-methoxy-1-methyl-methylene)-6-<br>
carbamoyl-2 -indolinone<br>
Prepared by reacting the resin obtained according to Example I with trimethyl orthoacetate<br>
(3)	resin charged with 3-Z-(1-methoxy-l-ethyl-methylene)-6-<br>
carbamoyl-2 -indolinone<br>
Prepared by reacting the resin obtained according to Example" I with trimethyl orthopropionate<br>
(4)	resin charged with 3-Z-(1-methoxy-l-propyl-methylene)-6-<br>
carbamoyl-2-indolinone<br>
Prepared by reacting the product of Example I and trimethyl orthobutyrate<br>
Example III<br>
N-(4-nitrophenyl)-N-methyl-methanesulphonamide 3.0 g of N-methyl-4-nitroaniline are dissolved in 2 0 ml of pyridine and 2.4 g of methanesulphonic acid chloride added dropwise at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is poured onto water, the precipitate formed is filtered off and dried at 50°C in  vafcuo.<br>
Yield: 4.0 g (87 % of theory),<br>
Rf value: 0.5 (silica gel, ethyl acetate/toluene = 7:3)<br>
Melting point: 107-108 °C<br>
Example IV<br>
N-(2-dimethylamino-ethvl)-N-methylsulphonyl-4-nitroaniline 38.9 g of N-methylsulphonyl-4-nitroaniline are dissolved in 2.0 1 of acetone, 51.9 g of l-chloro-2-dimethylamino-ethane, 77.4 g of potassium carbonate and 5.0 g of sodium iodide are added and the mixture is stirred for a total of 4 days at 50°C, while after 12 hours a further 25.9 g of l-chloro-2-dimethylamino-ethane, 49.8 g of potassium carbonate and 5.0 g of sodium iodide in 500 ml of acetone are added and after 3 6 hours another 26.0 g of l-chloro-2-dimethylamino-ethane, 50.0 g of potassium carbonate and 5.0 g of sodium iodide in 100 ml of acetone are added. After this time the mixture is filtered and the filtrate evaporated down. The residue is stirred with ether, suction filtered and dried at 40°C. Yield: 25.3 g (49 % of theory),<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia = 9:1:0.1)<br>
ESI  mass  spectrum: m/z  = 288   [M-t-H+l<br>
The following compounds are prepared analogously to Example IV:<br>
(1)	4- [N-(3-dimethylamino-propyl)-N-methylsulphonyl-amino]-nitrobenzene<br>
(2)	N-carboxymethyl-N-methylsulphonyl-4-nitroaniline<br>
(3)	N-cyanomethyl-N-methylsulphonyl-p-phenylenediamine<br>
(4)	4- [N- (2- (N-benzyl-N-methyl-amino) -ethyl) -li¬me thyl sulphonyl-amino] -nitrobenzene<br>
(5)	4- [N-(3-phthalimido-2-yl-propyl)-N-methylsulphonyl-amino]-nitrobenzene<br>
(6)	4-[N- (3-(N-benzyl-N-methyl-amino)-propyl)-N-<br>
methylsulphonyl-amino]-nitrobenzene<br>
Example V<br>
N-(dimethylaminocarbonyl-methyl)-N-methylsulphonyl-4-<br>
nitroaniline	_____<br>
7.0 g of N-carboxymethyl-N-methylsulphonyl-4-nitroaniline, 2.5 g of dimethylamine hydrochloride, 8.1 g of TBTU and 3.9 g of HOBT are dissolved in 125 ml of dimethylformamide and at 0°C 17.6 ml of N-ethyl-diisopropylamine are added. The mixture is stirred for 4 hours at room temperature, diluted with 1 1 of water and the precipitate formed is suction filtered. After washing with water, ethanol and ether the residue is dried at 70°C in  vacuo.<br>
Yield: 5.3 g (69 % of theory),<br>
Rf value:   0.40    (silica  gel,   methylene  chloride/methanol   =   9:1)<br>
C11H1SN305S<br>
ESI   mass   spectrum:   m/z   =   300    [M-H~]The following compounds are prepared analogously to Example V:<br>
(1)	4-[(N-dimethylaminocarbonylmethyl)-amino] -nitrobenzene<br>
■prepared from 4-(N-carboxymethyl-amino)-nitrobenzene and<br>
dimethylamine hydrochloride<br>
(2)	4-(N-methylaminocarbonylmethyl-N-methylsulphonyl-amino)-<br>
nitrobenzene      .,"<br>
Prepared from N-carboxymethyl-N-methylsulphonyl-4-nitroaniline and rnethylamine hydrochloride<br>
(3)	4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]-<br>
nitrobenzene<br>
Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]-nitrobenzene and rnethylamine hydrochloride<br>
(4)	4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)-methyl]-<br>
nitrobenzene<br>
Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]-nitrobenzene and dimethylamine hydrochloride<br>
Example VI<br>
4-fN-(2-dimethvlamino-ethvl)-N-acetyl-amino]-nitrobenzene 3.6 g of 4-(2-dimethylamino-ethylamino)-nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969)) are dissolved in 50 ml of methylene chloride and 5.0 ml of triethylamine are added. 1.3 ml of acetyl chloride are slowly added dropwise to this mixture at room temperature and the mixture is stirred for 2 hours at room temperature. After this time another 5.0 ml of triethylamine and 1.3 ml of acetylchloride are added and the mixture is refluxed for another 2 hours. The solvent is removed, the residue is taken up in ethyl acetate and the organic phase is extracted twicewith water. After drying over MgS04 the solvent is removed and the residue dried in  vacuo.<br>
Yield: 2.0 g (45 % of theory),<br>
Rf value: 0.55 (silica gel, methylene<br>
chloride/methanol/ammonia = 9:1:0.1)<br>
C12H17N303<br>
ESI mass spectrum: m/z = 252 [M+H+]<br>
The following compounds are prepared analogously to Example VI:<br>
(1)	4-[N-(3-dimethylamino-propyl)-N-acetyl-amino]-nitrobenzene<br>
Prepared from 4-(3-dimethylamino-propylamino)-nitrobenzene<br>
(according to Gabbay et al., J. Am. Chem. Soc. 91,   5136 (1969)<br>
and acetyl chloride<br>
(2)	4-[N-(2-dimethylamino-ethyl)-N-propionyl-amino]-<br>
nitrobenzene<br>
Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and propionyl chloride<br>
(3)	4- [N-acetyl-N-(dimethylaminocarbonylmethyl)-amino]-<br>
nitrobenzene<br>
Prepared from 4-[N-(dimethylaminocarbonylmethyl)-amino]-nitrobenzene and acetyl chloride<br>
(4)	4-[N-(2-dimethylamino-ethyl)-N-butyryl-amino]-nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and butyryl chloride<br>
(5)	4-[N-(2-dimethylamino-ethyl)-N-isobutyryl-amino]-nitrobenzene<br>
Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and isobutyryl chloride<br><br><br><br>
(6)	4-[N-(2-dimethylamino-ethyl)-N-benzoyl-amino]-nitrobenzene Prepared from 4-(2-dimethylamxno-ethylamino)-nitrobenzene and benzoyl chloride<br>
(7)	4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-1,3-dinitrobenzene<br>
Prepared from 4 -(2-dimethylamino-ethyl-amino)-1,3 -dinitrobenzene and acetyl chloride<br>
(8)	4-[N-(2-dimethylamino-ethyl)-N-(furan-2-carbonyl)-amino]-<br>
nitrobenzene<br>
Prepared from 4-(2-dimethylamxno-ethylamino)-nitrobenzene and furan-2-carbonyl chloride<br>
(9)	4-[N-(2-dimethylamino-ethyl)-N-(2-methoxy-benzoyl)-amino]-<br>
nitrobenzene<br>
Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and 2-methoxy-benzoyl chloride<br>
(10)	4-[N-(2-dimethylamino-ethyl)-N-(pyridine-3-carbonyl)-<br>
amino]-nitrobenzene<br>
Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and nicotinic acid chloride<br>
(11)	4-[N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)-amino]-<br>
nitrobenzene<br>
Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and phenylacetyl-chloride<br>
(12)	4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-3-bromo-<br>
nitrobenzene<br>
Prepared from 4-[N-(2-dimethylamino-ethyl)-amino]-3-bromo-nitrobenzene and acetyl chloride<br>
(13)	N-acryloyl-N-methyl-4-nitro-aniline <br><br>
Prepared from 4-methylamino-nitrobenzene and acrylic acid chloride<br>
(14)	N-acryloyl-N-isopropyl-4-nitro-aniline<br>
Prepared from 4-isopropylamino-nitrobenzene and acrylic acid chloride<br>
(15)	N-acryloyl-N-benzyl-4-nitro-aniline<br>
Prepared from 4-ben.zylamino-nitrobenzene and acrylic acid chloride<br>
(16)	N-bromoacetyl-N-methyl-4-nitro-aniline<br>
Prepared from 4-methylamino-nitrobenzene and bromoacetyl chloride<br>
(17)	N-bromoacetyl-N-isopropyl-4-nitro-aniline<br>
Prepared from 4-isopropylamino-nitrobenzene and bromoacetyl chloride<br>
(18)	N-bromoacetyl-N-benzyl-4-nitro-aniline<br>
Prepared from 4-benzylamino-riitrobenzene and bromoacetyl chloride<br>
Example VII<br>
N-(dimethylaminomethvlcarbonyl)-N-methyl-4-nitro-aniline 1.8 g of dimethylamine hydrochloride and 5.5 g of potassium carbonate are placed in 8 0 ml of acetone and 4.2 g of N-bromoacetyl-N-methyl-4-nitroaniline are added in three batches at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is filtered and the filtrate is evaporated down. The residue is dissolved in ethyl acetate,, washed twice with water,, dried over sodium sulphate and finally concentrated by rotary evaporation. Yield: 2.8 g (79 % of theory), Rf value: 0.5 (silica gel, ethyl acetate/methanol = 7:3)<br>
Melting point: 121-122°C<br>
The following compounds are prepared analogously to Example VII:<br>
(1)	N-(piperidin-1-yl-methylcarbonyl)-N-methyl-4-nitroaniline<br>
(2)	N-(morpholin-4-yl-methylcarbonyl)-N-methyl-4-nitroaniline<br>
(3)	N-[(4-benzyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(4)	N-(pyrrolidin-1-yl-methylcarbonyl)-N-methyl-4-nitroaniline<br>
(5)	N-[(N-aminocarbonylmethyl-N-methyl-amino)-methylcarbonyl]-N-methyl-4-nitroaniline<br><br>
(6)	N-[(N-benzyl-N-methyl-amino)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(7)	N-[di-(2-methoxyethyl)-amino-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(8)	N-(dimethylaminomethylcarbonyl)-N-isopropyl-4-nitro-aniline<br>
(9)	N-(piperidin-1-yl-methylcarbonyl)-N-isopropyl-4-nitro-aniline<br><br>
(10)	N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-isopropyl-4-nitro-aniline<br>
(11)	N-[(N-benzyl-N-methyl-amino)-methylcarbonyl]-N-benzyl-4-nitro-aniline<br>
(12)	N-(dimethylaminomethylcarbonyl)-N-benzyl-4-nitro-aniline <br>
(13)	N-(piperidin-1-yl-methylcarbonyl)-N-benzyl-4-nitro-aniline<br>
(13)	N-[di-(2-hydroxyethyl)-amino-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(14)	N-[(N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(15)	N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(16)	N-[(4-methyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
(17)	N- [ (imidazol-1-yl) -methylcarbonyl] -N-"methyl-4-nitroaniline<br>
(18)	N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-4-nitroaniline<br>
Example VIII<br>
N-f(2-dimethylamino-ethyl)-carbonvl]-N-benzvl-4-nitro-aniline 0.5 g of dimethylamine hydrochloride, 1.1 ml of triethylamine and 1.2 g of N-acryloyl-N-benzyl-4-nitro-aniline are dissolved in 50 ml of methanol and stirred for 24 hours at room temperature. After this time the mixture is evaporated down. The residue is purified over an aluminium oxide column (activity 2-3) with methylene chloride/ethanol 50:1 as eluant. Yield: 1.4 g (98 % of theory),<br>
Rf value: 0.8 (aluminium oxide, methylene chloride/ethanol = 20:1) Melting point: 73°C<br><br>
The following compounds are prepared analogously to Example VIII:<br>
(1)	N-[(2-dimethylamino-ethyl)-carbonyl] -N-isopropyl-4-nitro-<br>
aniline<br>
Prepared from N-acryloyl-N-isopropyl-4-nitro-aniline and dimethylamine hydrochloride<br>
(2)	N- [ (2-dimethylathino-ethyl) -carbonyl] -N-methyl-4-nitro-<br>
aniline<br>
Prepared from N-acryloyl-N-methyl-4-nitro-aniline and dimethylamine hydrochloride<br>
(3)	N- [(2-(4-tert.butoxycarbonyl-piperazin-1-yl)-ethyl)-<br>
carbonyl]-N-methyl-4-nitro-aniline<br>
Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-tert.butoxycarbonyl-piperazine<br>
(4)	N-[(2-(piperidin-1-yl)-ethyl)-carbonyl] -N-methyl-4-nitro-<br>
aniline<br>
Prepared from N-acryloyl-N-methyl-4-nitro-aniline and piperidine<br>
(5)	N-[(2-(N-benzyl-N-methyl-amino)-ethyl)-carbonyl]-N-methyl-<br>
4-nitro-aniline<br>
Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-benzyl-N-methyl-amine<br>
Example IX<br>
4-(4-methyl-piperazine-l-yl)-nitrobenzene	<br>
31.5 g of 4-chloro-l-nitrobenzene and 44.4 ml of 1-methylpiperazine are combined and stirred for 18 hours at 90°C. Then the solution is poured onto ice water and the precipitate formed is suction filtered, washed with water and<br><br>
recrystallised from ethanol/water 1:1. The residue is dried in<br>
vacuo  at 75°C.<br>
Yield: 44.0 g (99 % of theory),<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
Melting point: 108-112°C<br>
The following compounds are prepared analogously to Example IX:<br>
(1)	N-(2-dimethylaminoethyl)-N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and l-dimethylamino-2-methylamino-ethane<br>
(2)	N-(3-dimethylaminopropyl)-N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and l-dimethylamino-3-methylamino-propane<br><br>
(3)	4-(N-carboxymethyl-amino)-nitrobenzene Prepared from 1-fluoro-4-nitrobenzene and glycine<br>
(4)	N-cyclohexyl-p-phenylenediamine<br>
Prepared from 1-fluoro-4-nitrobenzene and cyclohexylamine<br>
(5)	6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-<br>
phthalimido-2-yl-nitrobenzene<br>
Prepared from 2-nitro-4-phthalimido-2-yl-fluorobenzene, N-(2-dimethylamino-ethyl)-methanesulphonamide and sodium hydride as base<br>
(6)	6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-1,3-<br>
dinitrobenzene<br>
Prepared from 2,4-dinitro-chlorobenzene, N-(2-dimethylamino-ethyl) -methanesulphonamide and sodium hydride as base<br><br><br>
(7)	4-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-<br>
chloro-nitrobenzene<br>
Prepared from 2-fluoro-5-nitro-chlorobenzene, N-(2-dimethyl¬amino-ethyl) -methanesulphonamide and sodium hydride as base<br>
(8)	4-(2-dimethylamino-ethyl-amino)-1, 3-dinitrobenzene Prepared from l-chloro-2,4-dinitro-benzene and N, N-dimethyl-ethylenediamine<br>
(9)	4-[N-(2-dimethylamino-ethyl)-N-(ethylsulphonyl)-amino]-nitrobenzene<br>
Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl) -ethanesulphonamide and sodium hydride as base<br>
(10)	4- [N- (2-dimethylamino-ethyl) -N- (propylsulphonyl) -amino] -<br>
nitrobenzene<br>
Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl) -propanesulphonamide and sodium hydride as base<br>
(11)	4-[N-(2-dimethylamino-ethyl)-N-(butylsulphonyl)-amino]-<br>
nitrobenzene<br>
Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl) -butanesulphonamide and sodium hydride as base<br>
(12)	4- [N- (2-dimethylamino-ethyl) -N- (benzylsulphonyl) -amino] -<br>
nitrobenzene<br>
Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl) -C-phenylmethanesulphonamide and sodium hydride as base<br>
(13)	4- [N- (2-dimethylamino-ethyl) -N- (phenylsulphonyl) -amino] -<br>
nitrobenzene<br>
Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl) -benzenesulphonamide and sodium hydride as base<br>
(14)	4-[N-(2-dimethylamino-ethyl)-N-(isopropylsulphonyl)-<br>
amino]-nitrobenzene<br><br><br>
Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylamino-ethyl)-isopropylsulphonamide and sodium hydride as base<br>
(15)	4- [N-(2-dimethylamino-ethyl)-amino]-3-bromo-nitrobenzene Prepared from 2-bromo-l-fluoro-4-nitro-benzene and N,N-dimethyl-ethylenediamine<br>
(16)	4-isopropylamino-nitrobenzene<br>
Prepared from 1-flu6ro-4-nitrobenzene and isopropylamine<br>
(17)	4-benzylamino-nitrobenzene<br>
Prepared from 1-fluoro-4-nitrobenzene and benzylamine<br>
Example X<br>
4-(imidazol-4-vl)-nitrobenzene<br>
9.5 g of 2-phenylimidazole are carefully dissolved in 50 ml of<br>
concentrated sulphuric acid and 5.8 g of ammonium nitrate are<br>
added to this solution at 0°C. After a further 60 minutes<br>
stirring at 0°C the mixture is poured onto ice water, made<br>
basic with ammonia water and the precipitate formed is suction<br>
filtered and recrystallised from ethanol.<br>
Yield: 8.0 g (64 % of theory),<br>
Rf value:   0.6   (silica gel,   ethyl  acetate/ethanol   =  10:1)<br>
C9H7N302<br>
Mass spectrum: m/z = 189 [M+]<br>
The following compounds are prepared analogously to Example X:<br>
(1)	4 -(imidazol-2-yl)-nitrobenzene<br>
Prepared from 4-(imidazol-2-yl)-benzene<br>
(2)	4-(5-methyl-imidazol-4-yl)-nitrobenzene<br>
Prepared from 4-methyl-5-phenyl-imidazole (J. Heterocycl. Chem. 1983, 20, 1277-1281)<br><br>
Example XI<br>
4-(2-(imidazol-4-yl)-ethylene)-nitrobenzene<br>
1.5 g of 4-nitrobenzaldehyde and 7.45 g of (N-trityl-imidazol-4-yl-methyl)-triphenylphosphonium chloride are dissolved in 75 ml of tetrahydrofuran and to this solution 3.0 ml of DBU are added dropwise at room temperature. After a further 120 minutes stirring at room temperature the mixture is poured onto water and the precipitate formed is suction filtered. The product is taken up in 25 ml of IN hydrochloric acid and refluxed for 4 hours. After this time it is neutralised with ammoniacal water, extracted with ethyl acetate and the organic phase is washed with water, dried over sodium sulphate and evaporated down. The residue is purified over a silica gel column with methylene chloride/methanol 10:1 as eluant. Yield: 1.0 g of (47 % of theory),<br>
Rf value: 0.6 (silica gel, ethyl acetate/ethanol = 10:1) Melting point: 185-188°C<br>
Example XII<br>
4-(piperidin-1-yl-methvl)-nitrobenzene<br>
40.0 g of 4-nitrobenzyl bromide are dissolved in 500 ml of<br>
methylene chloride, 51.5 ml of triethylamine are added and<br>
18.3 ml of piperidine are carefully added dropwise. After the<br>
end of the exothermic reaction the mixture is refluxed for<br>
another 30 minutes. After cooling it is washed with water and<br>
the organic phase is dried over sodium sulphate. Finally, the<br>
organic phase is evaporated down.<br>
Yield: 36.3 g of, (89 % of theory),<br>
Rf value:   0.6   (silica gel,   methylene  chloride/methanol  =   9:1)<br>
C12H16N202<br>
Mass   spectrum:   m/z   =  221   [M+]<br><br>
The following compounds are prepared analogously to Example XII:<br>
(1)	4-[(2,6-dimethyl-piperidin-l-yl) -methyl]-nitrobenzene<br>
(2)	3-(N,N-dimethyl-aminomethyl)-nitrobenzene<br>
(3)	4-(N,N-dimethyl-aminomethyl)-nitrobenzene<br>
l<br>
(4)	4-(2-dimethylamino-ethyl)-nitrobenzene<br>
(5)	4-(2-diethylamino-ethyl)-nitrobenzene<br>
(6)	4-(diethylamino-methyl)-nitrobenzene<br>
(7)	4-(N-benzyl-N-methyl-aminomethyl) -nitrobenzene<br>
(8)	4-(N-ethyl-N-methyl-aminomethyl)-nitrobenzene<br>
(9)	4-[N-(n-hexyl)-N-methyl-aminomethyl]-nitrobenzene<br><br>
(10)	4-(thiomorpholin-4-yl-methyl)-nitrobenzene<br>
(11)	4-[(4-methyl-piperazine-l-yl) -methyl]-nitrobenzene<br>
(12)	4 -(imidazol-1-yl-methyl)-nitrobenzene<br>
(13)	4- [2- (4-hydroxy-piperidin-l-yl) -ethyl-amino] -nitrobenzene<br>
(14)	4- [ (3-hydroxy-pyrrolidin-l-yl) -methyl] -nitrobenzene<br>
(15)	4-(1,2,4-triazol-1-yl-methyl)-nitrobenzene<br>
(16)	4-(1,2,3-triazol-2-yl-methyl)-nitrobenzene<br>
(17)	4-(1,2,3-triazol-l-yl-methyl)-nitrobenzene<br><br><br>
(18)	4-[(N-ethoxycarbonylmethyl-N-methyl-amino)-methyl]-nitrobenzene<br>
(19)	4-[(N-aminocarbonylmethyl-N-methyl-amino)-methyl]-nitrobenzene<br>
(20)	4-(azetidin-1-yl-methyl)-nitrobenzene<br>
(21)	4-[(di-(2-methoxy-ethyl)-amino)-methyl]-nitrobenzene<br>
(22)	4-[N-(N-tert.butoxycarbonyl-3-amino-propyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(23)	4-[(N-propyl-N-methyl-amino)-methyl]-nitrobenzene<br>
(24)	4-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-methyl]-nitrobenzene<br>
(25)	4-[(N-(3-dimethylamino-propyl)-N-methyl-amino)-methyl]-nitrobenzene<br>
(26)	4-[(N-(2-methoxy-ethyl)-N-methyl-amino)-methyl]-nitrobenzene<br>
(27)	4-[(N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl]-nitrobenzene<br>
(28)	4-[(N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl]-nitrobenzene<br>
(29)	4-(3-oxo-piperazine-l-yl-methyl)-nitrobenzene<br><br><br>
Example XIII<br>
4-[(N-carboxymethvl-N-methyl-amino)-methyll-nitrobenzene<br>
7.33 g of 4-[(N-ethoxycarbonylmethyl-N-methyl-amino)-methyl] -<br>
nitrobenzene are dissolved in 140 ml of ethanol, 34.0 ml of IN<br>
sodium hydroxide solution are added and the mixture is stirred<br>
for half an hour at room temperature. After this time the<br>
mixture is neutralised with 34 ml of IN hydrochloric acid, the<br>
solvent removed, the residue taken up in methylene chloride<br>
and extracted with water.  The aqueous phase is evaporated<br>
down and the residue is recrystallised from methylene<br>
chloride.<br>
Yield: 5.43 g (84 % of theory),<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 2:1)<br>
C10H12N2O4<br>
Mass spectrum: m/z = 223 [M+]<br>
Example XIV<br>
4-(N-ethyl-aminomethyl)-nitrobenzene<br>
6.0 g of 4-nitrobenzyl bromide are dissolved in 25 ml of<br>
ethanol, combined with 25 ml of 10% ethanolic ethylamine<br>
solution and refluxed for 2 hours. Then the solution is<br>
concentrated by rotary evaporation, the residue is taken up<br>
with methylene chloride and washed with dilute sodium<br>
hydroxide solution. Finally the organic phase is evaporated<br>
down.<br>
Yield: 2.3 g (46 % of theory),<br>
R£ value:   0.2   (silica gel,   methylene  chloride/methanol   =   9:1)<br>
C9H12N202<br>
ESI mass spectrum: m/z = 179 [M-H~]<br>
The following compounds are prepared analogously to Example XIV:<br>
(1) 4-[N-(4-chlorobenzyl)-aminomethyl] -nitrobenzene<br><br>
(2)	4-(N-cyclohexyl-aminomethyl)-nitrobenzene<br>
(3)	4-(N-isopropyl-aminomethyl)-nitrobenzene<br>
(4)	4-(N-propyl-aminomethyl)-nitrobenzene<br>
(5)	4-(N-methyl-aminomethyl)-nitrobenzene<br>
(6)	4-(N-butyl-aminomethyl)-nitrobenzene<br>
(7)	4-(N-methoxycarbonylmethyl-aminomethyl)-nitrobenzene<br>
(8)	4-(N-benzyl-aminomethyl)-nitrobenzene<br>
(9)	4-(aminomethyl)-nitrobenzene<br><br>
(10)	4-(pyrrolidin-1-yl-methyl)-nitrobenzene<br>
(11)	4-(morpholin-4-yl-methyl)-nitrobenzene<br>
(12)	4-(hexamethyleneiminomethyl)-nitrobenzene<br>
(13)	4-(4-hydroxy-piperidin-1-yl-methyl)-nitrobenzene<br>
(14)	4-(4-methoxy-piperidin-1-yl-methyl)-nitrobenzene<br>
(15)	4-(4-methyl-piperidin-l-yl-methyl)-nitrobenzene<br>
(16)	4-(4-ethyl-piperidin-l-yl-methyl)-nitrobenzene<br>
(17)	4-(4-isopropyl-piperidin-l-yl-methyl)-nitrobenzene<br>
(18)	4-(4-phenyl-piperidin-l-yl-methyl)-nitrobenzene<br>
(19)	4-(4-benzyl-piperidin-l-yl-methyl)-nitrobenzene<br>
(2 0) 4-(4-ethoxycarbonyl-piperidin-1-yl-methyl)-nitrobenzene<br>
(21)	4-(N,N-dipropyl-aminomethyl)-nitrobenzene<br>
(22)	4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)-nitrobenzene<br>
(23)	4- (2-morpholinJ-4-yl-ethyl) -nitrobenzene<br>
(24)	4-(2-pyrrolidin-l-yl-ethyl)-nitrobenzene<br>
(25)	4-(2-piperidin-l-yl-ethyl)-nitrobenzene<br>
(26)	4-(N-ethyl-N-benzyl-aminomethyl)-nitrobenzene<br>
(27)	4-(N-propyl-N-benzyl-aminomethyl)-nitrobenzene<br>
(28)	4-[N-methyl-N-(4-chlorobenzyl)-aminomethyl]-nitrobenzene<br>
(29)	4-[N-methyl-N-(4-bromobenzyl)-aminomethyl] -nitrobenzene<br>
(30)	4-[N-methyl-N-(4-fluorobenzyl)-aminomethyl]-nitrobenzene<br>
(31)	4-[N-methyl-N-(4-methylbenzyl)-aminomethyl]-nitrobenzene<br>
(32)	4-[N-methyl-N-(3-chlorobenzyl)-aminomethyl]-nitrobenzene<br><br>
(33)	4-[N-methyl-N-(3,4-dimethoxybenzyl)-aminomethyl]-nitrobenzene<br>
(34)	4-[N-methyl-N-(4-methoxybenzyl)-aminomethyl]-nitrobenzene<br>
(35)	4-(N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl)-nitrobenzene<br>
(36)	4-[N-2,2,2-trifluoroethyl-N-(4-chlorobenzyl)-aminomethyl]-nitrobenzene<br>
(37)	4-(thiomorpholin-4-yl-methyl)-nitrobenzene<br>
(38)	4-(azetidion-1-yl-methyl)-nitrobenzene<br>
(39)	4-(3,4-dihydropyrrolidin-1-yl-methyl)-nitrobenzene<br>
(40)	4-(3,4-dihydropiperidin-l-yl-methyl)-nitrobenzene<br>
(41)	4- (2-methoxycarbonyl-pyrrolidin-l-yl-methyl) -nitrobenzene<br>
(42)	4- (3,5-dimethyl-piperidin-l-yl-methyl) -nitrobenzene<br>
(43)	4-(4-phenyl-piperazin-l-yl-methyl)-nitrobenzene<br>
(44)	4-(4-phenyl-4-hydroxy-piperidin-1-yl-methyl)-nitrobenzene<br><br>
(45)	4-[N-(3,4,5-trimethoxybenzyl-N-methyl-aminomethyl)-nitrobenzene<br>
(46)	4-[N-(3,4-dimethoxybenzyl)-N-ethyl-aminomethyl]-nitrobenzene<br>
(47)	4-[N-(2,6-dichlorobenzyl)-N-methyl)-aminomethyl]-nitrobenzene<br>
(48)	4-[N-(4-trifluoromethylbenzyl)-N-methyl)-aminomethyl] -nitrobenzene<br>
(49)	4-(N-benzyl-N-isopropyl-aminomethyl)-nitrobenzene<br>
(50)	4-(N-benzyl-N-tert.butyl-aminomethyl)-nitrobenzene<br>
(51)	4-(N,N-diisopropyl-aminomethyl)-nitrobenzene<br>
(52)	4-(N,N-diisobutyl-aminomethyl)-nitrobenzene<br>
(53)	4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-nitrobenzene<br>
(54)	4-(2,3-dihydro-isoindol-2-yl-methyl)-nitrobenzene<br>
(55)	4- (6, 7-dimetho*y-l, 2,3, 4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(56)	4-(l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br><br>
(57)	4-[N-(2-hydroxyethyl)-N-benzyl-aminomethyl]-nitrobenzene<br>
(58)	4-[N-(1-ethyl-pentyl)-N-(pyridin-2-yl-methyl)-aminomethyl]-nitrobenzene<br>
(59)	4-(piperin-1-yl-methyl)-1,3-dinitrobenzene<br>
(60)	4-(N-phenethyl-N-methyl-aminomethyl)-nitrobenzene<br>
(61)	4-[N-(3,4-dihydroxy-phenethyl)-N-methyl-aminomethyl]-nitrobenzene<br><br>
(62)	4-[N-(3, 4,5-trimethoxy-phenethyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(63)	4-[N-(3,4-dimethoxy-phenethyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(64)	4-[N-(3,4-dimethoxy-benzyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(65)	4-[N-(4-chloro-benzyl)-N-methyl-aminomethyl]-nitrobenzene(66)	4- [N-(4-bromo-benzyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(67)	4-[N-(4-fluoro-benzyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(68)	4- [N-(4-methyl-benzyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(69)	4-[N-(4-nitro-phenethyl)-N-methyl-aminomethyl]-nitrobenzene       "<br>
(70)	4-(N-phenethyl-N-benzyl-aminomethyl)-nitrobenzene<br>
(71)	4-(N-phenethyl-N-cyclohexyl-aminomethyl)-nitrobenzene<br>
(72)	4-[N-(2-(pyridin-2-yl)-ethyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(73)	4-[N-(2-(pyridin-4-yl)-ethyl)-N-methyl-aminomethyl]-nitrobenzene<br><br>
(74)	4-[N-(pyridin-4-yl-methyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(75)	4-(N,N-dibenzyl-aminomethyl)-nitrobenzene<br>
(76)	4-[N-(4-nitro-phenethyl)-N-propyl-aminomethyl]-nitrobenzene<br><br>
(77)	4-(N-benzyl-N-(3-cyano-propyl)-aminomethyl)-nitrobenzene<br>
(78)	4-(N-benzyl-N-allyl-aminomethyl)-nitrobenzene<br>
(79)	4-[N-benzyl-N-(2,2,2-trifluoroethyl)-aminomethyl]-<br>
nitrobenzene4-[N-(2-benzo(l,3)dioxol-5-yl-methyl)-N-methyl-aminomethyl]-nitrobenzene<br>
(80)	4-(7-chloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-nitrobenzene<br>
(81)	4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-nitrobenzene<br>
(82)	4-(7-methoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-nitrobenzene<br>
(83)	4- (7-rnethyl-2, 3,4, 5-tetrahydro-benzo(d) azepin-3-yl-methyl)-nitrobenzene<br>
(84)	4-(7,8-dimethoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-nitrobenzene<br>
(85)	4-(6,7-dichloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(86)	4-(6,7-dimethyl-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(87)	4-(6-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(88)	4-(7-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(89)	4-(6-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-nitrobenzene<br>
(90)	4-(7-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -nitrobenzene<br><br><br>
(92)	4-[(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl)-methyl]-nitrobenzene<br>
(93)	4-[(7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl)-methyl]-nitrobenzene<br>
(94)	4-[(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-yl)-methyl]-nitrobenzene<br>
(95)	4-[(5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-yl)-methyl]-nitrobenzene<br>
Example XV<br>
4-(1,l-dioxo-thiomorpholin-4-yl-methyl)-nitrobenzene<br>
6.0 g of 4-(thiomorpholin-4-yl-methyl)-nitrobenzene are<br>
dissolved in 100 ml of methylene chloride and 10.3 g of meta-<br>
chloroperbenzoic acid are slowly added. After a further 3<br>
hours stirring at room temperature the precipitate obtained is<br>
filtered off.<br>
Yield: 6.2 g (91 % of theory)<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 1:1)<br>
CnH14N204S<br>
Mass spectrum: m/z = 270 [M+]<br>
The following compound is prepared analogously to Example XV:<br>
(1) 4-(1-oxo-thiomorpholin-4-yl-methyl)-nitrobenzene<br>
Example XVI<br>
4-fN-(3-amino-propyl)-N-methvlsulphonyl-amino]-nitrobenzene 9.5 g of 4-[N-(3-phthalimido-2-yl-propyl)-N-methylsulphonyl-amino] -nitrobenzene are dissolved in 200 ml of ethanol, 11.5 ml of hydrazine hydrate are added and the mixture is stirred for 1.5 hours at 50 °C. After cooling the residue is largely<br><br><br>
evaporated down, water is added and the solution is extracted<br>
with methylene chloride.  The organic phase is dried,<br>
evaporated down and purified over a silica gel column with<br>
methylene chloride/methanol/ammonia 9:1:0.1.<br>
Yield: 2.5 g (39 % of theory)<br>
Rf value: 0.2 (silica gel, methylene chloride/methanol = 9:1)<br>
C10H15N3O4S<br>
ESI mass spectrum: m/z = 272 [M-H"]<br>
The following compound is prepared analogously to Example XVI:<br>
(1) 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-amino-nitrobenzene<br>
Prepared from 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-phthalimido-2-yl-nitrobenzene<br>
Example XVII<br>
4-(l-methyl-imidazol-2-yl)-nitrobenzene<br>
7.5 g of 4-(imidazol-2-yl)-nitrobenzene are dissolved in 50 ml<br>
of dimethylsulphoxide and at 0°C 5.0 g of potassium<br>
tert.butoxide are added. After one hour of stirring at room<br>
temperature 2.6 ml of methyl iodide are added dropwise and the<br>
mixture is stirred for one hour at room temperature. After<br>
this time the residue is poured onto ice water and the<br>
precipitate formed is suction filtered, washed with water and<br>
dried.<br>
Yield: 6.1 g (76 % of theory)<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 10:1)<br>
Melting point: 186-187°C<br><br>
The following compounds are prepared analogously to Example XVII:<br>
(1)	4-(l-ethyl-imidazol-2-yl)-nitrobenzene<br>
Prepared from 4-(imidazol-2-yl)-nitrobenzene and ethyl iodide<br>
(2)	4-(l-benzyl-imidazol-2-yl)-nitrobenzene<br>
Prepared from 4-(imidazol-2-yl)-nitrobenzene and benzyl<br>
bromide	
Example XVIII<br>
4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)-methyl]-<br>
nitrobenzene	<br>
5.0 g of 4-methylaminomethyl-nitrobenzene are dissolved in 30<br>
ml of dimethylformamide and 4.6 g of 2-(2-methoxy-ethoxy)-<br>
ethyl chloride are added. After six hours" stirring at 100°C<br>
the solvent is removed and the residue is taken up in ethyl<br>
acetate.  The organic phase is washed with water and dried<br>
over sodium sulphate. After the elimination of the solvent the<br>
residue is purified over an aluminium oxide column (activity<br>
2-3) with toluene/ethyl acetate 5:1 as eluant.<br>
Yield: 2.3 g (29 % of theory)<br>
Rf value: 0.5 (aluminium oxide, toluene/ethyl acetate = 5:1)<br>
C13H20N2O4<br>
ESI mass spectrum: m/z = 267 [M-H~]<br>
Example XIX<br>
4-(N-ethyl-N-tert.butoxvcarbonyl-aminomethyl)-nitrobenzene 2.2 g of 4-(ethylaminomethyl)-nitrobenzene are dissolved in 50 ml of ethyl acetate and stirred with 2.6 g of di-tert-butyl. dicarbonate (tert.butoxycarbonyl-anhydride) for 30 minutes at room temperature. Then the solution is washed with water and evaporated down. Yield: 3.4 g of theory<br><br><br>
Rf value:  0.3 (silica gel, methylene chloride/methanol =<br>
50:1)<br>
Melting point: 85 °C<br>
The following compounds are prepared analogously to Example XIX:<br>
(1)	4-[N-(4-chlorophenyl-methyl)-N-tert.butoxycarbonyl-aminomethyl] -nitrobenzene<br>
(2)	4-(N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br>
(3)	4-(N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br>
(4)	4-(N-isopropyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br><br>
(5)	4-(N-methyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br>
(6)	4-(N-propyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br>
(7)	4-(N-butyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br>
(8)	4-(N-methoxycarbonylmethyl-N-tert.butoxycarbonyl-aminomethyl) -nitrobenzene<br>
(9)	4-(N-benzyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene<br><br>
(10)	4- [N- (3-trifluoroacetylamino-propyl) -N-methylsulphonyl-<br>
amino]-nitrobenzene<br>
Prepared from 4- [N- (3-amino-propyl) -N-methylsulphonyl-amino] -nitrobenzene and trifluoroacetic acid anhydride<br>
(11)	4-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methyl] -<br>
nitrobenzene<br>
Example XX<br>
4-(piperidin-1-yl-methvl)-aniline<br>
37.0 g of 4-(piperidin-1-yl-methyl)-nitrobenzene are dissolved<br>
in 3 00 ml of methanol, 8.0 g of Raney nickel are added and the<br>
mixture is hydrogenated for 85 minutes with 3 bars of hydrogen<br>
at room temperature. The catalyst is filtered off and the<br>
filtrate is evaporated down.<br>
Yield: 24.0 g (75 % of theory),<br>
R£ value:   0.4   (silica gel,   methylene  chloride/methanol   =   9:1)<br>
C12H18N2<br>
ESI mass spectrum: m/z = 191 [M+H+]<br>
The following compounds are prepared analogously to Example VIII:<br>
(1)	4-[(2,6-dimethyl-piperidin-l-yl)-methyl]-aniline<br>
(2)	N-(2-dimethylamino-ethyl)-N-methylsulphonyl-p-phenylenediamine<br>
(3)	3-(dimethylaminomethyl)-aniline<br>
(4)	4-(dimethylaminomethyl)-aniline<br>
(5)	4-(2-dimethylamino-ethyl)-aniline<br>
(6)	4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-aniline<br><br>
(7)	4-[N-(3-dimethylamino-propyl)-N-acetyl-amino]-aniline<br>
(8)	4-[N-(2-dimethylamino-ethyl)-N-benzoyl-amino]-aniline<br>
(9)	4-[N-(2-dimethylamino-ethyl)-N-propionyl-amino]-aniline<br><br>
(10)	4-[N-(2-dimethylamino-ethyl)-N-butyryl-amino]-aniline<br>
(11)	4-[N-(2-dimethylamino-ethyl)-N-isobutyryl-amino]-aniline<br>
(12)	4-(N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(13)	4-(N-ethyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br><br>
(14)	4-[N-(4-chlorophenyl-methyl)-N-tert.butoxycarbonyl-aminomethyl] -aniline<br>
(15)	4-(N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(16)	4-(N-isopropyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(17)	4-(N-propyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(18)	4-(N-methyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(19)	4-(N-butyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(2 0) 4-(N-methoxycarbonyl-methyl-N-tert.butoxycarbonyl-aminomethyl) -aniline<br>
(21)	4-(N-benzyl-N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
(22)	4-(pyrrolidin-1-yl-methyl)-aniline<br><br>
(23)	4-(morpholin-4-yl-methyl)-aniline<br>
(24)	4- (hexamethyleneirninomethyl) -aniline<br>
(25)	4-(4-hydroxy-piperidin-l-yl-methyl)-aniline<br>
(26)	4-(4-methoxy-piperidin-1-yl-methyl)-aniline<br>
(27)	4-(4-methyl-piperidin-l-yl-methyl)-aniline<br>
(28)	4-(4-ethyl-piperidin-l-yl-methyl)-aniline<br>
(29)	4-(4-isopropyl-piperidin-l-yl-methyl)-aniline<br>
(30)	4-(4-phenyl-piperidin-l-yl-methyl)-aniline<br>
(31)	4-(4-benzyl-piperidin-l-yl-methyl)-aniline<br>
(32)	4-(4-ethoxycarbonyl-piperidin-l-yl-methyl)-aniline<br>
(33)	4-(N,N-dipropyl-aminomethyl)-aniline<br>
(34)	4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)-aniline<br>
(35)	4-(2-morpholin-4-yl-ethyl)-aniline<br>
(36)	4-(2-pyrrolidin-l-yl-ethyl)-aniline<br>
(37)	4-(2-piperidin-l-yl-ethyl)-aniline<br>
(38)	4-(N-propyl-N-benzyl-aminomethyl)-aniline<br>
(39)	4-[N-(n-hexyl)-N-methyl-aminomethyl]-aniline<br>
(40)	4-[N-methyl-N-(4-chlorobenzyl)-aminomethyl]-aniline<br><br>
41)	4-[N-methyl-N-(4-bromobenzyl)-aminomethylJ-aniline<br>
(42)	4-[N-methyl-N-(4-methylbenzyl)-aminomethyl]-aniline<br>
(43)	4-[N-methyl-N-(4-fluorobenzyl)-aminomethyl]-aniline<br>
(44)	4-[N-methyl-N-(3-chlorobenzyl)-aminomethyl]-aniline<br>
(45)	4-[N-methyl-N-(3,4-dimethoxybenzyl)-aminomethyl]-aniline<br>
(46)	4-[N-methyl-N-(4-methoxybenzyl)-aminomethyl]-aniline<br>
(47)	4-(N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl)-aniline<br>
(48)	4-[N-2,2,2-trifluoroethyl-N-(4-chlorobenzyl)-aminomethyl]-aniline<br>
(49)	4-(thiomorpholin-4-yl-methyl)-aniline<br>
(50)	4-(l-oxo-thiomorpholin-4-yl-methyl)-aniline<br>
(51)	4-(1,l-dioxo-thiomorpholin-4-yl-methyl)-aniline<br>
(52)	4-(azetidion-1-yl-methyl)-aniline<br>
(53)	4-(3,4-dihydropyrrolidin-l-yl-methyl)-aniline<br>
(54)	4-(3,4-dihydropiperidin-l-yl-methyl)-aniline<br>
(55)	4-(2-methoxycarbonyl-pyrrolidin-l-yi-methyl)-aniline<br>
(56)	4-(3,5 -dimethyl-piperidin-1-yl-methyl)-aniline<br>
(57)	4-(4-phenyl-piperazin-l-yl-methyl)-aniline<br>
(58)	4-(4-phenyl-4-hydroxy-piperidin-1-yl-methyl)-aniline<br><br>
(59)	4-[N-(3,4,5-trimethoxy-benzyl)-N-methyl-aminomethyl]-aniline<br>
(60)	4-[N-(3,4-dimethoxy-benzyl)-N-ethyl-aminomethyl]-aniline<br>
(61)	4-(N-benzyl-N-ethyl-aminomethyl)-aniline<br>
(62)	4-[N-(2,6-dichlorobenzyl)-N-methyl-aminomethyl]-aniline<br>
(63)	4-[N-(4-trifluoromethylbenzyl)-N-methyl-aminomethyl]-aniline<br>
(64)	4-(N-benzyl-N-isopropyl-aminomethyl)-aniline<br>
(65)	4-(N-benzyl-N-tert.butyl-aminomethyl)-aniline<br>
(66)	4-(diethylamino-methyl)-aniline<br>
(67)	4-(2-diethylamino-ethyl)-aniline<br>
(68)	4-(N,N-diisopropyl-aminomethyl)-aniline<br>
(69)	4-(N,N-diisobutyl-aminomethyl)-aniline<br>
(70)	4-(2,3,4,5-tetrahydro~benzo(d)azepin-3-yl-methyl)-aniline<br>
(71)	4-(2,3-dihydro-isoindol-2-yl-methyl)-aniline<br><br>
(72)	4-(6,7-dimethoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-aniline<br>
(73)	4-(l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-aniline<br>
(74)	4-[N-(2-hydroxy-ethyl)-N-benzyl-aminomethyl]-aniline<br><br>
75)	4- [N-(1-ethyl-pentyl)-N-(pyridin-2-yl-methyl)-<br>
aminomethyl]-aniline<br>
(76)	4-(piperidin-1-yl-methyl)-3-nitro-aniline<br>
(77)	4-(piperidin-1-yl-methyl)-3-amino-aniline<br>
(78)	4-(N-benzyl-N-methyl-aminomethyl)-aniline<br>
(79)	4-(N-ethyl-N-methyl-aminomethyl)-aniline<br>
(80)	4-(N-phenethyl-N-methyl-aminomethyl)-aniline<br><br>
(81)	4-[N-(3,4-dihydroxy-phenethyl)-N-methyl-aminomethyl]-aniline<br>
(82)	4-[N-(3,4,5-trimethoxy-phenethyl)-N-methyl-aminomethyl] -aniline<br>
(83)	4- [N-(3,4-dimethoxy-phenethyl)-N-methyl-aminomethyl]-aniline<br>
(84)	4- [N-(3,4-dimethoxy-benzyl)-N-methyl-aminomethyl]-aniline<br>
(85)	4- [N- (4-chloro-benzyl)-N-methyl-aminomethyl]-aniline<br>
(86)	4-[N-(4-bromo-benzyl)-N-methyl-aminomethyl]-aniline<br>
(87)	4- [N- (4-fluoro-benzyl)-N-methyl-aminomethyl]-aniline<br>
(88)	4-[N-(4-methyl-benzyl)-N-methyl-aminomethyl]-aniline<br>
(89)	4- [N-(4-nitro-phenethyl)-N-methyl-aminomethyl]-aniline<br>
(90)	4-(N-phenethyl-N-benzyl-aminomethyl)-aniline<br><br><br>
(91)	4-(N-phenethyl-N-cyclohexyl-aminomethyl)-aniline<br>
(92)	4-[N-(2-(pyridin-2-yl)-ethyl)-N-methyl-aminomethyl]-aniline<br>
(93)	4-[N-(2-(pyridin-4-yl)-ethyl)-N-methyl-aminomethyl]-aniline<br>
(94)	4-[N-(pyridin-4-yl-methyl)-N-methyl-aminomethyl]-aniline<br>
(95)	4-(N,N-dibenzylaminomethyl)-aniline<br>
(96)	4-[N-(4-nitro-benzyl)-N-propyl-aminomethyl]-aniline<br>
(97)	4-[N-benzyl-N-(3-cyano-propyl)-aminomethyl]-aniline<br>
(98)	4-(N-benzyl-N-allyl-aminomethyl)-aniline<br>
(99)	4-[N-benzyl-N-(2,2,2-trifluoroethyl)-aminomethyl]-aniline<br><br>
(100)	4-[(benzo(1,3)dioxol-5-yl-methyl)-methyl-aminomethyl]-aniline<br>
(101)	4-(7-chloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-aniline<br><br>
(102)	4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-aniline<br>
(103)	4-(7-methoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-aniline<br>
(104)	4-(7-methyl-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-aniline<br><br><br>
(105) 4-(7,8-dimethoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-aniline<br>
(10 6) 4-(6,7-dichloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-aniline<br>
(107)	4-(6,7-dimethyl-1,2,3,4-tetrahydro-isoquinolin-2-yl-<br>
methyl)-aniline<br>
(108)	4-(6-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -<br>
aniline<br>
(109)	4-(7-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -aniline<br>
(110)	4-(6-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-aniline<br>
(111)	4-(7-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)-aniline<br>
(112)	4-(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl-methyl)-aniline<br>
(113)	4-(7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl-methyl)-aniline<br>
(114)	4-(2-amino-5,6,7,8-tetrahydro-azepino(4, 5-d)thiazol-6-yl-methyl)-aniline<br>
(115)	4-(5,6,7,8-tetrahydro-azepino(4, 5-d) thiazol-6-yl-methyl) -aniline<br><br>
(116)	4-(4-methyl-piperazin-l-yl)-aniline<br>
(117)	4-[N-(2-dimethylamino-ethyl)-N-methyl-amino]-aniline<br><br>
(118)	4-[N-(3-dimethylamino-propyl)-N-methyl-amino]-aniline<br>
(119)	N-(3-dimethylamino-propyl)-N-methylsulphonyl-p-phenylenediamine<br>
(12 0) 4-[(N-dimethylaminocarbonylmethyl-N-methylsulphonyl)-amino]-aniline<br>
(121)	N-(4-aminophenyl)-N-methyl-methanesulphonamide<br>
(122)	4-(imidazol-4-yl)-aniline<br>
(123)	4-(tetrazol-5-yl)-aniline<br>
(124)	4-[N-(2-dimethylamino-ethyl)-N-propionyl-amino]-aniline<br><br>
(125)	N-(dimethylaminomethylcarbonyl)-N-methyl-p-phenylenediamine<br>
(126)	N-[(2-dimethylamino-ethyl)-carbonyl]-N-methyl-p-phenylenediamine<br><br>
(127)	4-(N-acetyl-N-dimethylaminocarbonylmethyl)-amino)-aniline<br>
(128)	N-methylaminocarbonylmethyl-N-methylsulphonyl-p -phenylenediamine<br>
(12 9) N-aminocarbonylmethyl-N-methylsulphonyl-p-phenylenediamine<br>
(130)	4-(imidazolidin-2,4-dion-5-ylidene-methyl)-aniline<br>
(131)	4-(imidazolidin-2,4-dion-5-yl-methyl)-aniline<br><br><br>
(132)	4-(2-oxo-pyrrolidin-l-yl-methyl)-aniline<br>
(133)	N-cyanomethyl-N-methylsulphonyl-p-phenylenediamine<br>
(134)	4-[2-(imidazol-4-yl)-ethyl] -aniline<br>
(135)	4-[(4-methyl-piperazin-l-yl)-methyl]-aniline<br>
(136)	4- [N- (2- (N-bejizyl-N-methyl-amino) -ethyl) -N-methylsulphonyl-amino]-aniline<br>
(137)	4-[N-(3-(N-benzyl-N-methyl-amino)-propyl)-N-methylsulphonyl-amino]-aniline<br>
(13 8) N-cyclohexyl-p-phenylenediamine<br>
(13 9) 4-(pyridin-4-yl-methyl)-aniline<br>
(140)	4-(imidazol-1-yl-methyl)-aniline<br>
(141)	4-benzyl-aniline<br>
(142)	N-(3-trifluoroacetylamino-propyl)-N-methylsulphonyl-p-phenylenediamine<br>
(143)	tert.butyl 4-amino-phenylacetate<br>
(144)	4-(imidazol-2-yl)-aniline<br>
(145)	4-(l-methyl-imidazol-2-yl)-aniline<br>
(14G)	4-(l-ethyl-imidazol-2-yl)-aniline<br>
(147)	4-(l-benzyl-imidazol-2-yl)-aniline<br>
(148)	4-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-amino-ani1ine<br>
(149)	4-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3-chloro-aniline<br>
(150)	4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-3-amino-aniline<br>
(151)	4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-3-bromo-aniline<br>
(152)	4-[2-(4-hydroxy-piperidin-l-yl)-ethyl-amino]-aniline<br>
(153)	N-(2-dimethylamino-ethyl)-N-ethylsulphonyl-p-phenylenediamine<br><br>
(154)	N-(2-dimethylamino-ethyl)-N-propylsulphonyl-p-phenylenediamine<br>
(155)	N-(2-dimethylamino-ethyl)-N-isopropylsulphonyl-p-phenylenediamine<br>
(156)	N-(2-dimethylamino-ethyl)-N-butylsulphonyl-p-phenylenediamine<br>
(157)	N-(2-dimethylamino-ethyl)-N-benzylsulphonyl-p-phenylenediamine<br>
(158)	N-(2-dimethylamino-ethyl)-N-phenylsulphonyl-p-phenylenediamine<br>
(159)	4-((3-hydroxy-pyrrolidin-l-yl)-methyl)-aniline<br>
(160)	4-[N-(2-dimethylamino-ethyl)-N-(furan-2-carbonyl)-<br>
amino]-aniline<br>
(161)	4-[N-(2-dimethylamino-ethyl)-N-(2-methoxy-benzoyl)-amino]-aniline<br>
(162)	4-[N-(2-dimethylamino-ethyl)-N-(pyridine-3-carbonyl)-amino]-aniline<br>
(163)	4-[N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)-amino]-aniline	.,"<br>
(164)	N-(piperidin-1-yl-methylcarbonyl)-N-methyl-p-phenylenediamine<br>
(165)	N-(morpholin-4-yl-methylcarbonyl)-N-methyl-p-phenylenediamine<br>
(166)	N- [ (4-benzyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine<br>
(167)	N-(pyrrolidin-1-yl-methylcarbonyl)-N-methyl-p-phenylenediamine<br>
(168)	4-(5-methyl-imidazol-4-yl)-aniline<br>
(169)	N-[(2-dimethylamino-ethyl)-carbonyl]-N-isopropyl-p-phenylenediamine<br>
(170)	N-[(2-dimethylamino-ethyl)-carbonyl]-N-benzyl-p-phenylenediamine<br>
(171)	N-(N-aminocarbonylmethyl-N-methyl-amino)-methylcarbonyl)-N-methyl-p-phenylenediamine<br>
(172)	N-[(N-benzyl-N-methyl-amino)-methylcarbonyl]-N-methyl-p-phenylenediamine<br><br>
(173)	N-[di-(2-methoxyethyl)-amino-methylcarbonyl]-N-methyl-p-phenylenediamine<br>
(174)	N- f (2- (4-tert.butoxycarbonyl-piperazin-1-yl)-ethyl)-carbonyl]-N-methyl-p-phenylenediamine<br>
(175)	N-[(2-(piperidin-1-yl)-ethyl)-carbonyl]-N-methyl-p-phenylenediamine<br>
(176)	N-[(2-(N-benzyl-N-methyl-amino)-ethyl)-carbonyl]-N-methyl-p-phenylenediamine<br>
(177)	N-(dimethylaminomethylcarbonyl)-N-isopropyl-p-phenylenediamine<br>
(178)	N-(piperidin-1-yl-methylcarbonyl)-N-isopropyl-p-phenylenediamine<br>
(179)	N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-isopropyl-p-phenylenediamine<br>
(180)	N- [ (N-benzyl-N-methyl-amino) -methylcarbonyl]-N-benzyl-p-phenylenediamine<br>
(181)	N-(dimethylaminomethylcarbonyl)-N-benzyl-p-phenylenediamine<br>
(182)	N-(piperidin-1-yl-methylcarbonyl)-N-benzyl-p-phenylenediamine<br>
(183)	4-(1,2,4-triazol-l-yl-methyl)-aniline<br>
(184)	4-(1,2,3-triazol-2-yl-methyl)-aniline<br>
(185)	4-(1,2,3-triazol-l-yl-methyl)-aniline<br><br>
(186)	4-[(N-ethoxycarbonylmethyl-N-methyl-amino)-methyl]-aniline<br>
(187)	4-[(N-aminocarbonylmethyl-N-methyl-amino)-methyl]-aniline<br>
(188)	4-(azetidin-1-yl-methyl)-aniline<br>
(189)	4-[(di-(2-methoxy-ethyl)-amino)-methyl]-aniline<br>
(190)	4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)-methyl]-aniline<br>
(191)	4-[N-(N-tert.butoxycarbonyl-3-amino-propyl)-N-methyl-<br>
aminomethyl]-aniline<br>
(192)	4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]-aniline<br>
(193)	4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)-methyl]-aniline<br>
(194)	4-[(N-propyl-N-methyl-amino)-methyl] -aniline<br>
(195)	4-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-methyl]-<br>
aniline<br>
(196)	4- [ (N-(3-dimethylamino-propyl)-N-methyl-amino)-methyl]-aniline<br>
(197)	4-[(N-(2-methoxy-ethyl)-N-methyl-amino)-methyl]-aniline<br>
(198)	4-[(N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl]-aniline<br>
(199)	4-[(N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl]-aniline<br><br><br>
(200)	4-(3-oxo-piperazin-l-yl-methyl)-aniline<br>
(201)	N-[di-(2-hydroxyetttyl)-amino-methylcarbonyl]-N-methyl-p-<br>
phenylenediamine<br>
(202)	N- [ (N- (2-methoxyethyl) -N-methyl-aiuino) -m.ethylcarban.Yll -<br>
N-methyl-p-phenylenediamine<br>
l<br>
(203)	N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-<br>
methylcarbonyl]-N-methyl-p-phenylenediamine<br>
(204)	N-[(4-methyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine<br>
(205)	N-[(imidazol-1-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine<br>
(206)	N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine<br>
Example XXI<br>
4-(4-hvdroxvmethyl-piperidin-l-yl-methvl-amino)-aniline 1.1 g of 4-(4-ethoxycarbonyl-piperidin-l-yl-methyl-amino)-aniline are suspended in 15 ml of tetrahydrofuran. 175 mg of lithium borohydride are added at room temperature, stirred for 24 h, another 175 mg of lithium borohydride are added and after a further 7.5 hours 15 ml of water are added and the mixture is stirred for 10 minutes. It is extracted three times with 15 ml of ethyl acetate.  The combined organic phases are washed with water and saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is purified over a silica gel column with methylene chloride/methanol/ammonia 4:1:0.01 as eluant. Yield: 20 0 mg (2 7 % of theory)<br><br><br>
Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia 4:1:0.01)<br>
Melting point: 157°C Example XXII<br>
methyl 4-methoxycarbonylmethyl-3-nitro-benzoate 54.3 g of methyl 3-nitro-benzoate and 29.0 g of methyl chloroacetate are dissolved in 10 0 ml of dimethylformamide and this solution is added dropwise at -10°C to a solution of 78.5 g of potassium-tert. butoxide in 500 ml of dimethylformamide. The mixture is stirred for another 10 minutes at room temperature and after this time the solution is poured onto 350 ml of concentrated hydrochloric acid in 2 1 of ice water. The solution is stirred for 0.5 hours, the precipitate obtained is suction filtered and washed with water. The product is recrystallised from 150 ml of methanol and dried at 4 0°C in  vacuo.<br>
Yield: 48.3 g of (51 % of theory), contains about 20 % of<br>
methyl 6-methoxycarbonylmethyl-3-nitro-benzoate<br>
Rf value: 0.7 (silica gel, petroleum ether/ethyl acetate =<br>
1:1)<br>
Melting point: 65-73 °C<br>
The following compound is prepared analogously to Example XXII:<br>
(1) ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate Prepared from ethyl 4-thoxycarbonylmethyl-3-nitro-benzoate<br>
Example XXIII<br>
methyl 2-indolinone-6-carboxylate<br>
4 8.3 g of methyl 4-methoxycarbonylmethyl-3-nitro-benzoate are<br>
dissolved in 800 ml of concentrated acetic acid, 5.0 g of<br><br>
palladium on carbon (10%) are added and the solution is hydrogenated for 2.5 hours at room temperature and 5 0 psi. The catalyst is filtered off and the filtrate is evaporated down. The residue is taken up in 150 ml of tert.-butylmethyl ether, filtered again and dried in vacuo  at 100°C.<br>
Yield: 28.6 g (98 % of theory),<br>
R£ value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
Melting point: 208-211 °C<br>
The following compound is prepared analogously to Example XXIII:<br>
(1) ethyl 2-indolinone-6-carboxylate Prepared from ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate<br>
Example XXIV<br>
1-acetyl-3-(l-ethoxy-1-phenylmethylene)-6-ethoxycarbonyl-<br>
2-indolinone	<br>
15.0 g of ethyl 2-indolinone-6-carboxylate, 49.6 ml of triethyl orthobenzoate and 150 ml of acetic anhydride are stirred for 4 hours at 110°C. After this time the solvent is removed, the residue is recrystallised from petroleum ether and dried in vacuo  at 50°C.<br>
Yield: 16.9 g (61 % of theory),<br>
Rf value: 0.5 (silica gel, petroleum ether/methylene<br>
chloride/ethyl acetate =5:4:1)<br>
Melting point: 98-100°C<br>
C22H21N05<br>
The following compounds are prepared analogously to Example XXIV:<br>
(1) 1-acetyl-3-(l-ethoxy-1-phenylmethylene)-6-methoxycarbonyl-2-indolinone<br><br>
Preparation of the final compounds:<br>
Example 1<br>
3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene!- 6-carbamoyl-2-indolinone-trifluoroacetate	<br>
300 mg of resin obtained according to Example II are suspended<br>
in 3 ml of dimethylformamide and shaken with 0.2 g of 4-<br>
(piperidin-1-yl-methyl)-aniline for 22 hours at 70°C. Then it<br>
is filtered off and the resin is washed several times with<br>
methylene chloride, methanol and dimethylformamide. Then 1 ml<br>
of methanolic ammonia is added for 2 hours in order to<br>
eliminate the acetyl group. Then after further washing 4 ml of<br>
10% trifluoroacetic acid in methylene chloride are added<br>
during another 60 minutes, the resin is separated off and the<br>
solution is evaporated down.<br>
Yield: 69 mg<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol = 9:1)<br>
C2eH28N402<br>
Mass spectrum: m/z = 452 (m+)<br>
The following compounds are prepared analogously to Example 1:<br>
(1)	3-Z-(1-Anilino-l-phenyl-methylene)-6-carbamoyl-2-<br>
indolinone<br>
Prepared from the resin obtained according to Example II and<br>
aniline<br>
C22H17N302<br>
Mass spectrum: m/z = 355 (m+)<br>
(2)	3-Z-[1-(4-dimethylaminomethyl-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-dimethylaminomethyl-aniline<br>
C25H24N402<br>
Mass spectrum: m/z = 412 (m+)<br><br>
(3)	3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(2-diethylamino-ethyl)-aniline<br>
C28H30N4O2<br>
Mass spectrum: m/z = 454 (m+)<br>
(4)	3-Z-[1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6 -carbamoyl-2 -indolinone-1ri fluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(morpholin-4-yl-methyl)-aniline<br>
Rf value: 0.50 (silica gel, methylene chloride/methanol = 4:1)<br>
C27H26N403<br>
Mass spectrum: m/z = 454 (m+)<br>
(5)	3-Z- [1-(4-(l-oxo-thiomorpholin-4-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(l-oxo-thiomorpholin-4-yl-methyl)-aniline<br>
Rf value: 0.3 0 (silica gel, methylene chloride/methanol = 9:1)<br>
C27H26N403S<br>
Mass spectrum: m/z = 486 (m+)<br>
(6)	3-Z-[l-(4-(l,l-dioxo-thiomorpholin-4-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6 -carbamoyl-2 -indolinone-tri fluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(1,l-dioxo-thiomorpholin-4-yl-methyl)-aniline<br>
Rf value: 0.30 (silica gel, methylene chloride/methanol = 9:1)<br>
C27H26N404S<br>
Mass spectrum: m/z = 502 (m+)<br>
(7)	3-Z-[1-(4-(benzylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br><br><br>
Prepared from the resin obtained according to Example II and<br>
4-[N-(phenyl-methyl)-N-tert.butoxycarbonyl-aminomethyl]-<br>
aniline<br>
Rf value: 0.40 (silica gel, methylene chloride/methanol =4:1)<br>
C30H26N4O2<br>
Mass spectrum: m/z = 474 (m+)<br>
(8)	3-Z- [1-(4-(amino-methyl)-anilino)-1-phenyl-methylene]-<br>
6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared f rom the resin obtained according to Example II and<br>
4-(N-tert.butoxycarbonyl-aminomethyl)-aniline<br>
Rf value: 0.10 (silica gel, methylene chloride/methanol =4:1)<br>
C23H20N4O2<br>
Mass spectrum: m/z = 384 (m+)<br>
(9)	3-Z- [1-(4-(2,6-dimethylpiperidin-l-yl-methyl)-anilino)-<br>
1-phenyl-methylene]- 6-ca^bamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(2,6-dimethylpiperidin-i-yl-methyl)-aniline<br>
Rf value: 0.45 (silica gel, methylene chloride/methanol =4:1)<br>
C30H32N4O2<br>
Mass spectrum: m/z = 480 (m+)<br>
(10)	3-Z-[1-(4-(pyrrolidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2 -indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(pyrrolidin-l-yl-methyl)-aniline<br>
Rf value: 0.15 (silica gel, methylene chloride/methanol =4:1)<br>
^"27-"-26-"-"4^2<br>
Mass spectrum: m/z = 438 (m+)<br>
(11)	3-Z- [1-(3-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
3-dimethylaminomethyl-aniline<br>
Rf value: 0.23 (silica gel, methylene chloride/methanol =4:1)<br><br>
C25H24N403<br>
Mass spectrum: m/z = 412 (m+)<br>
(12)	3-Z-[1-(3-(N-methyl-N-ethyl-aminomethyl)-anilino)-<br>
1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
3- (N-methyl-N-ethyl-aminomethyl)-aniline<br>
Rf value: 0.23 (silica gel, methylene chloride/methanol = 4:1)<br>
C26H26N402<br>
Mass spectrum: m/z .= 426 (m+)<br>
(13)	3-Z-[1-(3-(methylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-(N-tert.butoxycarbonyl-N-methyl-aminomethyl)-aniline<br>
Rf value: 0.06 (silica gel, methylene chloride/methanol =4:1)<br>
C24H22N402<br>
Mass spectrum: m/z = 399 (m+H+)<br>
(14)- 3-Z- [1- (3-hydroxymethyl-anilino) -1-phenyl-methylene] -<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example II and<br>
3-amino-benzyl alcohol<br>
Rf value: 0.7 (silica gel, methylene chloride/methanol =4:1)<br>
C23H19N303<br>
Mass spectrum: m/z = 385 (m+)<br>
(15) 3-Z- [1- (4- (methoxycarbonylmethyl-aminomethyl) -anilino) -<br>
1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4- (N-methoxycarbonylmethyl-N-tert.butoxycarbonyl-aminomethyl) -<br>
aniline<br>
Rf  value:   0.4 0   (silica gel,   methylene  chloride/methanol   =   9:1)<br>
C26H24N404<br>
Mass   spectrum:   m/z   =  457   (m+H+)<br><br><br>
(16)	3-Z-[1-(4-(N-methylsulphonyl-N-(dimethylaminocarbonyl-<br>
methyl)-amino)-anilino)-1-phenyl-methylene]-6-carbamoyl-<br>
2-indolinone<br>
Prepared from the resin obtained according to Example II and<br>
4-(N-methylsulphonyl-N-(dimethylaminocarbonylmethyl)-amino) -<br>
aniline<br>
Rf value: 0.40 (silica gel/ methylene chloride/methanol = 9:1)<br>
C27H27N505S<br>
Mass spectrum: m/z - 533 (m+)<br>
(17)	3-Z-[1-(4-(N-acetyl-aminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone<br>
Prepared from the resin obtained according to Example II and<br>
4-(N-acetyl-aminomethyl)-aniline<br>
R£ value: 0.70 (silica gel, methylene chloride/methanol = 4:1)<br>
C2SH22N403<br>
Mass spectrum: m/z = 426 (m+)<br>
(18)	3-Z-[1-(3,4-dimethoxy-anilino)-1-phenyl-methylene]-<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example II and<br>
3,4-dimethoxy-aniline<br>
Rf value: 0.40 (silica gel, methylene chloride/methanol = 9:1)<br>
C24H21N304<br>
Mass spectrum: m/z = 415 (m+)<br>
(19)	3-Z-[1-(4-(morpholin-4-yl)-anilino)-1-phenyl-methylene]-<br>
6 -carbamoyl-2 -indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-morpholin-4-yl-aniline<br>
Rf value: 0.2 0 (silica gel, methylene chloride/methanol = 9:1)<br>
C26H24N403<br>
Mass spectrum: m/z = 440 (m+)<br>
(20)	3-Z-[1-(4-acetylamino-anilino)-1-phenyl-methylene]-<br>
6-carbamoyl-2 -indolinone<br><br><br>
Prepared from the resin obtained according to Example II and<br>
4 -acetylamino-aniline<br>
Rf value: 0.25 (silica gel, methylene chloride/methanol = 9:1)<br>
C24H20N4O3<br>
Mass spectrum: m/z = 412 (m+)<br>
(21)	3-Z- [1-(4-amino-anilino)-1-phenyl-methylene]-6-carbamoyl-<br>
2-indolinone<br>
Prepared from the resin obtained according to Example II and<br>
4-amino-aniline<br>
Rf value: 0.40 (silica gel, methylene chloride/methanol = 9:1)<br>
C22H18N402<br>
Mass spectrum: m/z = 370 (m+)<br>
(22)	3-Z-[1-(4-N-methyl-N-acetyl-amino-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone<br>
Prepared from the resin obtained according to Example II and 4-(N-methyl-N-acetyl-amino)-aniline<br>
Mass spectrum: m/z = 426 (m+)<br>
(23)	3-Z-[1-(4-ethoxycarbonyl-anilino)-1-phenyl-methylene]-<br>
6-carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example II and<br>
ethyl 4-amino-benzoate<br>
C25H21N304<br>
Mass spectrum: m/z = 427 (m+)<br>
(24)	3-Z-[1-(4-carboxy-anilino)-1-phenyl-methylene]-<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example II and<br>
4-amino-benzoic acid<br>
Rf value: 0.11 (silica gel, methylene chloride/methanol = 9:1)<br>
C23H17N304<br>
Mass spectrum: m/z = 398 (m-H+)<br><br><br>
(25)	3-Z-[1-(4-benzylcarbamoyl-anilino)-1-phenyl-methylene]-<br>
6 -carbamoyl- 2 -indolinone<br>
Prepared from the resin obtained according to Example II and<br>
4-amino-benzoic acid-benzylamide<br>
R£ value: 0.21 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H24N4O3<br>
Mass spectrum: m/z = 488 (m+)<br>
(26)	3-Z-[1-(cyclohexyl-amino)-1-phenyl-methylene]-6-<br>
carbamoyl-2-indolinone<br>
Prepared from the resin obtained according to Example II and<br>
cyclohexylamine<br>
Rf value: 0.60 (silica gel, methylene chloride/methanol = 9:1)<br>
C22H23N302<br>
Mass spectrum: m/z = 361 (m+)<br>
(27)	3-Z-[1-(4-amino-cyclohexyl-amino)-1-phenyl-methylene]-<br>
6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-amino-cyclohexylamine<br>
C22H24N402<br>
Mass spectrum: m/z = 376 (m+)<br>
(28)	3-Z-[1-(N-methyl-piperidine-4-yl-amino)-1-phenyl-<br>
methylene] -6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
4-amino-1-methyl-piperidine<br>
Rf value: 0.15 (silica gel, methylene chloride/methanol =4:1)<br>
C22H24N402<br>
Mass spectrum: m/z = 376 (m+)<br>
(29)	3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-1-methyl-<br>
methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-(piperidin-1-yl-methyl)-aniline<br>
Rf value: 0.3 0 (silica gel, methylene chloride/methanol = 4:1)<br><br><br>
C23H2SN402<br>
Mass spectrum: m/z = 390 (m+)<br>
(30)	3-Z-[1-(3-dimethylaminomethyl-anilino)-1-methyl-<br>
methylene]-6-carbamoyl-2 -indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 3-dimethylaminomethyl-aniline<br>
Rf value: 0.51 (silica gel, methylene chloride/methanol = 4:1)<br>
C H N O	"<br>
Mass spectrum: m/z = 351 (m+H+)<br>
(31)	3-Z-[1-(4-(N-methyl-N-benzyl-aminomethyl)-anilino)-<br>
1-methyl-methylene]-6 -carbamoyl-2 -indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-(N-methyl-N-benzyl-aminomethyl)-aniline<br>
Rf value: 0.73 (silica gel, methylene chloride/methanol = 4:1)<br>
C26H26N402<br>
Mass spectrum: m/z = 426 (m+)<br>
(32)	3-Z-[1-(4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-<br>
amino)-anilino)-1-methyl-methylene]-6-carbamoyl-2-indolinone-<br>
trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-amino)-<br>
aniline<br>
C22H27N504S<br>
Mass spectrum: m/z = 458 (m+H+)<br>
(33)	3-Z- [1-(4-chloro-anilino)-1-methyl-methylene]-6-<br>
carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-chloro-aniline<br>
Rf value: 0.10 (silica gel, methylene chloride/methanol = 9:1)<br>
C17H14C1N302<br>
Mass spectrum: m/z = 327/329 (m+)<br><br>
(34)	3-Z-[1-(3-chloro-anilino)-1-methyl-methylene]-6-<br>
carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 3-chloro-aniline<br>
Rf value: 0.11 (silica gel, methylene chloride/methanol = 9:1)<br>
C17H14C1N302<br>
Mass spectrum: m/z = 327/329 (m+)<br>
(35)	3-Z-[1-(4-methoxycarbonyl-anilino)-1-methyl-methylene]-<br>
6 -carbamoyl-2-indolinone<br>
Prepared from the resin obtained according to Example 11(2)<br>
and methyl 4-amino-benzoate<br>
Rf value: 0.11 (silica gel, methylene chloride/methanol = 9:1)<br>
C19H17N304<br>
Mass spectrum: m/z = 351 (m+)<br>
(36)	3-Z-[1-(4-carboxy-anilino)-1-methyl-methylene]-6-<br>
carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-amino-benzoic acid<br>
C18H15N304<br>
Mass spectrum: m/z = 336 (m-H+)<br>
(37)	3-Z-[1-(4-methyl-3-nitro-anilino)-1-methyl-methylene]-<br>
6-carbamoyl-2-indolinone<br>
Prepared from the resin obtained according to Example 11(2)<br>
and 4-methyl-3-nitro-aniline<br>
R£ value: 0.82 (silica gel, methylene chloride/methanol =4:1)<br>
C1BH16N404<br>
Mass spectrum: m/z = 352 (m+)<br>
(38)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-propyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-(piperidin-1-yl-methyl)-aniline<br>
Rf value: 0.37 (silica gel, methylene chloride/methanol =4:1)<br><br>
C2SH30N4O2<br>
Mass spectrum: m/z = 418 (m+)<br>
(39)	3-Z-[1-(3-dimethylaminomethyl-anilino)-1-propyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 3-dimethylaminomethyl-aniline<br>
R£ value: 0.42 (silica gel, methylene chloride/methanol =4:1)<br>
C22H26N402<br>
Mass spectrum: m/z = 3 78 (m+)<br>
(40)	3-Z-[1-(4-(N-methyl-N-benzyl-aminomethyl)-anilino)-1-pro-<br>
pyl-methylene]-6-carbamoyl-2 -indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-(N-methyl-N-benzyl-aminomethyl)-aniline<br>
Rf value: 0.81 (silica gel, methylene chloride/methanol =4:1)<br>
C28H3oN402<br>
Mass spectrum: m/z = 454 (m+)<br>
(41)	3-Z- [1-(4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-<br>
amino)-anilino)-1-propyl-methylene]-6-carbamoyl-2-indolinone-<br>
trif luoroace tat e<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-amino)-<br>
aniline<br>
Rf value: 0.59 (silica gel, methylene chloride/methanol = 4:1)<br>
C24H31Ns04S<br>
Mass spectrum: m/z =   486 (m+H+)<br>
(42)	3-Z-[1-(4-chloro-anilino)-1-propyl-methylene]-6-<br>
carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-chloro-aniline<br>
Rf value: 0.17 (silica gel, methylene chloride/methanol = 9:1)<br>
C19H18C1N302<br>
Mass spectrum: m/z = 355/357 (m+)<br><br><br>
(43)	3-Z-[1-(3-chloro-anilino)-1-propyl-methylene]-6-<br>
carbamoyl- 2 -indolinone<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 3-chloro-aniline<br>
Rf value: 0.12" (silica gel, methylene chloride/methanol = 9:1)<br>
C19H18C1N302<br>
Mass spectrum: m/z = 355/357 (m+)<br>
(44)	3-Z-[1-(4-methoxycarbonyl-anilino)-1-propyl-methylene]-<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(4) and methyl 4-amino-benzoate " Rf value: 0.8 (silica gel, methylene chloride/methanol = 4:1) C21H21N304 Mass spectrum: m/z = 379 (m+)<br>
(45)	3-Z-[1-(4-carboxy-anilino)-1-propyl-methylene]-<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-amino-benzoic acid<br>
C20H19N3O4<br>
Mass spectrum: m/z = 364 (m-H+)<br>
(46)	3-Z-[1-(4-methyl-3-nitro-anilino)-1-propyl-methylene]-<br>
6 -carbamoyl-2 -indolinone<br>
Prepared from the resin obtained according to Example 11(4)<br>
and 4-methyl-3-nitro-aniline<br>
Rf value: 0.86 (silica gel, methylene chloride/methanol = 4:1)<br>
C30H20N4O4<br>
Mass spectrum: m/z = 380 (m+)<br><br><br>
Example 2<br>
3-Z-[1-(3-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate<br>
2.0 g of resin obtained according to Example II are reacted<br>
analogously to Example 1 with 2.0 g of 3-aminobenzyl alcohol<br>
in 20 ml of dimethylformamide for 22 hours at 70°C. Then the<br>
solvent is suction filtered and the resin is washed several<br>
times with dimethylformamide and methylene chloride. Then 200<br>
mg of the moist charged resin are suspended in 2 ml of<br>
methylene chloride and left to stand with 0.2 ml of<br>
methanesulphonic acid chloride and 0.1 ml of triethylamine for<br>
2 hours at room temperature. Then the resin is washed several<br>
times with methylene chloride, suspended in 2 ml of methylene<br>
chloride and combined with 0.2 ml of piperidine. After 1 hour<br>
the resin is washed with methylene chloride and<br>
dimethylformamide and then treated with trifluoroacetic acid<br>
analogously to Example 1.<br>
Yield: 15 mg<br>
Rf value: 0.3 0 (silica gel, methylene chloride/methanol = 4:1)<br>
C28H28N402<br>
Mass spectrum: m/z = 452 (m+)<br>
The following compounds are prepared analogously to Example 2:<br>
(1)	3-Z-[1-(3-(diethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
diethylamine<br>
Rf value: 0.80 (silica gel, methylene chloride/methanol =4:1)<br>
C27H28N402<br>
Mass spectrum: m/z = 440 (m+)<br>
(2)	3-Z-[1-(3-(benzylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br><br>
Prepared from the resin obtained according to Example II and<br>
benzylamine<br>
Rf value: 0.80 (silica gel, methylene chloride/methanol =4:1)<br>
C30H26N4O2<br>
Mass spectrum: m/z = 474 (m+)<br>
(3)	3-Z- [1- (3- (N-methyl-N-benzyl-atninomethyl) -anilino) -<br>
1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
N-methyl-benzylamine<br>
Rf value: 0.80 (silica gel, methylene chloride/methanol =4:1)<br>
C31H28N402<br>
Mass spectrum: m/z = 488 (m+)<br>
(4)	3-2- [1-(3-(butylaminomethyl)-anilino)-1-phenyl-methylene]-<br>
6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
butylamine<br>
Rf value: 0.40 (silica gel, methylene chloride/methanol =4:1)<br>
C27H28N402<br>
Mass spectrum: m/z = 440 (m+)<br>
(5)	3-Z-[l-(3-(aminomethyl)-anilino)-1-phenyl-methylene]-<br>
6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
ammonia<br>
C23H20N402<br>
Mass spectrum: m/z = 3 85 (m+H+)<br>
(6)	3-Z- [1-(3-(N-(3-dimethylaminopropyl)-N-methyl-amino¬<br>
methyl) -anilino)-1-phenyl-methylene]- 6-carbamoyl^-indolinone-<br>
trifluoroacetate<br>
Prepared from the resin obtained according to Example II and<br>
l-dimethylamino-3-methylaminopropane<br>
Rf value: 0.67 (silica gel, methylene chloride/methanol =4:1)<br>
C2gH33N502<br><br><br><br>
Mass spectrum: m/z = 484 (m+H+)<br>
(7) 3-Z-[1-(3-(N-(2-dimethylaminoethyl)-N-methyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate<br>
Prepared from the resin obtained according to Example II and 1-dimethylamino-2-methylaminoethane Rf value: 0.4 0 (silica gel, methylene chloride/methanol = 4:1)<br>
Mass spectrum: m/z = 470 (m+H+)<br>
Example 3<br>
3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] -6-ethoxycarbonvl-2-indolinone	____<br>
1.5 g of l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 1.1 g of 4-(piperidin-1-yl-<br>
methyl)-aniline are dissolved in 15 ml of dimethylformamide<br>
and stirred for 45 minutes at 100°C. After cooling 5.0 ml of<br>
piperidine are added and the mixture is stirred for another 3<br>
hours at room temperature. The solvent is removed and the<br>
residue purified over an aluminium oxide column (activity:<br>
2-3) with methylene chloride/ethanol (100:3) as eluant.<br>
Yield: 1.1 g (58% of theory),<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol =<br>
100:3)<br>
C30H31N3O3<br>
Mass spectrum: m/z = 481 [M+]<br>
The following compounds are prepared analogously to Example 3:<br>
(1) 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-6-ethoxy-carbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-ethoxycarbonyl-2-indolinone and 4-bromoaniline Rf value: 0.4 (silica gel, toluene/ethyl acetate = 5:1)<br><br>
C24Hx3BrN203<br>
Mass spectrum: m/z = 462/464 [M+]<br>
(2)	3-Z-[1-(3-(dimethylaminomethyl) -anilino)-1-phenyl-<br>
methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 3-(dimethylaminomethyl)-<br>
aniline<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol =<br>
30:1)<br>
C27H27N303<br>
ESI mass spectrum: m/z = 442 [M+H+]<br>
(3)	3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene) -6~<br>
ethoxycarbonyl-2-indolinone and 4-(dimethylaminomethyl)-<br>
aniline<br>
R£ value: 0.7 (aluminium oxide, ethyl acetate/ethanol = 20:1)<br>
C27H27N303<br>
ESI mass spectrum: m/z = 442 [M+H+]<br>
(4)	3-Z- [1- (4- [ (2,6-dimethyl-piperidin-l-yl)-methyl]-anilino)<br>
1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from- l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-[ (2 , 6-dimethyl-piperidin-l-<br>
yl) -methyl]-aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/ethanol = 5:1)<br>
C32H35N303<br>
Mass spectrum: m/z = 509 [M+]<br>
(5)	3-Z- [1-(4-(2-dimethylamino-ethyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-ethoxycarbonyl-2-indolinone and 4-(2-dimethylamino-ethyl)-aniline<br><br><br>
Rf value: 0.2 (silica gel, methylene chloride/ethanol =5:1)<br>
C28H29N303<br>
Mass spectrum: m/z = 455 [M+]<br>
(6)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-1-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-acetyl-amino)-aniline<br>
Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol =<br>
20:1)<br>
C30H32N4O4<br>
Mass   spectrum:   m/z  =   512   [M+]<br>
(7)	3-Z-[1-(4-tert.butyloxycarbonyl-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone  and 4 -tert.butyloxycarbonyl-<br>
aniline<br>
Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol =<br>
4 0:1)<br>
Mass spectrum: m/z = 484 [M+]<br>
(8)	3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(N-(3-dimethylamino-propyl)-<br>
N-acetyl-amino)-aniline<br>
RBvalue: 0.2 (aluminium oxide, methylene chloride/ethanol =<br>
4C:1)<br>
C11H34N404<br>
Mass  spectrum:   m/z  =  526   [M+]<br><br><br><br>
(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
1-p-phenylenediamine<br>
(aluminium oxide, methylene chloride/ethanol =<br>
m/z = 548 [M+]<br>
-(4-methyl-piperazin-l-yl)-anilino)-1-phenyl-thoxycarbonyl-2 -indolinone<br>
1-acetyl-3-(1-ethoxy-l-phenylmethylene)-6--2-indolinone and 4-(4-methyl-piperazin-l-yl)-<br>
aluminium oxide, ethyl acetate)<br>
rum: m/z = 483 [M+H+]<br>
-(N-(2-dimethylamino-ethyl)-N-methyl-amino)-lyl-methylene]- 6-ethoxycarbonyl-2 -indolinone L-acetyl-3-(1-ethoxy-l-phenylmethylene)-6--2-indolinone and 4-(N-(2-dimethylamino-ethyl)-i-aniline aluminium oxide, methylene chloride/ethanol =<br>
:um: m/z = 485 [M+H+]<br>
- (N-(3-dimethylamino-propyl)-N-methyl-amino)-lyl-methylene]-6-ethoxycarbonyl-2-indolinone L-acetyl-3-(1-ethoxy-l-phenylmethylene)-6--2-indolinone and 4-(N-(3-dimethylamino-propyl)--aniline aluminium oxide, ethyl acetate)<br><br>
(9)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
methylsulphonyl-p-phenylenediamine<br>
R£ value: 0.3 (aluminium oxide, methylene chloride/ethanol =<br>
40:1)<br>
C29H32N405S<br>
Mass   spectrum:   m/z   =  548    [M+]<br>
(10)	3-Z-[1-(4-(4-methyl-piperazin-l-yl)-anilino)-l-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone  and 4-(4-methyl-piperazin-l-yl)-<br>
aniline<br>
Rf value: 0.3 (aluminium oxide, ethyl acetate)<br>
C29H30N4O3<br>
ESI   mass   spectrum:   m/z   =  483    [M+H+]<br>
(11)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone  and 4-(N-(2-dimethylamino-ethyl)-<br>
N-methyl-amino)-aniline<br>
Rf value:   0.5   (aluminium oxide,   methylene  chloride/ethanol   =<br>
20:1)<br>
C29H32N403<br>
ESI   mass   spectrum:   m/z   =   485    [M+H+]<br>
(12)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone  and 4-(N-(3-dimethylamino-propyl)-<br>
N-methyl-amino)-aniline<br>
Rf value:   0.5   (aluminium oxide,   ethyl  acetate)<br><br><br>
C30H34N4O3<br>
ESI mass spectrum: m/z = 499 [M+H+]<br>
(13)	3-Z- [1-(4-(N-methyl-acetylamino)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-amino-N-methyl-acetanilide<br>
Rf value: 0.3 (silica gel, methylene chloride/ethanol = 15:1)<br>
C27H25N304<br>
Mass spectrum: m/z = 455 [M+]<br>
(14)	3-Z- [1-(4-(N-methyl-methylsulphonylamino)-anilino)-1-<br>
phenyl-methylene]-6-e thoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-(4-aminophenyl)-N-methyl-<br>
methanesulphonamide<br>
Rf value: 0.8 (aluminium oxide, ethyl acetate)<br>
C26H25N305S<br>
Mass spectrum: m/z ■= 491 [M+]<br>
(15)	3-Z- [1- (4-(N- (3-dimethylamino-propyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-(3-dimethylamino-propyl)-N-<br>
methylsulphonyl-p-phenylenediamine<br>
Rf value: 0.6 (silica gel, methylene chloride/ethanol/ammonia<br>
=5:2:0.01)<br>
C30H34N4O5S<br>
ESI mass spectrum: m/z = 563 [M+H+]<br>
(16)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br><br><br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone  and 4-(N-<br>
dimethylaminocarbonylmethyl-N-methylsulphonyl)-amino)-aniline<br>
Rf value:   0.6   (silica gel,   methylene  chloride/ethanol  =  10:1)<br>
C29H30N4O6S<br>
ESI mass spectrum: m/z = 561 [M-H~]<br>
(17)	3-Z-[1-(4-(imidazol-4-yl)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl- 2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(imidazol-4-yl)-aniline<br>
Rr value: 0.5 (silica gel, methylene chloride/ethanol/ammonia<br>
= 10:1:0.01)<br>
C27H22N403<br>
Mass spectrum: m/z = 450 [M+]<br>
(18)	3-Z-[1-(4-(tetrazol-5-yl)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(tetrazol-5-yl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/ethanol = 5:1)<br>
C25H20N6O3<br>
ESI mass spectrum: m/z = 451 [M-JT]<br>
(19)	3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(N-benzyl-N-methyl-<br>
aminomethyl) -aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/ethanol = 10:1)<br>
C33H31N303<br>
ESI mass spectrum: m/z = 516 [M-H~]<br>
(20)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-propionyl-amino)-<br>
aniline)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br><br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2 -indol inone and 4- [N- (2-dimeth.ylamino-ethyl) -<br>
N-propionyl-amino]-aniline<br>
Rf value: 0.2 (silica gel, methylene chloride/ethanol = 5:1)<br>
C31H34N404<br>
ESI mass spectrum: m/z = 525 [M-H~]<br>
(21)	3-Z-[1-(4-(pyrrolidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(pyrrolidin-1-yl-methyl)-<br>
aniline<br>
Rf value: 0.1 (silica gel, methylene chloride/ethanol = 5:1)<br>
C29H29N303<br>
ESI mass spectrum: m/z = 466 [M-H"]<br>
(22)	3-Z-[1-(4-(N-methyl-N-phenethyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(N-phenethyl-N-methyl-<br>
aminomethyl)-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/ethanol = 10:1)<br>
C34H33N3O3<br>
ESI mass spectrum: m/z = 530 [M-H"]<br>
(23)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-dimethylaminomethylcarbonyl-<br>
N-methyl-p-phenylenediamine<br>
Rf value: 0.1 (silica gel, methylene chloride/ethanol = 10:1)<br>
C23H30N4O4<br>
ESI mass spectrum: m/z = 497 [M-H"]<br><br><br>
(24)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-ethylsulphonyl-<br>
amino)-andlino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
ethylsulphonyl-p-phenylenediamine<br>
Rf value: 0.6 (silica gel, methylene chloride/ethanol = 5:1)<br>
C30H34N4O5S<br>
ESI mass spectrum: rh/z = 561 [M-H"]<br>
(25)	3-Z-[1-(4-(N-tert.butoxycarbonyl-N-ethyl-aminomethyl)-<br>
anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(N-tert.butoxycarbonyl-N-<br>
ethyl-aminomethyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C32H35N3Os<br>
ESI mass spectrum: m/z = 54 0 [M-H"]<br>
(26)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-ethyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-ethyl-methylene)-6-<br>
ethoxycarbonyl-2-indolinone and 4-(piperidin-1-yl-methyl)-<br>
aniline<br>
Rf value: 0.9 (silica gel, methylene chloride/ethanol = 5:1)<br>
C26H31N303<br>
ESI mass spectrum: m/z = 432 [M-H"]<br>
(27)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-ethyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-ethyl-methylene)-6-<br>
ethoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
methylsulphonyl-p-phenylenediamine<br>
Rf value: 0.3 (silica gel, methylene chloride/ethanol = 5:1)<br>
C2SH32N405S<br><br><br>
ESI mass spectrum: m/z = 499 [M-H~]<br>
(28)	3-2-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(dimethylaminomethyl)-<br>
aniline<br>
R£ value: 0.6 (silica gel, methylene chloride/methanol = 5:1)<br>
C26H2SN303<br>
ESI mass spectrum: m/z = 428 [M+H+]<br>
(29)	3-Z-[1-(4-[(2,6-dimethyl-piperidin-l-yl)-methyl]-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)~6-<br>
methoxycarbonyl-2-indolinone and 4-[(2,6-dimethyl-piperidin-l-<br>
yl) -methyl]-aniline<br>
Rf value: 0.5 (RP 8, methanol/five percent saline solution =<br>
4:1)<br>
C31H33N303<br>
ESI mass spectrum: m/z = 4 96 [M+H+]<br>
(30)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-ti¬me thyl sulphonyl -p-phenylenediamine<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 5:1) C28H30N4O5S ESI mass spectrum: m/z = 533 [M-H~]<br>
(31)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br><br><br>
Prepared  from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and N-(3-dimethylamino-propyl)-N-<br>
methylsulphonyl-p-phenylenediamine<br>
Rf value:   0.5   (aluminium oxide,   methylene   chloride/methanol   =<br>
30:1)<br>
C29H32N405S<br>
ESI mass spectrum: m/z = 547 [M-H~]<br>
(32)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-dimethylaminocarbonyl¬methyl -N-methylsulphonyl) -amino)-aniline<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol = 20:1) C28H28N4OsS ESI mass spectrum: m/z = 547 [M-IT]<br>
(33)	3-Z-[1-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-acetyl-N-<br>
dimethylaminocarbonylmethyl)-amino)-aniline<br>
R£ value: 0.6 (silica gel, methylene chloride/methanol = 10:1)<br>
C29H28N4Os<br>
ESI  mass   spectrum:   m/z   =  511   [M-H~]<br>
(34)	3-Z- [1-(4- (N-dimethylaminocarbonylmethyl-amino)-anilino)-<br>
1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-dimethylaminocarbonyl¬methyl) -amino)-aniline<br>
Rf value:   0.6   (aluminium oxide,   methylene   chloride/methanol   = 30:1) C27H26N404<br><br><br><br>
ESI mass spectrum: m/z = 469 [M-H"]<br>
(35)	3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(3-dimethylamino-propyl)-N-<br>
acetyl-p-phenylenediamine<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C30H33N4O4<br>
ESI mass spectrum: m/z = 511 [M-H"]<br>
(36)	3-Z-[1-(4-(N-methylaminocarbonylmethyl-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-methylaminocarbonylmethyl-<br>
N-methylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C27H26N406S<br>
ESI mass spectrum: m/z = 533 [M-H"]<br>
(37)	3-Z-[l-(4-((imidazolidin-2,4-dion-5-ylidene)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((imidazolidin-2,4-dion-5-<br>
ylidene)-methyl)-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C27H20N4O5<br>
ESI mass spectrum: m/z = 479 [M-H"]<br>
(38)	3-Z- [1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br><br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((2-dimethylamino-ethyl)-<br>
carbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C29H30N4O4<br>
ESI mass spectrum: m/z = 497 [M-H"]<br>
(39)	3-Z-[l-(4-(N-tert.butoxycarbonyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-tert.butoxycarbonyl-aminomethyl) -aniline<br>
Rf value: 0.3 (aluminium oxide, methylene chloride/methanol = 20:1) C25H29N305 ESI mass spectrum: m/z = 498 [M-H"]<br>
(40)	3-Z-[1-(4-(2-oxo-pyrrolidin-l-yl-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(2-oxo-pyrrolidin-l-yl-<br>
methyl) -aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 20:1)<br>
C28H2SN304<br>
ESI mass spectrum: m/z = 466 [M-H"]<br>
(41)	3-Z-[l-(4-(N-aminocarbonylmethyl-N-methy1sulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-aminocarbonylmethyl-N-<br>
methylsulphonyl-p-phenylenediamine<br>
Rf value: 0.7 (silica gel, methylene chloride/methanol = 5:1)<br>
C26H24N406S<br>
ESI mass spectrum: m/z = 519 [M-H"]<br><br><br>
(42)	3-Z-[1-(4-(thiomorpholin-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and 4-(thiomorpholin-4-yl-<br>
methyl)-aniline<br>
Rf value:   0.4   (silica gel,   methylene  chloride/methanol  =   15:1)<br>
C28H27N303S<br>
ESI mass spectrum: jh/z = 484 [M-H~]<br>
(43)	3-Z-.[l- (4- (1, l-dioxo-thiomorpholin-4-yl-methyl) -anilino) -<br>
1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(1,l-dioxo-thiomorpholin-4-<br>
yl-methyl)-aniline<br>
Rf value-. 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C2BH27N305S<br>
ESI mass spectrum: m/z = 516 [M-H~]<br>
(44)	3-2- [1- (4- (N-cyanomethyl-N-methylsulphonyl-amino)-<br>
anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-cyanomethyl-N-methyl-<br>
sulphonyl-p-phenylenediamine<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 10:1)<br>
C2SH22N405S<br>
ESI mass spectrum: m/z = 501 [M-H"]<br>
(45)	3-Z-[1-(4-(N-tert.butoxycarbonyl-ethylaminomethyl)-<br>
anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-ethyl-N-<br>
tert.butoxycarbonyl-aminomethyl)-aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol =10:1)<br>
C31H33N305<br>
ESI mass spectrum: m/z = 526 [M-H"]<br><br>
(46)	3-Z- [1-(4-(N-benzyl-N-raethyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-benzyl-N-methyl-<br>
aminomethyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C32H29N303<br>
ESI mass spectrum: rti/z = 502 [M-H"]<br>
(47)	3-Z- [1-(4-(l-oxo-thiomorpholin-4-yl-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(l~ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(l-oxo-thiomorpholin-4-yl-<br>
methyl)-aniline<br>
R£ value: 0.7 (silica gel, methylene chloride/methanol = 10:1)<br>
C28H27N304S<br>
ESI mass spectrum: m/z = 500 [M-H"]<br>
(48)	3-Z- [1-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(2-(imidazol-4-yl)-ethyl)-<br>
aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 5:1)<br>
C2aH24N403<br>
ESI mass spectrum: m/z = 463 [M-H"]<br>
(49)	3-Z-[1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(morpholin-4-yl-methyl)-<br>
aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C28H27N304<br>
ESI mass spectrum: m/z = 468 [M-H"]<br><br><br><br>
(50)	3-Z-[1-(4-((4-methyl-piperazin-l-yl)-methyl)-anilino)-1-<br>
phenyl -methylene] - 6 -methoxycarbonyl"- 2 - indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((4-methyl-piperazin-l-yl) -<br>
methyl)-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol 5:1)<br>
C29H30N4O3<br>
ESI mass spectrum: m/z = 481 [M-H~]<br>
(51)	3-Z- [1- (4- ( (2-(N-benzyl-N-methyl-amino) -ethyl)-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-(2-(N-benzyl-N-methyl-amino) -ethyl)-N-methylsulphonyl-amino)-aniline<br>
Rf value: 0.7 (silica gel, methylene chloride/methanol = 10:1) C34H34N405S ESI mass spectrum: m/z = 609 [M-H"]<br>
(52)	3-Z- [1-(4-cyclohexylamino-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-cyclohexyl-p-phenylenediamine Rf value: 0.8 (silica gel, methylene chloride/methanol = 10:1)<br>
ESI mass spectrum: m/z = 451 [M-H"]<br>
(53)	3-Z-[1-(4-(pyridin-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(pyridin-4-yl-methyl)-<br>
aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br><br><br>
C29H23N303<br>
ESI mass spectrum: m/z = 460 [M-H"]<br>
(54)	3-Z- [1- (4-(imidazol-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(imidazol-1-yl-methyl)-<br>
aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia<br>
= 10:1:0.01)<br>
C27H22N403<br>
ESI mass spectrum: m/z = 449 [M-H"]<br>
(55)	3-Z- [1-(4-(imidazol-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(imidazol-1-yl-methyl)-<br>
aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia<br>
=10:1:0.01)<br>
C27H22N403<br>
ESI mass spectrum: m/z = 449 [M-H"]<br>
(56)	3-Z-[1-(N-methyl-piperidine-4-yl-amino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-amino-1-methyl-piperidine<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 5:1)<br>
C23H25N303<br>
ESI mass spectrum: m/z = 3 90 [M-H"]<br>
(57)	3-Z- [1-(4-(imidazol-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(imidazol-4-yl-methyl)-aniline<br><br><br>
Rf  value:   0.2    (silica gel,   methylene  chloride/methanol   =   5:1)<br>
C27H22N403<br>
ESI mass spectrum: m/z = 449 [M-H~]<br>
(58)	3-Z-[1-(4-((4-hydroxy-piperidin-l-yl)-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-((4-hydroxy-piperidin-l-yl) -methyl)-aniline/<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol = 10:1) C29H29N303 ESI mass spectrum: m/z = 482 [M-JT]<br>
(59)	3-Z-[1-(4-((4-methoxy-piperidin-l-yl)-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-((4-methoxy-piperidin-l-yl) -methyl)-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1) C30H31N3O4 ESI mass spectrum: m/z = 496 [M-H"]<br>
(60)	3-Z-[1-(4-benzyl-anilino)-1-phenyl-methylene]-6-methoxy-<br>
carbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-benzyl-aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol -   10:1)<br>
C30H24N2O3<br>
Melting point: 224°C<br>
(61)	3-Z-[1-(4-(N-(3-trifluoroacetylamino-propyl)-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-(3-trifluoroacetylamino-propyl) -N-methylsulphonyl-p-phenylenediamine<br><br><br><br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C29H27F3N406S<br>
ESI mass spectrum: m/z = 615 [M-H"]<br>
(62)	3-Z- [1-(4-tert.butoxycarbonylmethyl-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
ethoxycarbonyl-2-indolinone and tert.butyl 4-<br>
aminophenylacetate<br>
Rr value: 0.5 (aluminium oxide, ethyl acetate)<br>
C30H30N2O5<br>
ESI mass spectrum: m/z = 497 [M-H"]<br>
(63)	3-Z- [1-(4-tert.butoxycarbonyl-anilino)-1-ethyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-ethylmethylen)-6-<br>
ethoxycarbonyl-2-indolinone" and 4-tert.butoxycarbonyl-aniline<br>
R£ value: 0.4 (aluminium oxide, methylene chloride/ethanol =<br>
20:1)<br>
C25H28N205<br>
ESI   mass   spectrum:   m/z   =  435    [M-H"]<br>
(64)	3-Z- [1- (4- (4-tert.butoxycarbonyl-piperazin-1-yl-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and 4-(4-tert.butoxycarbonyl-<br>
piperazin-1-yl-methyl)-aniline<br>
Rf value:   0.5   (silica  gel,   methylene  chloride/methanol   =   10:1)<br>
C33H36N405<br>
ESI mass spectrum: m/z = 567 [M-H"]<br>
(65)	3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(1-methyl-imidazol-2-yl)-<br>
aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 5:1)<br>
C27H22N403<br>
ESI mass spectrum: m/z = 449 [M-H"]<br>
(66)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino)-3-nitro-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 6-(N-(2-dimethylamino-ethyl)-<br>
N-methylsulphonyl-amino)-3-amino-nitrobenzene<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 5:1)<br>
C28H29Ns07S<br>
ESI mass spectrum: m/z = 578 [M-H"]<br>
(67)	3-2-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino) -3-amino-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-methylsulphonyl-amino)-3 -amino-ani1ine<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C28H31N505S<br>
ESI   mass   spectrum:   m/z   =   548    [M-H"]<br>
(68)	3-Z-[1-(4-((3-(N-benzyl-N-methyl-amino)-propyl)-N-methyl¬<br>
sulphonyl-amino) -anilino)-l-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and 4-(N-(3-(N-benzyl-N-methyl-<br>
amino)-propyl)-N-methylsulphonyl-amino)-aniline<br>
Rf value:   0.6   (silica  gel,   methylene  chloride/methanol   =   10:1)<br>
C3SH36N405S<br><br><br>
ESI mass spectrum: m/z = 623 [M-JT]<br>
(69)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-<br>
amino)-3-chloro-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-methylsulphonyl-amino)-3-chloro-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C28H29C1N40SS<br>
ESI mass spectrum: m/z = 567/569 [M-H"]<br>
(70)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-<br>
dimethylaminomethylcarbonyl-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C28H28N404<br>
ESI mass spectrum: m/z = 483 [M-H"]<br>
(71)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-acetyl-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C29H30N4O4<br>
ESI mass spectrum: m/z = 497 [M-H"]<br>
(72)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-propionyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-propionyl-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H32N4O4<br>
ESI mass spectrum: m/z = 511 [M-H"]<br>
(73)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-butyryl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-butyryl-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C31H34N404<br>
ESI mass spectrum: m/z = 525 [M-H"]<br>
(74)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-isobutyryl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-isobutyryl-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C31H34N404<br>
ESI mass spectrum: m/z = 525 [M-H"]<br>
(75)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-benzoyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-benzoyl-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C34H32N404<br>
ESI mass spectrum: m/z = 559 [M-H"]<br>
(76)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3-<br>
amino-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3-amino-aniline<br><br>
R£ value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C29H31Ns04<br>
ESI mass spectrum: m/z = 512 [M-H~]<br>
(77)	3-Z-[1-(4-(4-hydroxymethyl-piperidin-l-yl-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(4-hydroxymethyl-piperidin-<br>
1-yl-methyl-amino)-aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 5:1)<br>
C30H31N3O4<br>
ESI mass spectrum.: m/z =   496 [M-H~]<br>
(78)	3-Z-[1-(4-(2-(4-hydroxy-piperidin-l-yl)-ethyl)-anilino)-<br>
1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(2-(4-hydroxy-piperidin-l-<br>
yl) -ethyl-amino) -aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol =5:1)<br>
C30H31N3O4<br>
ESI mass spectrum: m/z = 496 [M-H~]<br>
(79)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-propylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
propylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H34N4O5S<br>
ESI mass spectrum: m/z = 561 [M-H~]<br>
(80)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-butylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br><br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
butylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C31H36N405S<br>
ESI mass spectrum: m/z = 575 [M-H"]<br>
(81)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-phenylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
phenylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C33H32N4OsS<br>
ESI mass spectrum: m/z = 595 [M-H"]<br>
(82)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-benzylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
benzylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C34H3«N4OsS<br>
ESI mass spectrum: m/z = 609 [M-H"]<br>
(83)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-ethylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(2-dimethylamino-ethyl)-N-<br>
ethylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C29H32N405S<br>
ESI mass spectrum: m/z = 547 [M-H"]<br><br><br><br>
(84)	3-Z-[1-(4-((imidazolidin-2, 4-dion-5-yl)-methyl)-anilino)-<br>
1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((imidazolidin-2,4-dion-5-<br>
yl)-methyl)-aniline<br>
Rf  value:   0.6   (silica gel,   methylene  chloride/methanol   =  5:1}<br>
C27H22N405<br>
ESI mass spectrum: jh/z = 481 [M-H~]<br>
(85)	3-Z- [1-(4-((3-hydroxy-pyrrolidin-l-yl)-methyl)-anilino)-<br>
1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbony1-2-indolinone and 4-((3-hydroxy-pyrrolidin-l-yl) -methyl)-aniline<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol = 10:1) C28H27N304 ESI mass spectrum: m/z = 468 [M-H"]<br>
(86)	3-Z- [1-(4-(cyclohexylyl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(cyclohexyl-methyl)-aniline (Eur. J. Med. Chem. Chim. Ther. 1992, 27, 537-544) Rj. value: 0.6 (silica gel, methylene chloride/methanol = 10:1) C30H30N2O3 ESI mass spectrum: m/z = 465 [M-H~]<br>
(87)	3-Z- [1-(4-(cyclohexyl-carbonyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(cyclohexyl-carbonyl)-<br>
aniline<br>
Rf value:   0.5    (silica  gel,   methylene  chloride/methanol   =  10:1)<br>
C30H28N3O4<br>
ESI  mass   spectrum:   m/z   =  479   [M-H"]<br><br><br>
(88)	3-Z-[1-(4-diethylaminomethyl-anilino)-1-phenyl-<br>
methylene]- 6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(l~ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(diethylamino-methyl)-<br>
aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C28H29N303<br>
ESI mass spectrum: rti/z = 454 [M-H~]<br>
(89)	3-Z-[1-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-(n-hexyl)-N-methyl-aminomethyl) -aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 10:1) C31H35N303 ESI mass spectrum: m/z = 496 [M-H~].<br>
(90)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2-<br>
carbonyl)-amino)-anilino)-1-phenyl-methylene] -6-<br>
methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbony1-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-(furan-2-carbonyl)-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C32H30N4O5<br>
ESI mass spectrum: m/z = 549 [M-H~]<br>
(91)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(2-methoxy-<br>
benzoyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxy-<br>
carbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-N-(2-methoxy-benzoyl)-amino)-aniline Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br><br><br>
C35H34N405<br>
ESI mass spectrum: m/z = 589 [M-H"]<br>
(92)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(pyridine-3-<br>
carbonyl)-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl) -<br>
N-(pyridine-3-carbonyl)-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C33H31Ns04<br>
ESI mass spectrum: m/z = 560 [M-H"]<br>
(93)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-(phenyl-acetyl)-amino)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C35H34N404<br>
ESI mass spectrum: m/z = 573 [M-H"]<br>
(94)	3-Z-[1-(4-(N-ethyl-N-methyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-ethyl-N-methyl-<br>
aminomethyl) -aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 10:1)<br>
C27H27N303<br>
ESI mass spectrum: m/z = 440 [M-H"]<br>
(95)	3-Z- [1-(4-(imidazol-2-yl)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(imidazol-2-yl)-aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol = 10:1)<br>
C26H20N4O3<br>
ESI mass spectrum: m/z = 435 [M-H"]<br>
(96)	3-Z-[1-(4-(l-ethyl-imidazol-2-yl)-anilino)-l-phenyl-<br>
methylene]- 6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(i-ethyl-imidazol-2-yl)-<br>
aniline	."<br>
R£ value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C23H24N403<br>
ESI mass spectrum: m/z = 463 [M-H"]<br>
(97)	3-Z-[1-(4-(l-benzyl-imidazol-2-yl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(l-benzyl-imidazol-2-yl)-<br>
aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 20:1)<br>
C33H26N403<br>
ESI mass spectrum: m/z = 525 [M-H"]<br>
(98)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-<br>
isopropylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N- (2-d.imethylamino-ethyl) -N-<br>
isopropylsulphonyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H34N4OsS<br>
ESI mass spectrum: m/z = 561 [M-H"]<br>
(99)	3-Z-[1-(4-(N-(piperidin-1-yl-methylcarbonyl)-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br><br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and N-(piperidin-1-yl-<br>
methylcarbonyl)-N-methyl-p-phenylenediamine<br>
R£  value:   0.5   (silica  gel,   methylene  chloride/methanol   =   9:1)<br>
C31H32N404<br>
ESI mass spectrum: m/z = 523 [M-H~]<br>
(100)	3-Z- [1-(4-(N-(morpholin-4-yl-methylcarbonyl)-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(morpholin-4-yl-<br>
methylcarbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H30N4Os<br>
ESI mass spectrum: m/z = 525 [M-H~]<br>
(101)	3-Z- [1-(4-(N-((4-benzyl-piperazin-l-yl)-methylcarbonyl) -<br>
N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbony1-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((4-benzyl-piperazin-l-yl) -<br>
methylcarbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C37H37N504<br>
ESI  mass  spectrum:   m/z   =   614    [M-H~]<br>
(102)	3-Z- [1-(4-(N-(pyrrolidin-1-yl-methylcarbonyl)-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and N-(pyrrolidin-1-yl-<br>
methylcarbonyl)-N-methyl-p-phenylenediamine<br>
R£  value:   0.5   (silica gel,   methylene   chloride/methanol   =   9:1)<br>
C3oH3oN404<br>
ESI  mass   spectrum:   m/z   =  509   [M-H~]<br><br>
(103)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3-<br>
bromo-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-(2-dimethylamino-ethyl)-<br>
N-acetyl-amino)-3-bromo-aniline<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol = 5:1)<br>
C29H29BrN404<br>
ESI mass spectrum: m/z = 575/577 [M-H~]<br>
(104)	3-Z-[1-(4-(5-methyl-imidazol-4-yl)-anilino)-1-phenyl-<br>
methylene] -6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(5-methyl-imidazol-4-yl)-<br>
aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia<br>
=10:1:0.01)<br>
C27H22N403<br>
ESI mass spectrum: m/z = 449 [M-H~]<br>
(105)	3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-<br>
isopropyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((2-dimethylamino-ethyl)-<br>
carbonyl)-N-isopropyl-p-phenylenediamine<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol = 10:1)<br>
C31H34N404<br>
ESI mass spectrum: m/z = 525 [M-H"]<br>
(106)	3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-<br>
benzyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-<br>
2-indolinone<br><br><br><br>
Prepared from 1-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((2-dimethylamino-ethyl)-<br>
carbonyl)-N-benzyl-p-phenylenediamine<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol = 10:1)<br>
C31H34N404<br>
ESI mass spectrum: m/z"= 525 [M-H"]<br>
(107)	3-Z-[1-(4-(N-butyl-N-tert.butoxycarbonyl-aminomethyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-butyl-N-<br>
tert.butoxycarbonyl-aminomethyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C33H37N305<br>
ESI mass spectrum: m/z = 554 [M-H*]<br>
(108)	3-Z-[1-(4-(N-((N-aminocarbonylmethyl-N-methyl-amino)-<br>
methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(N-aminocarbonylmethyl-N-<br>
methyl-amino)-methylcarbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C29H29NsOs<br>
ESI mass spectrum: m/z = 526 [M-H"]<br>
(109)	3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)-methylcarbonyl)-<br>
N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((N-benzyl-N-methyl-amino)-<br>
methylcarbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C34H32N404<br>
ESI mass spectrum: m/z = 559 [M-H"]<br><br><br>
(110)	3-Z- [1- (4-(N-(di-(2-methoxyethyl)-amino-methylcarbonyl)-<br>
N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-(di-(2-methoxyethyl)-amino-methylcarbonyl )-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1) C32H36N406 ESI mass spectrum: m/z = 571 [M-H"]<br>
(111)	3-Z-[1-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-1-yl)-<br>
ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((2-(4-tert.butoxycarbonyl-<br>
piperazin-1-yl)-ethyl)-carbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.8 (silica gel, methylene chloride/methanol = 5:1)<br>
C36H41N506<br>
ESI mass spectrum: m/z = 638 [M-H"]<br>
(112)	3-Z- [1- (4- (N- ( (2- (piperidin-1-yl) -ethyl).-carbonyl) -N-<br>
methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N~((2-(piperidin-1-yl)-<br>
ethyl)-carbonyl)-N-methyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 5:1)<br>
C32H34N404<br>
ESI mass spectrum: m/z = 537 [M-H"]<br>
(113)	3-Z- [1- (4- (N-((2-(N-benzyl-N-methyl-amino)-ethyl)-<br>
carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-((2-(N-benzyl-N-methyl-amino) -ethyl)-carbonyl)-N-methyl-p-phenylenediamine<br><br><br><br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C35H34N404<br>
ESI mass spectrum: m/z = 573 [M-H"J<br>
(114)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-isopropyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-<br>
(dimethylaminomethylcarbonyl)-N-isopropyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1) C30H32N4O4 ESI mass spectrum: m/z = 511 [M-H~]<br>
(115)	3-Z-[1-(4-(N-(piperidin-1-yl-methylcarbonyl)-N-<br>
isopropyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(piperidin-1-yl-<br>
methylcarbonyl)-N-isopropyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C33H36N404<br>
ESI mass spectrum: m/z = 551 [M-H"]<br>
(116)	3-Z-[1-(4-(N-((4-tert.butoxycarbonyl-piperazin-1-yl)-<br>
methylcarbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-<br>
methylene] - 6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-((4-tert.butoxycarbonyl-<br>
piperazin-1-yl)-methylcarbonyl)-N-isopropyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C37H43N506<br>
ESI mass spectrum: m/z = 652 [M-H"]<br><br><br><br>
(117) 3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)-methylcarbonyl) -N-benzyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and N-((N-benzyl-N-methyl-amino) -methylcarbonyl)-N-benzyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1) C40H36N4O4 ESI mass spectrum: m/z = 635 [M-H"]<br>
(118)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-benzyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and N-(dimethylaminomethyl-<br>
carbonyl)-N-benzyl-p-phenylenediamine<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C34H32N404<br>
ESI mass spectrum: m/z = 559 [M-H"]<br>
(119)	3-Z-[1-(4-(N-(piperidin-1-yl-methylcarbonyl)-N-benzyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(5-methyl-imidazol-4-yl)-<br>
aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
L.37ri36JN4U4<br>
ESI mass spectrum: m/z = 559 [M-H"]<br>
(120)	3-Z-[1-(4-(l,2,4-triazol-2-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(1,2,4-triazol-l-yl-methyl)-aniline , R£ value: 0.5 (silica gel, methylene chloride/methanol = 10 .-1)<br><br><br>
C26H21N503<br>
ESI  mass   spectrum:   m/z   =  450   [M-H~]<br>
(121)	3-Z- [1-(4-(1,2,3-triazol-2-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl~2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(1,2,3-triazol~2-yl-<br>
methyl)-aniline<br>
Rr value: 0.5 (silica gel, methylene chloride/methanol = 20:1)<br>
C„H21N503<br>
ESI mass spectrum: m/z = 450 [M-H"]<br>
(122)	3-Z- [1- (4-(1,2,3-triazol-l-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-(1,2,3-triazol-l-yl-methyl) -aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol - 9:1) C26H21N503 ESI mass spectrum: m/z = 450 [M-H~]<br>
(123)	3-Z-[1-(4-((N-aminocarbonylmethyl-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-aminocarbonylmethyl-N-<br>
methyl-amino)-methyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C27H26N404<br>
ESI mass spectrum: m/z = 469 [M-H"]<br>
(124)	3-Z-[1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((di-(2-methoxy-ethyl)-<br>
amino)-methyl)-aniline<br><br><br><br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H33N3O5<br>
ESI mass spectrum: m/z = 514 [M-H"]<br>
(125)	3-Z-[1-(4-(pyrrolidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(pyrrolidin-1-yl-methyl)-<br>
aniline	,<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C28H27N303<br>
ESI mass spectrum: m/z = 452 [M-H"]<br>
(126)	3-Z- [1-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2~indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((di-(2-hydroxy-ethyl)-<br>
amino)-methyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C28H23N305<br>
ESI mass spectrum: m/z = 486 [M-H"]<br>
(127)	3-Z-[1-(4-((N-ethoxycarbonylmethyl-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-((N-ethoxycarbonylmethyl-N-methyl-amino)-methyl)-aniline Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol =<br>
40:1)<br>
C29H29N305<br>
ESI mass spectrum: m/z = 498 [M-H"]<br>
(128)	3-Z-[1-(4-(azetidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(azetidin-1-yl-methyl)-<br>
aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol/ammonia<br>
= 9:1:0.5)<br>
C27H2SN303<br>
ESI mass spectrum: m/z *= 438 [M-H~]<br>
(129)	3-Z-[1-(4-(N-propyl-N-tert.butoxycarbonyl-aminomethyl)-<br>
anilino)-l-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-(N-propyl-N-<br>
tert .butoxycarbonyl-aminomethyl)-aniline<br>
Rf value.- 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C32H3SN305<br>
ESI mass spectrum: m/z - 540 [M-H"]<br>
(130)	3-Z-[1-(4((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-<br>
amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-(2-(2-methoxy-ethoxy)-<br>
ethyl)-N-methyl-amino)-methyl)-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H33N3O5<br>
ESI mass spectrum: m/z = 514 [M-H"]<br>
(131)	3-Z- [1- (4- ( (N- (tert.butoxycarbonyl-3-amino-propyl)-N-<br>
methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-methoxy¬<br>
carbonyl -2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6 -<br>
methoxycarbonyl-2-indolinone and 4-(N-(N-tert.butoxycarbonyl-<br>
3-amino-propyl)-N-methyl-aminomethyl)-aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C33H38N405<br>
ESI mass spectrum: m/z = 571 [M+H+]<br><br>
(132)	3-Z- [1-(4-( (N-(methylcarbamoyl-methyl)-N-methyl-amino) -<br>
methyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-(methylcarbamoyl-<br>
methyl)-N-methyl-amino)-methyl)-aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9.-1)<br>
C28H28N404<br>
ESI mass spectrum: m/z *= 483 [M-H"]<br>
(133)	3-Z- [1-(4-((N-(dimethylcarbamoyl-methyl)-N-methyl-<br>
amino) -methyl) -anilino) -1 -phenyl-methylene] -6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-(dimethylcarbamoyl-<br>
methyl)-N-methyl-amino)-methyl)-aniline<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 10:1)<br>
C29H30N4O4<br>
ESI mass spectrum: m/z = 497 [M-H"]<br>
(134)	3-Z- [1-(4-methyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-methyl-aniline<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 9:1)<br>
C24H20N2O3<br>
ESI mass spectrum: m/z - 383 [M-H"]<br>
(135)	3-Z- [1-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-propyl-N-methyl-amino)-<br>
methyl)-aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C28H29N303<br><br>
ESI mass spectrum: m/z = 454 [M-H"]<br>
(136)	3-Z-[1-(4-((N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-(2-hydroxy-ethyl)-N-<br>
methyl-amino)-methyl)-aniline<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol =<br>
40:1)<br>
C27H27N304<br>
ESI mass spectrum: m/z = 456 [M-H"]<br>
(137)	3-Z-[1-(4-((N-(2-dimethylamino-ethyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl-2-indolinone and 4-((N-(2-dimethylamino-ethyl) -N-methyl-amino)-methyl)-aniline<br>
Rf value: 0."5 (silica gel, methylene chloride/methanol = 9:1) C29H32N403 ESI mass spectrum: m/z = 483 [M-H"]<br>
(138)	3-Z-[1-(4-((N-(3-dimethylamino-propyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone and 4-((N-(3-dimethylamino-<br>
propyl)-N-methyl-amino)-methyl)-aniline aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H34N4O3<br>
ESI mass spectrum: m/z = 497 [M-H"]<br>
(139)	3-Z-[1-(4-(3-oxo-piperazin-l-yl-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br><br>
Prepared  from  l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-<br>
methoxycarbonyl-2-indolinone  and 4-(3-oxo-piperazin-1-yl-<br>
methyl)-aniline  aniline<br>
R£  value:   0.46   (silica  gel,   methylene   chloride/methanol   =   9:1)<br>
C28H26N404<br>
ESI  mass   spectrum:   m/z   =   481   [M-H~]<br>
Example  4<br>
3-Z-[1-(4-carboxy-anilino)-1-phenyl-methylene]-6-ethoxy-<br>
carbonyl-2 -indolinone   	<br>
485 mg of 3-Z- [1-(4-tert.butoxycarbonyl-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone are dissolved in 15<br>
ml of methylene chloride and 6.0 ml of trifluoroacetic acid<br>
are added. The mixture is stirred for 2 hours at room<br>
temperature. Then the solvent is removed and the residue<br>
recrystallised from ether.<br>
Yield: 375 mg (87 % of theory),<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 10:1)<br>
C25H20N2O5<br>
Mass spectrum: m/z = 428 [M+]<br>
The following compounds are prepared analogously to Example 4 :<br>
(1)	3-Z-[1-(4-aminomethyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-aminomethyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C24H21N303<br>
ESI  mass   spectrum:   m/z   =   398   [M-H"]<br>
(2)	3-Z- [1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br><br>
Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-ethylamino-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
R£ value: 0.4 (silica gel, methylene chloride/methanol/ammonia<br>
= 10:1:0.01) C26H2SN303 ESI mass spectrum: m/z = 426 [M-H~]<br>
(3)	3-Z- [1-(4-carboxymethyl-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-tert.butoxycarbonylmethyl-anilino)-1-<br>
phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
Rf value: 0.1 (aluminium oxide, methylene<br>
chloride/ethanol/ammonia = 5:1:0.01)<br>
C26H22N2Os<br>
ESI mass spectrum: m/z = 441 [M-H~]<br>
(4)	3-Z-[1-(4-carboxy-anilino)-1-ethyl-methylene]-6-ethoxy-<br>
carbonyl-2 -indolinone<br>
Prepared from 3-Z-[1-(4-tert.butoxycarbonyl-anilino)-1-ethyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
Rf value: 0.1 (aluminium oxide, methylene chloride/ethanol =<br>
20:1)<br>
ESI mass spectrum: m/z = 3 79 [M-H"]<br>
(5)	3-Z- [1-(4-(piperazin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(4-tert.butoxycarbonyl-piperazin-l-yl-<br>
methyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.1 (silica gel, methylene chloride/methanol/ammonia<br>
= 10:1:0.01)<br>
C28H28N403<br>
ESI   mass   spectrum:   m/z   =   469    [M+H+]<br><br><br>
(6)	3-Z-[1-(4-butylaminomethyl-anilino) -1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-butyl-N-tert.butoxycarbonyl-<br>
aminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C28H29N303<br>
ESI   mass   spectrum:   m/z   =   454    [M-H~]<br>
(7)	3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
Prepared  from  3-Z- [1-(4-(N-tert.butoxycarbonyl-N-ethyl-<br>
aminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
R£  value:   0.3    (silica gel,   methylene  chloride/methanol/ammonia<br>
=   10:1:0.01)<br>
C27H27N303<br>
ESI mass spectrum: m/z = 442 [M+H+]<br>
(8)	3-Z-[1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene]-6-<br>
carbamoyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-ethylamino-<br>
methyl)-anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinone<br>
R£ value: 0.2 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C2SH24N402<br>
ESI  mass   spectrum:   m/z  =  411   [M-H"]<br>
(9)	3-Z-[1-(4-(N- (piperazin-1-yl-methylcarbonyl)-N-isopropyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared  from 3-Z- [1- (4-(N-((4-tert.butoxycarbonyl-piperazin-1-yl) -methylcarbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone<br><br><br>
Rf value: 0.35 (silica gel, methylene chloride/methanol = 9:1)<br>
C32H35Ns04<br>
ESI mass spectrum: m/z = 552 [M-H~]<br>
(10)	3-Z-[1-(4-(N-((2-(piperazin-1-yl)-ethyl)-carbonyl)-N-<br>
methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-((2-(4-tert.butoxycarbonyl-<br>
piperazin-1-yl)-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-<br>
phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone<br>
R£ value: 0.4 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C31H33N504<br>
ESI mass spectrum: m/z = 540 [M+H+]<br>
(11)	3-Z-[1-(4-(N-propyl-aminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl- 2 -indolinone<br>
Prepared from 3-Z-[1-(4-(N-propyl-N-tert.butoxycarbonyl-<br>
aminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Rf value:   0.35   (silica gel,   methylene  chloride/methanol  =   9:1)<br>
C27H27N303<br>
ESI mass spectrum: m/z = 440 [M-H~]<br>
(12)	3-Z-[1-(4-((N-(3-amino-propyl)-N-methyl-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-((N-(tert.butoxycarbonyl-3-amino-<br>
propyl) -N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.3 5 (silica gel, methylene chloride/methanol = 9:1)<br>
C2aH30N4O3<br>
ESI mass spectrum: m/z = 471 [M+H+]<br><br><br>
Example 5<br>
3-Z-[1-(4-methylaminomethyl-anilino)-1-phenyl-methylene] -6-<br>
e thoxycarbonyl - 2 - indol inone	 "<br>
100 mg of 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)-<br>
1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone are<br>
dissolved in 20 ml of ethanol, 0.2 ml of IN hydrochloric acid<br>
are added and the mixture is hydrogenated for 70 minutes at<br>
room temperature and 50 psi hydrogen pressure.  The reaction<br>
solution is filtered and the filtrate concentrated by rotary<br>
evaporation. The residue is dried in  vacuo  at 100°C.<br>
Yield: 50 mg (53 % of theory),<br>
Rf value: 0.3 (silica gel, methylene chloride/ethanol/ammonia<br>
=5:1:0.01)<br>
C26H2SN303<br>
ESI mass spectrum: m/z = 426 [M-H"]<br>
The following compounds are prepared analogously to Example 5:<br>
(1)	3-Z-[1-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Prepared from 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
R£ value: 0.2 (silica gel, methylene chloride/methanol/ammonia<br>
= 10:1:0.01)<br>
C2SH23N303<br>
ESI mass spectrum: m/z = 412 [M-H"]<br>
(2)	3-Z^[1-(4-(N-(2-methylamino-ethyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from 3-Z-[1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia<br>
= 10:1:0.01)<br>
C27H28N405S<br>
ESI mass spectrum: m/z = 519 [M-H"]<br>
(3)	3-Z- [1-(4-(N-(2-amino-ethyl)-N-methylsulphonyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-cyanomethyl-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C26H26N4OsS<br>
ESI mass spectrum: m/z = 505 [M-H"]<br>
(4)	3-Z-[1-(4-(N-(3-methylamino-propyl)-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from 3-Z-[1-(4-(N-(3-(N-benzyl-N-methyl-amino)-<br>
propyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C28H30N4O5S<br>
ESI mass spectrum: m/z = 533 [M-H ]<br>
(5)	3-Z-[1-(4-(N-(piperazin-1-yl-methylcarbonyl)-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from 3-Z-[1-(4-(N-((4-benzyl-piperazin-l-yl)-<br>
methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H31NsO4<br>
ESI mass spectrum: m/z = 524 [M-H"]<br><br><br><br>
(6)	3-Z-[1-(4-(N-(methylamino-methylcarbonyl)-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)-<br>
methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 9:1)<br>
C27H26N404<br>
ESI mass spectrum: m/z = 469 [M-H~]<br>
(7)	3-Z-[1-(4-(N-((2-methylamino-ethyl)-carbonyl)-N-methyl-<br>
amino) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from 3-Z- [1- (4-(N-((2-(N-benzyl-N-methyl-amino)-<br>
ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia<br>
= 5:1:0.01)<br>
C2BH28N404<br>
ESI  mass   spectrum:   m/z   =  483    [M-H"]<br>
Example   6<br>
3-Z-[1-(4-ureidomethyl-anilino)-1-phenyl-methylene]-6-methoxy-<br>
carbonvl-2 -indolinone	<br>
300 mg of 3-Z-[1-(4-aminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone are dissolved in 15 ml of methanol and 200 ml of triethylamine are added. Then 4 00 mg of potassium cyanate in 5 ml of water are added. After 2 days of stirring at room temperature the reaction solution is concentrated by rotary evaporation, the residue taken up in methylene chloride and washed once with water and once with saturated sodium chloride solution.  The organic phase is dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried in  vacuo  at 10 0°C.<br>
Yield: 100 mg of (21 % of theory),<br><br><br>
Rf value:   0.7   (silica gel,   methylene  chloride/methanol   =  5:1)<br>
C25H22N404<br>
ESI  mass   spectrum:   m/z   =  441   [M-H~]<br>
Example   7<br>
3-Z-[1-(4-guanidinomethyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonvl-2 -indolinone	<br>
300 mg of 3-Z- [1- (4,-aminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of dimethylformamide and 300 ml of triethylamine are added. Then 700 mg of 3,5-dimethylpyrazol-l-carboxylic acid amidine in 5 ml of dimethylformamide are added. After one day of stirring at room temperature the reaction solution is concentrated by rotary evaporation. The residue is dried at 100°C in  vacuo.<br>
Yield: 200 mg (87 % of theory),<br>
Rf value: 0.1 (Reversed phase RP 8, methanol/five percent<br>
saline solution = 6:4)<br>
^25^23^03<br>
Mass spectrum: m/z = 441 [M+]<br>
Example 8<br>
3-Z-[1-(4-acetylaminomethyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone	<br>
100. mg of 3-Z-[1-(4-aminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of glacial acetic acid, 0.1 ml of acetic anhydride is added and the mixture is stirred for 10 minutes at room temperature. After this time the reaction solution is poured onto saturated soda solution and extracted four times with methylene chloride.  The combined organic phases are washed with saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried at 100°C in  vacuo.<br><br><br>
Yield: 20 mg (23 % of theory),<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C26H23N304<br>
ESI mass spectrum: m/z = 440 [M-H"]<br>
The following compounds are prepared analogously to Example 8:<br>
(1)	3-Z-[1-(4-(N-methylsulphonyl-aminomethyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl- 2 -indolinone<br>
Prepared from 3-Z-[1-(4-aminomethyl-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone and methanesulphonyl<br>
chloride/triethylamine<br>
Rf value: 0.7 (silica gel, methylene chloride/methanol = 5:1)<br>
ESI mass spectrum: m/z = 476 [M-H"]<br>
(2)	3-Z-[1-(4-(4-benzoyl-piperazin-l-yl-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
Prepared from 3-Z- [1-(4-(piperazin-1-yl-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2-indolinone and benzoyl<br>
chloride<br>
Rf value: 0.7 (silica gel, methylene chloride/methanol = 10:1)<br>
C3SH32N404<br>
ESI mass spectrum: m/z = 571 [M-H"]<br>
(3)	3-Z-[1-(4-((N-(3-acetylamino-propyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-<br>
indolinone<br>
Prepared from 3-Z-[1-(4-((N-(3-amino-propyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 9:1)<br>
C30H32N4O4<br>
ESI mass spectrum: m/z = 511 [M-H ]<br><br>
Example 9<br>
3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene1-6-carboxy-2-indolinone	<br>
0.8 g of 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone are dissolved in 30 ml of ethanol, 8.3 ml of IN sodium hydroxide solution are added and the mixture is stirred for 1 hour at 8 0°C. After cooling, it is neutralised with 8.3 ml of IN hydrochloric acid. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried in  vacuo  at 100°C.<br>
Yield: 0.7 g of (89 % of theory),<br>
RE value: 0.2 (silica gel, methylene chloride/methanol = 5:2)<br>
C28H27N303<br>
Mass spectrum: m/z = 453 [M+]<br>
The following compounds are prepared analogously to Example 9:<br>
(1)	3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene] -6-carboxy-<br>
2-indolinone<br>
Prepared from 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-<br>
6 -ethoxycarbony1-2-indolinone<br>
Rf value: 0.4 (silica gel, toluene/ethyl acetate = 5:1)<br>
C22H15BrN203<br>
ESI mass spectrum: m/z = 43 5/43 7 [M+H+]<br>
(2)	3-Z-[1-(3-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(3-(dimethylaminomethyl)-anilino)-<br>
1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
Rf value: 0.7 (Reversed phase RP 8, methanol/five percent<br>
saline solution =4:1)<br>
C25H23N303<br>
ESI mass spectrum: m/z = 414 [M+H+]<br><br><br><br><br>
(3)	3-Z-[1-(4-(dimethylaminomethyl)-anilino) -1-phenyl-<br>
methylene]- 6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-<br>
1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
Rf value: 0.7 (Reversed phase RP 8, methanol/five percent<br>
saline solution =4:1)<br>
C25H23N303<br>
ESI mass spectrum: m/z = 412 [M-H"]<br>
(4)	3-Z-[1-(4- [ (2,6-dimethyl-piperidin-l-yl)-methyl]-anilino)-<br>
1-phenyl-methylene]- 6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-[ (2,6-dimethyl-piperidin-l-yl)-<br>
methyl] -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.6 (Reversed phase RP 8, methanol/five percent<br>
saline solution = 4:1)<br>
C30H31N3O3<br>
ESI mass spectrum: m/z = 482 [M+H+]<br>
(5)	3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-1-phenyl-<br>
methylene]- 6-carboxy-2 -indolinone<br>
Prepared from 3-Z- [1-(4-(l-methyl-imidazol-2-yl) -anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Rf value: 0.6 (Reversed phase RP 8, methanol/five percent<br>
saline solution =4:1)<br>
C26H20N4O3<br>
ESI mass spectrum: m/z = 435 [M-H"]<br>
(6)	3-Z-[1-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-acetyl-N-<br>
dimethylaminocarbonylmethyl-amino) -anilino) -1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Rf value: 0.3 (silica gel, methylene chloride/methanol = 10:1)<br>
C28H26N405<br>
ESI mass spectrum: m/z = 497 [M-H"]<br><br>
(7)	3-Z- [1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6-<br>
carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
Rf value: 0.6 (Reversed phase RP 8, methanol/five percent<br>
saline solution = 4:1)<br>
C2SH23N303<br>
ESI mass spectrum: m/z = 412 [M-H~]<br>
(8)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -<br>
anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-<br>
methyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-<br>
2-indolinone<br>
Rf value: 0.6 (Reversed phase RP 8, methanol/five percent<br>
saline solution = 4:1)<br>
C27H26N404<br>
ESI mass spectrum: m/z = 469 [M-H"]<br>
(9)	3-Z-[1-(4-(N-tert.butoxycarbonyl-ethylaminomethyl)-<br>
anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-ethylamino¬<br>
methyl) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-<br>
indolinone<br>
Rf value: 0.4 (silica gel, methylene chloride/methanol = 10:1)<br>
C30H31N3O5<br>
ESI mass spectrum: m/z = 512 [M-H"]<br>
(10)	3-Z-[1-(4-((N-carboxymethyl-N-methyl-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-((N-ethoxycarbonylmethyl-N-methyl-<br>
amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl<br>
-2-indolinone<br><br><br>
Rf value: 0.4 (silica gel, methylene chloride/methanol =6:1)<br>
C27H25N305<br>
ESI mass spectrum: m/z = 470 [M-H ]<br>
Example 10<br>
3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxvcarbonyl-2 -indolinone	<br>
0.9 g of 3-Z- [1- (4-,"(piperidin-l-yl-methyl) -anilino) -l-phenyl-methylene]-6-carboxy-2-indolinone are suspended in 35 ml of dimethylformamide and 0.4 g of carbonyldiimidazole are added. The mixture is stirred for 14 hours at 80°C. After this time<br>
2	0 ml of methanol are added and the mixture is stirred for<br>
another 3 hours at 50°C. The solvent is removed and the<br>
residue is purified over a silica gel column with methylene<br>
chloride/methanol (3:1) as eluant.<br>
Yield: 0.5 g of (49% of theory),<br>
RE value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
3	0:1)<br>
C29H29N303<br>
ESI mass spectrum: m/z = 468 [M+H+]<br>
The following compounds are prepared analogously to Example 10:<br>
(1)	3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenyl-<br>
methylene]- 6-benzyloxycarbonyl-2 -indolinone<br>
Prepared from 3-Z- [1-(4-(piperidin-l-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxy-2-indolinone and benzyl alcohol<br>
Rf value: 0.6 (aluminium oxide, methylene chloride/methanol =<br>
30:1)<br>
C3SH33N303<br>
Mass   spectrum:   m/z   =   543    [M+]<br>
(2)	3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-isopropyloxycarbonyl-2 -indolinone<br><br><br>
Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone and isopropanol Rf value: 0.4 (aluminium oxide, methylene chloride/isopropanol<br>
= 30:1)<br>
Mass   spectrum:   m/z   =   495    [M+]<br>
(3)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] -6-propyloxycarbonyl-2-indolinone<br>
Prepared  from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxy-2-indolinone  and n-propanol<br>
Rf  value:   0.7   (silica  gel,   methylene  chloride/methanol   =" 5:1)<br>
C31H33N303<br>
Mass   spectrum:   m/z   =  495    [M+]<br>
(4)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] -6-butyloxycarbonyl-2-indolinone<br>
Prepared  from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxy-2-indolinone  and n-butanol<br>
Rf  value:   0.5   (silica gel,   methylene  chloride/methanol   =   10:1)<br>
C32H35N303<br>
Mass   spectrum:   m/z   =  509    [M+]<br>
(5)	3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-6-carbamoyl-<br>
2 -indolinone<br>
Prepared  from 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-<br>
6-carboxy-2-indolinone  and ammonia<br>
Rf  value:   0.5   (silica  gel,   methylene  chloride/methanol   =   10:1)<br>
C22H16BrN203<br>
Mass spectrum: m/z = 432/434 [M-H~]<br>
(6)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-ethylcarbamoyl-2 -indolinone<br>
Prepared from 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone and ethylamine gas Rf value: 0.6 (silica gel, methylene chloride/methanol = 5:1)<br><br><br>
C30H32N4O2<br>
Mass spectrum: m/z = 480 [M+]<br>
(7)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-[(2-methoxy-ethoxy)-carbonyl]-2-indolinone<br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)~<br>
l-phenyl-methylene]-6-carboxy-2-indolinone and methylglycol<br>
Rf value: 0.8 (silica gel, methylene chloride/methanol = 4:1)<br>
C25H23N303<br>
ESI mass spectrum: m/z = 470 [M-H"]<br>
(8)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-l-phenyl-<br>
methylene]-6-[(2-dimethylamino-ethoxy)-carbonyl]-2-indolinone<br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-<br>
l-phenyl-methylene]-6-carboxy-2-indolinone and<br>
2-dimethylaminoethanol aniline<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol = 5:2)<br>
C29H32N403 •<br>
ESI mass spectrum: m/z = 483 [M-JTJ<br>
(9)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-l-phenyl-<br>
methylene]-6-[(2-N-tert.butoxycarbonyl-amino-ethoxy)-<br>
carbonyl]-2-indolinone<br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-l-phenyl-methylene]-6-carboxy-2-indolinone and 2-N-tert .butoxycarbonyl-amino-ethanol aniline<br>
Rf value: 0.8 (silica gel, methylene chloride/methanol = 5:2) C32H36N405 ESI mass spectrum: m/z = 412 [M-H"]<br>
(10)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-l-phenyl-<br>
methylene]-6-[(2,2,2-trifluoroethoxy)-carbonyl]-2-indolinone<br><br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-<br>
1-phenyl-methylene]- 6-carboxy-2-indolinone and 2,2,2-<br>
trifluoroethanol aniline<br>
R£ value: 0.5 (silica gel, methylene chloride/methanol = 5:1)<br>
C27H24F3N303<br>
ESI   mass   spectrum:   m/z   =   494    [M-H~]<br>
Example 11<br>
3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methvlene]-6-carbamoyl-2-indolinone	<br>
0.9 g of 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone, 0.8 g of TBTU and 0.4 g of HOBT are suspended in 25 ml of dimethylformamide and 1.0 ml of triethylamine are added.  The mixture is stirred for 15 minutes at room temperature. After this time ammonia gas is introduced at 10-15°C over a period of 15 minutes and the mixture is stirred for 1.5 hours at room temperature. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried at 10 0°C in  vacuo.<br>
Yield: 0.6 g (64 % of theory),<br>
Rf value: 0.4 (Reversed phase RP 8, methanol/five percent<br>
saline solution = 6:4)<br>
C28H28N402<br>
ESI mass spectrum: m/z = 453 [M+H+]<br>
The following compounds are prepared analogously to Example 11:<br>
(1) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-dimethylcarbamoyl-2-indolinone Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone and dimethylamine hydrochloride/diisopropylethylamine<br><br><br><br>
R£ value:   0.5   (silica  gel,   methylene   chloride/methanol   =   5:1)<br>
C30H32N4O2<br>
ESI  mass   spectrum:   m/z   =  481   [M+H+]<br>
(2)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] -6-(N-ethyl-N-methyl-carbamoyl)-2-indolinone<br>
Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxy-2-indolinone  and N-ethyl-<br>
N-methyl-amine<br>
Rf value:   0.5   (aluminium oxide,   methylene  chloride/ethanol   =<br>
20:1)<br>
C31H34N402<br>
ESI mass spectrum: m/z = 495 [M+H+]<br>
(3)	3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] - 6-methylcarbamoyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxy-2-indolinone and methylamine<br>
hydrochloride/diisopropylethylamine<br>
Rf value: 0.3 (aluminium oxide, methylene chloride/ethanol =<br>
20:1)<br>
C29H30N4O2<br>
ESI  mass   spectrum:   m/z   =  467   [M+H+]<br>
(4)	3-Z-[1-(3-(dimethylaminomethyl)-anilino)-1-phenyl-<br>
methylene] -6-methylcarbamoyl-2-indolinone<br>
Prepared  from  3-Z-[1-(3-(dimethylaminomethyl)-anilino)-<br>
1-phenyl-methylene]-6-carboxyl-2-indolinone  and methylamine<br>
hydrochloride/triethylamine<br>
Rf value:   0.3    (silica  gel,   methylene  chloride/ethanol   =  2:1)<br>
C26H26N402<br>
Mass   spectrum:   m/z   =  426    [M+]<br>
(5)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-<br>
methylene] -6-(2-hydroxyethyl-carbamoyl)-2-indolinone<br><br>
Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-<br>
1-phenyl-methylene]- 6-carboxy-2-indolinone and<br>
ethanolamine/diisopropylethylamine<br>
Rf value: 0.5 (aluminium oxide, methylene chloride/methanol =<br>
20:1)<br>
C30H32N4O3<br>
ESI mass spectrum: m/z = 4 95 [M-H~]<br>
(6)	3-Z- [1- (4- (pipe.ridin-1-yl-methyl) -anilino) -1-phenyl-<br>
methylene]-6-diethylcarbamoyl-2 -indolinone<br>
Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-indolinone and diethylamine hydrochloride/diisopropylethylamine R£ value: 0.8 (aluminium oxide, methylene chloride/methanol =<br>
10:1)<br>
C32H36N402<br>
ESI mass spectrum: m/z = 509 [M+H+]<br>
(7)	3-Z-[IT(4-(N-tert.butoxycarbonyl-ethylaminomethyl)-<br>
anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-<br>
ethylaminomethyl)-anilino)-1-phenyl-methylene]-6-carboxy-2-<br>
indolinone<br>
Rf value: 0.3 (silica gel, toluene/ethyl acetate/ethanol =<br>
4:2:1)<br>
C30H32N4O4<br>
ESI mass spectrum: m/z = 511 [M-H"]<br>
(8)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinone<br>
Prepared from 3-Z-[1-(4-(N-dimethylaminomethylcarbohyl-N-<br>
methyl-amino)-anilino)-1-phenyl-methylene]-6-carboxy-2-<br>
indolinone<br>
Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia = 5:1:0.01)<br><br><br><br>
C27H27N503<br>
ESI   mass   spectrum:   m/z   =   468    [M-H"]<br>
Example   12<br>
3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
x citric acid	<br>
3.25 g of citric acid monohydrate are placed in 50 ml of methanol and 5.0 g of 3-Z-[1-(4-(N-dimethylaminomethyl-carbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone are added at room temperature. The solution formed is evaporated down, the residue is washed with ether and recrystallised from ethyl acetate. Yield: 6.3 g (90 % of theory),<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia =5:1:0.01) Melting point: 198°C C28H28N4Os x C6H807<br>
ESI mass spectrum: m/z = 483 [M-H"]<br>
Elemental analysis: calc: C 60.34  H 5.37  N 8.28<br>
found:   59.98    5.25    8.13<br>
The following compound is prepared analogously to Example 12:<br>
(1) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-2-indolinone x methanesulphonic acid<br>
Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and methanesulphonic acid<br>
Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia = 5:1:0.01) Melting point: 275°C C26H25N303 x CH403S ESI mass spectrum: m/z = 426 [M-H"]<br><br><br>
Elemental analysis: calc.: C 61.92  H 5.59  N 8.03  S 6.12<br>
found:   61.43    5.87    7.85    5.39<br>
The following compounds may be prepared analogously to the foregoing Examples:<br>
(1)	3-Z-(1-anilino-1-phenyl-methylene)-6-ethoxycarbonyl-2-indolinone<br>
(2)	3-Z-[1-(4-nitro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(3)	3-Z- [1-(4-fluoro-anilino)-1-phenyl-methylene]-6-ethoxy-carbonyl-2 -indolinone<br>
(4)	3-Z- [1-(4-chloro-anilino)-1-phenyl-methylene]-6-ethoxy-carbonyl-2 -indolinone<br>
(5)	3-Z-[1-(4-iodo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(6)	3-Z- [1-(4-cyano-anilino)-1-phenyl-methylene]-6-ethoxy-carbonyl-2 -indolinone<br>
(7)	3-Z-[1-(4-methoxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(8)	3-Z-[1-(4-ethoxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(9)	3-Z-[1-(4-trifluoromethyl-anilino)-1-phenyl-methylene]-<br>
6-ethoxycarbonyl-2-indolinone<br>
(10)	3-Z-[1-(4-methyl-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br><br>
(11)	3-Z-[1-(4-methylmercapto-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(12)	3-Z-[1-(4-aminomethyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(13)	3-Z-[1-(4-(isopropylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(14)	3-Z-[1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(15)	3-Z-[1-(4-(propylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(16)	3-Z-[1-(4-(butylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(17)	3-Z-[1-(4-(isobutylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(18)	3-Z-[1-(4-(cyclohexylaminomethyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(19)	3-Z-[1-(4-(benzylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(20)	3-Z-[1-(4-((N-ethyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(21)	3-Z-[1-(4-((N-methyl-N-propyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(22)	3-Z-[1-(4-((N-isopropyl-N-methyl-amino)-methyl)-anilino) 1-phenyl-methylene]- 6 -ethoxycarbonyl-2 -indolinone<br><br><br><br>
(23)	3-Z- [1-(4-((N-ethyl-N-propyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(24)	3-Z- [1-(4-((N-ethyl-N-isopropyl-amino)-methyl)-anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(25)	3-Z-[1-(4-(dipropylaminomethyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(26)	3-Z- [1-(4-(diisopropylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
(27)" 3-Z-[1-(4-((N-benzyl-N-ethyl-amino)-methyl)-anilino)-1-phenyl-methylene]- 6 -ethoxycarbonyl-2 -indolinone<br>
(28)	3-Z-[1-(4-(dibenzylaminomethyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbony1-2 -indolinone<br>
(29)	3-Z- [1-(4-(3,6-dihydro-2H-pyridin-l-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(30)	3-Z- [1-(4-(3,5-dimethyl-piperidin-l-yl-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(31)	3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(32)	3-Z- [1-(4-(piperazin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(33)	3-Z- [1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(34)	3-Z- [1-(4-(thiomorpholin-4-yl-methyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(35)	3-Z-[1-(4-(l-oxo-thiomorpholin-4-yl-methyl)-anilino)-<br>
1-phenyl-methylene]-6 -ethoxycarbonyl- 2 -indolinone<br>
(36)	3-Z- [1- (4- (1,l-dioxo-thiomorpholin-4-yl-methyl)-anilino)-1-phenyl-methylene]- 6 -ethoxycarbonyl-2 -indolinone<br>
(37)	3-Z-[1-(4-(acetylamino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(38)	3-Z-[1-(4-(2-amino-ethyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(39)	3-Z-[1-(4-(2-methylamino-ethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(40)	3-Z- [1- (4-.(2-ethylamino-ethyl) -anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(41)	3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(42)	3-Z-[1-(4-(2-piperidin-l-yl-ethyl)-anilino)-1-phenyl-methylene]- 6 -ethoxycarbonyl-2 -indolinone<br>
(43)	3-Z-[1-(4-(2-acetylamino-ethyl)-anilino)-l-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(44)	3-Z-[1-(4-(3-amino-propyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(45)	3-Z-[1-(4-(3-dimethylamino-propyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(46)	3-Z-[1-(4-(N-aminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(47)	3-Z-[1-(4-(N-methylaminomethylcarbonyl-N-methyl-amino) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl~2-indolinone<br>
(48)	3-Z- [1-(4-(N-ethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(49)	3-Z-11- (4- lE-diethylaminomethylcarbonyl-TSI-methyl-amino) anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(50)	3-Z- [1- (4- (N- (pipejridin-1-yl-methylca-rbonyl) -N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(51)	3-Z-[1-(4-(N-(morpholin-4-yl-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(52)	3-Z- [1-(4-(N-(piperazin-1-yl-methylcarbonyl)-N-methyl-amino]-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl~2-indolinone<br>
(53)	3-Z-[1-(4-(N-(2-amino-ethylcarbonyl) -N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(54)	3-Z-[1-(4-(N-(2-methylamino-ethylcarbonyl)-N-methyl-amino) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(55)	3-Z-[1-(4-(N-(2-diethylamino-ethylcarbonyl)-N-methyl-amino) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(56)	3-Z-[1-(4-(N-acetyl-N-(2-aminoethyl) -amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(57)	.3-Z-[1-(4-(N-acetyl-N-(2-methylamino-ethyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(58)	3-Z-[1-(4-(N-acetyl-N-(2-methylamino-propyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(59)	3-Z-[1-(4-(N-acetyl-N-(2-piperidin-l-yl-ethyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(60)	3-Z-[1-(4-(N-acetyl-N-(aminocarbonylmethyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(61)	3-Z-[1-(4-(N-acetyl-N-(dimethylaminocarbonylmethyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(62)	3-Z-[1-(4-(N-acetyl-N-(piperidin-1-yl-carbonylmethyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(63)	3-Z-[1-(4-(N-methyl-N-(aminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(64)	3-Z-[1-(4-(N-methyl-N-(methylaminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(65)	3-Z-[l-(4-(N-methyl-N-(dimethylaminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(66)	3-Z-[1-(4-(N-methyl-N-(piperidin-1-yl-carbonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(67)	3-Z-[1-(4-(N-(2-aminoethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(68)	3-Z-[1-(4-(N-(2-methylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(69)	3-Z-[1-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(70)	3-Z-[1-(4-(N-(2-disthylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(71)	3-Z-[1-(4-(N-(2-pyrrolidin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(72)	3-Z-[1-(4-(N-(2-piperidin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(73)	3-Z-[1-(4-(N-(2-piperazin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(74)	3-Z-[1-(4-(N-(2-(morpholin-4-yl)-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br><br>
(75)	3-Z-[l-(4-(N-(aminocarbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(76)	3-Z-[1-(4-(N-(methylaminocarbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br><br><br>
(77)	3-Z-[1-(4-(N-(ethylaminocarbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(78)	3-Z-[1-(4-(N-(N-(2-dimethylamino-ethyl)-N-methyl-amino)-carbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2 -indolinone<br>
(79)	3-Z-[l-(4-(N-(diethylaminocarbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(80)	3-Z-[1-(4-(N-(pyrrolidin-1-yl-carbonylmethyl)-N-methyl¬<br>
sulphonyl -amino) -anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(81)	3-Z-[1-(4-(N-(piperidin-1-yl-carbonylmethyl)-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(82)	3-Z-[1-(4-(N-(piperazin-1-yl-carbonylmethyl)-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(83)	3-Z- [1- (4- (N- ( (morpholin-4-yl)-carbonylmethyl)-N-methyl¬<br>
sulphonyl-amino) -anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(84)	3-Z-[1-(4-(2-dimethylamino-ethoxy)-anilino)-1-phenyl-<br>
methylene] - 6-ethoxycarbonyl-2 -indolinone<br>
(85)	3-Z-[1-(4-(3-dimethylamino-propoxy)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2 -indolinone<br>
(86)	3-Z-[1-(4-(aminocarbonylmethyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br><br><br>
(87)	3-Z-[1-(4-(2-aminocarbonyl-ethyl)-anilino)-1-phenyl-<br>
methylene]-6-ethoxycarbonyl-2-indolinone<br>
(88)	3-Z-[1-(4-(pyridin-2-yl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(89)	3-Z-[1-(4-(pyridine-3-yl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(90)	3-Z-[1-(4-(pyridin-4-yl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(91)	3-Z-[1-(4-(N-acetyl-N-methyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(92)	3-Z-[1-(4-(N-ethylcarbonyl-N-(dimethylaminocarbonyl-methyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(93)	3-Z-[1-(carbamoylmethyl-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(94)	3-Z-[1-(4-dimethylcarbamoylmethyl-anilino)-1-phenyl-methylene] -6 -ethoxycarbonyl-2 -indolinone<br>
(95)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(96)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-propylidene]-6-ethoxycarbonyl-2 -indolinone<br>
(97)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-butylidene]-6-ethoxycarbonyl-2 -indolinone<br><br>
(98)	3-Z- [1- (4- (N- (3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(99)	3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-ethylidene]-6-ethoxycarbonyl-2-indolinone<br><br>
(100)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-propylidene]-6-ethoxycarbonyl-2-indolinone<br>
(101)	3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-butylidene]-6-ethoxycarbonyl-2-indolinone<br>
(102)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(103)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-propylidene]-6-ethoxycarbonyl-2-indolinone<br>
(104)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-butylidene]-6-ethoxycarbonyl-2-indolinone<br>
(105)	3-Z-[1-(4-tetrazol-5-yl-anilino)-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(106)	3-Z-[1-(4-tetrazol-5-yl-anilino)-ethylidene] -6-ethoxy-carbonyl-2 -indolinone<br><br>
(107)	3-Z- [1- (4-tetrazol-5-yl--anilino) -propylidene] -6-ethoxy-carbonyl-2 -indolinone<br>
(108)	3-Z-[1-(4-tetrazol-5-yl-anilino)-butylidene]-6-ethoxycarbonyl-2-indolinone<br>
(109)	3-Z-[1-(4-carboxy-anilino)-methylene] -6-ethoxycarbonyl-2-indolinone<br><br>
(110)	3-Z-[1-(4-carboxy-anilino)-propylidene]-6-ethoxycarbonyl-2 -indolinone<br>
(111)	3-Z- [1-(4-carboxy-anilino)-butylidene] -6-ethoxycarbonyl-2-indolinone<br>
(112)	3-Z- [1-(4-(N-(3-dimethylamino-propionyl)-N-dimethylaminocarbonylmethyl-amino)-anilino)-l-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(113)	3-Z- [1-(4-(N-(4-dimethylamino-butyryl)-N-dimethylaminocarbonylmethyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(114)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-(2-dimethylamino-ethylsulphonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(115)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-(3-dimethylamino-propylsulphonyl)-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(116)	3-Z-[1-(4-((2-hydroxy-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(117)	3-Z-[1-(4-((2-methoxy-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(118)	3-Z-[1-(4-((2-dimethylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(119)	3-Z-[1-(4-((3-dimethylamino-propyl)-amino-methyl)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br><br>
(120)	3-Z-[1-(4-((N-tert.butoxycarbonyl-2-amino-ethyl)-amino-methyl) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(121)	3-Z-[1-(4-((N-tert.butoxycarbonyl-3-amino-propyl)-amino-methyl) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(122)	3-Z- [1- (4- ( (2.-amino-ethyl) -amino-methyl) -anilino) -1-pheny1-methylene]-6-ethoxyc arbony1-2 -indo1inone<br>
(123)	3-Z-[1-(4-((3-amino-propyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(124)	3-Z-[1-(4-((2-acetylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(125)	3-Z-[1-(4-((3-acetylamino-propyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(126)	3-Z-[1-(4-((2-methylsulphonylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(127)	3-Z-[1-(4-((3-methylsulphonylamino-propyl)-amino-methyl) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(128)	3-Z-[1-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-N-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(129)	3-Z-[1-(4-(N-(2-amino-ethyl)-N-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br><br>
(130)	3-Z-[1-(4-(N-(2-acetylamino-ethyl)-N-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(131)	3-Z-[1-(4-(N-(2-methylsulphonylamino-ethyl)-N-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(132)	3-Z-[1-(4-(carboxymethyl-amino-methyl)-anilino)-1-phenyl-methylene-] -6-ethoxycarbonyl-2-indolinone<br><br>
(133)	3-Z-[1-(4-(ethoxycarbonylmethyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(134)	3-Z-[1-(4-(carbamoylmethyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(135)	3-Z-[1-(4-(dimethylcarbamoyl-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(136)	3-Z-[1-(4-(methylcarbamoyl-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(137)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-amino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(138)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-nitro-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(13 9) 3-Z-[l-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-acetylamino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br><br>
(140)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methylsulphonylamino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(141)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-cyano-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(142)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-hydroxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(143)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methoxy-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2 -indolinone<br><br>
(144)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-ethoxycarbonyl~anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(145)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-carboxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(146)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-carbamoyl-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(147)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-chloro-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(148)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-fluoro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(149)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-bromo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(150)	3-Z- [1- (4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(151)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-trifluoromethyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(152)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3,5-dibromo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(153)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3,5-dichloro-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(154)	3-Z- [1-(4-(dimethylaminomethyl)-3-amino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(155)	3-Z- [1-(4-(dimethylaminomethyl)-3-nitro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br><br>
(156)	3-Z- [1-(4-(dimethylaminomethyl)-3-acetylamino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(157)	3-Z-[1-(4-(dimethylaminomethyl)-3-(methylsulphonylamino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(158)	3-Z- [1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1-<br>
phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br><br>
(159)	3-Z-[1-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(160)	3-Z-[1-(4-(dimethylaminomethyl)-3-methoxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(161)	3-Z-[1-(4-(dimethylaminomethyl)-3-(ethoxycarbonyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(162)	3-Z-[1-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(163)	3-Z-[1-(4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(164)	3-Z-[1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(165)	3-Z-[1-(4-(dimethylaminomethyl)-3-fluoro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(166)	3-Z-[1-(4-(dimethylaminomethyl)-3-bromo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(167)	3-Z-[1-(4-(dimethylaminomethyl)-3-methyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(168)	3-Z-[1-(4-(dimethylaminomethyl)-3-trifluoromethyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(169)	3-Z-[1-(4-(dimethylaminomethyl)-3,5-dibromo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(170)	3-Z-[1-(4-(dimethylaminomethyl)-3,5-dichloro-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(171)	3-Z- [1-(4-(N-((4-methyl-piperazin-l-yl)-methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone<br>
(172)	3-Z-[1-(4-(N-(imidazo~l-yl-methylcarbonyl)-N-methyl-amino) -anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(173)	3-Z- [1- (4- (N-„"(phthalimido-2-yl-methylcarbonyl) -N-methyl-amino) -anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br>
(174)	3-Z-[1-(4-(N-aminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(175)	3-Z- [1-(4-(N-acetylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(176)	3-Z-[1-(4-(N-methylsulphonylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(177)	3-Z-[1-(4-(N-((N-(2-methoxyethyl) -N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6 -ethoxycarbony1-2 -indolinone<br><br>
(178)	3-Z- [1-(4- (N-((N-(2-dimethylaminoethyl)-N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(179)	3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)-methylcarbonyl)-N-methyl-amino)-anilino) -1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(180)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone<br><br>
(181)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-ethylidene]-6-ethoxycarbonyl-2-indolinone<br>
(182)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-propylidene]-6-ethoxycarbonyl-2-indolinone<br>
(183)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-butylidene]-6-ethoxycarbonyl-2-indolinone<br>
(184)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(185)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6-ethoxycarbonyl-2-indolinone<br>
(186)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-propylidene]-6-ethoxycarbonyl-2 -indolinone<br>
(187)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-butylidene]-6-ethoxycarbonyl-2 -indolinone<br>
(188)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(189)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(190)	3-Z-[1-(4-((imidazolidin-2/4-dion-5-ylidene)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(191)	3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(192)	3-Z-[1-(4-(N-tert.butoxycarbonyl-aminomethyl)-anilino) 1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(193)	3-Z-[1-(4-(2-oxo-pyrrolidin-l-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(194)	3-Z-[1-(4-(N-aminocarbonylmethyl-N-methylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(195)	3-Z-[1-(4-(N-cyanomethyl-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(196)	3-Z-[1-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(197)	3-Z-[1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-N-<br>
methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(198)	3-Z-[1-(4-cyclohexylamino-anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(199)	3-Z-[1-(4-(imidazol-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(200)	3-Z-[1-(4-(imidazol-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(201)	3-Z-[1-(N-methyl-piperidine-4-yl-amino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(202)	3-Z-[1-(4-(imidazol-4-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(203)	3-Z-[1-(4-((4-hydroxy-piperidin-l-yl)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(204)	3-Z- [1- (4- ( (4-methoxy-piperidin-l-yl)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(205)	3-Z-[1-(4-benzyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(206)	3-Z- [1-(4-(N-(3-trifluoroacetylamino-propyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(207)	3-Z- [1-(4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(208)	3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(209)	3-Z- [1-(4-(l-methyl-imidazol-2-yl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(210)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-3-amino-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(211)	3-Z-[1-(4-((3-(N-benzyl-N-methyl-amino)-propyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(212)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-acetyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(213)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-butyryl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br><br>
(214)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-isobutyryl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(215)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-benzoyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(216)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3-amino-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(217)	3-Z-[l-(4-(4-hydroxymethyl-piperidin-l-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(218)	3-Z-[1-(4-(2-(4-hydroxy-piperidin-l-yl)-ethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(219)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-propylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(220)	3-Z- [1- (4- (N- (2-dimethylamino-ethyl)-N-butylsulphonyl-<br>
amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-<br>
2-indolinone<br>
(221)	3-Z- [1- (4- (N- (2-dimethylamino-ethyl)-N-phenylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(222)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-benzylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(223)	3-Z-[1-(4-((imidazolidin-2,4-dion-5-yl)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(224)	3-Z-[1-(4-((3-hydroxy-pyrrolidin-l-yl)-methyl)-anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(225)	3-Z-[1-(4-(cyclohexylyl-methyl)-anilino) -1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(226)	3-Z-[1-(4-(cyclohexyl-carbonyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(227)	3-Z-[1-(4-diethylaminomethyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(228)	3-Z-[1-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(229)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2-carbonyl)-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2 -indolinone<br>
(230)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl) -N-(2-methoxy-benzoyl)-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(231)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(pyridine-3-<br>
carbonyl)-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(232)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)-<br>
amino)-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(233)	3-Z-[1-(4-(imidazol-2-yl)-anilino)-l-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(234)	3-Z-[1-(4-(l-ethyl-imidazol-2-yl)-anilino)-l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br><br><br>
(235)	3-Z-[1-(4-(l-benzyl-imidazol-2-yl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(236)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-isopropylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(237)	3-Z- [1- (4- (N-,"( (4-benzyl-piperazin-l-yl) -methylcarbonyl) -N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(238)	3-Z-[1-(4-(N-(pyrrolidin-1-yl-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(239)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3-bromo-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(240)	3-Z-[1-(4-(5-methyl-imidazol-4-yl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(241)	3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(242)	3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-benzyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(243)	3-Z-[1-(4-(N-butyl-N-tert.butoxycarbonyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(244)	3-Z-[1-(4-(N-((N-aminocarbonylmethyl-N-methyl-amino)-<br>
methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-ethoxycarbonyl-2 -indolinone<br>
(245)	3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(246)	3-Z- [1- (4- (N-,"(di- (2 - me thoxy ethyl) -amino-methylcarbonyl) -N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(247)	3-Z-[1-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-1-yl)-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6 -ethoxycarbonyl-2 -indolinone<br>
(248)	3-Z-[1-(4-(N-((2-(piperidin-1-yl)-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(249)	3-Z-[1-(4-(N-((2-(N-benzyl-N-methyl-amino)-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(250)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-isopropyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(251)	3-Z-[1-(4-(N-(piperidin-1-yl-methylcarbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(252)	3-Z-[1-(4-(N-((4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br><br>
(253)	3-Z- [1- (4-(N-((N-benzyl-N-methyl-amino)-methylcarbonyl) N-benzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl 2-indolinone<br>
(254)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-benzyl-amino) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(255)	3-Z- [1- (4- (N-,"(piperidin-l-yl-methylcarbonyl) -N-benzyl-amino) -anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(256)	3-Z-[l-(4-(l,2,4-triazol-2-yl-methyl)-anilino)-1-phenyl-methylene]-6 -ethoxycarbony1-2 -indolinone<br>
(257)	3-Z- [1-(4-(l,2,3-triazol-2-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(258)	3-Z- [1-(4-(1,2,3-triazol-l-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(259)	3-Z- [1- (4-( (N-aminocarbonylmethyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br>
(260)	3-Z-[1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(261)	3-Z-[1-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(262)	3-Z-[1-(4-((N-ethoxycarbonylmethyl-N-methyl-amino) -methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br><br><br>
(263)	3-Z- [1- (4-(azetidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(264)	3-Z-[1-(4-(N-propyl-N-tert.butoxycarbonyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(265)	3-Z-[1-(4-((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(266)	3-Z- [1-(4- ( (N-(tert.butoxycarbonyl-3-amino-propyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-<br>
ethoxycarbonyl-2 -indolinone<br>
(267)	3-Z-[1-(4-((N-(methylcarbamoyl-methyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(268)	3-Z-[1-(4-((N-(dimethylcarbamoyl-methyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(269)	3-Z-[1-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(270)	3-Z-[1-(4-((N-(2-dimethylamino-ethyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(271)	3-Z-[1-(4-((N-(3-dimethylamino-propyl)-N-methyl-amino)-<br>
methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-<br>
2-indolinone<br>
(272)	3-Z-[1-(4-((N-(2-methoxy-ethyl)-N-methyl-amino)-methyl)-<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br><br>
(273)	3-Z- [1-(4-((N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl) -<br>
anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(274)	3-Z-[1-(4-((N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone<br>
(275)	3-Z- [1- (4- (3-oxo-piperazin-l-yl-methyl)-anilino)-1-phenyl-methylene] -6,-ethoxycarbonyl-2-indolinone<br>
(276)	3-Z- [1-(4-(N-(piperazin-1-yl-methylcarbonyl)-N-isopropyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(277)	3-Z- [1- (4-(N-((2-(piperazin-1-yl)-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(278)	3-Z- [1- (4- ( (N-(3-amino-propyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(279)	3-Z-[1-(4-(N-(3-methylamino-propyl) -N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl-<br>
2-indolinone<br>
(280)	3-Z-[1-(4-Ureidomethyl-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2 -indolinone<br>
(281)	3-Z-[1-(4-guanidinomethyl-anilino)-1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone<br>
(282)	3-Z-[1-(4-(N-methylsulphonyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(283)	3-Z-[1-(4-(4-benzoyl-piperazin-l-yl-methyl)-anilino) -1-<br>
phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br><br>
(284)	3-Z-[1-(4-((N-(3-acetylamino-propyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(285)	3-Z-[1-(4-((N-(3-methylsulphonylamino-propyl)-N-methyl-amino) -methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(286)	3-Z-[1-(4-((N-carboxymethyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone<br>
(287)3-Z-(1-anilino-l-phenyl-methylene)-6-methoxycarbonyl-2-indolinone<br>
(288)	3-Z-[1-(4-nitro-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2 -indolinone<br>
(289)	3-Z- [1-(4-fluoro-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2-indolinone<br>
(290)	3-Z- [1-(4-chloro-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2-indolinone<br>
(291)	3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2-indolinone<br>
(292)	3-Z- [1-(4-iodo-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(293)	3-Z-[1-(4-cyano-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2 -indolinone<br>
(294)	3-Z-[1-(4-carboxy-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br><br>
(295)	3-Z-[1-(4-methoxy-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(296)	3-Z- [1-(4-ethoxy-anilino)-1-phenyl-methylene]-6-methoxy-carbonyl-2 -indolinone<br><br>
(297)	3-Z- [1-(4-trifluoromethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(298)	3-Z- [1-(4-methylmercapto-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(299)	3-Z- [1-(4-(isopropylaminomethyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone<br>
(300)	3-Z-[1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(301)	3-Z- [1-(4-(isobutylaminomethyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(302)	3-Z-[1-(4-(cyclohexylaminomethyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone<br><br>
(303)	3-Z- [1-(4-(benzylaminomethyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(304)	3-Z-[1-(4-((N-methyl-N-propyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(305)	3-Z- [1-(4-((N-isopropyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(306)	3-Z-[1-(4-((N-ethyl-N-propyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br><br>
(307) 3-Z- [1-(4-((N-ethyl-N-isopropyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(308)"3-Z- [1- (4-(dipropylaminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(309)	3-Z- [1-(4-(diisopropylaminomethyl)-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(310)	3-Z-[1-(4-((N-benzyl-N-ethyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(311)	3-Z-[1-(4-(dibenzylaminomethyl)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone<br>
(312)	3-Z-[1-(4-(3,6-dihydro-2H-pyridin-l-yl-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(313)	3-Z-[1-(4-(3,5-dimethyl-piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(314)	3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(315)	3-Z- [1- (4- (2-amino-ethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(316)	3-Z- [1- (4-(2-methylamino-ethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(317)	3-Z- [1-(4- (2-ethylamino-ethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(318)	3-Z-[1-(4-(2-dimethylamino-ethyl)-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl-2 -indolinone<br><br>
(319)	3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(320)	3-Z- [1- (4-(2-piperidin-l-yl-ethyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(321)	3-Z-[1-(4-(2-acetylamino-ethyl)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone<br><br>
(322)	3-Z-[1-(4-(3-amino-propyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(323)	3-Z- [1-(4-(3-dimethylamino-propyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(324)	3-Z-[1-(4-(N-aminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(325)	3-Z-[1-(4-(N-ethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(326)	3-Z-[1-(4-(N-diethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(327)	3-Z-[1-(4-(N-dipropylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(328)	3-Z-[1-(4-(N-((N-ethyl-N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
(329)	3-Z- [1-(4-(N-((N-ethyl-N-propyl-amino)-methylcarbonyl)-<br>
N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone<br><br>
(330)	3-Z-[1-(4-(N-((N-methyl-N-propyl-amino)-methylcarbonyl)-<br>
N-methyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl- 2 -indolinone<br>
(331)	3-Z- [1- (4- (N-"dimethylaminomethylcarbonyl-N-ethyl-amino) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(332)	3-Z- [1- (4- (N-dirnethylaminomethylcarbonyl-N-propyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(333)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-butyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(334)	3-Z-[l-(4-(N-(2-amino-ethylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(335)	3-Z-[1-(4-(N-(2-diethylamino-ethylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
(336)	3-Z-[1-(4-(N-acetyl-N-(2-aminoethyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(337)	3-Z-[1-(4-(N-acetyl-N-(2-methylamino-ethyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(338)	3-Z-[1-(4-(N-acetyl-N-(3-methylamino-propyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(339)	3-Z-[1-(4-(N-acetyl-N-(2-piperidin-l-yl-ethyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(340)	3-Z-[1-(4-(N-acetyl-N-(aminocarbonylmethyl)-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(341)	3-Z-[1-(4-(N-acetyl-N-(piperidin-1-yl-carbonylmethyl)-<br>
amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-<br>
indolinone<br>
(342)	3-Z-[1-(4-(N-methyl-N-(aminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(343)	3-Z-[1-(4-(N-methyl-N-(methylaminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(344)	3-Z-[1-(4-(N-methyl-N-(dimethylaminocarbonyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(345)	3-Z-[1-(4-(N-methyl-N-(piperidin-1-yl-carbonyl)-amino) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(346)	3-Z- [1-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(347)	3-Z- [1-(4-(N-(2-diethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(348)	3-Z-[1-(4-(N-(2-pyrrolidin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(349)	3-Z- [1- (4-(N-(2-piperidin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(350)	3-Z- [1- (4-(N-(2-piperazin-l-yl-ethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br><br><br>
(351)	3-Z- [1- (4- (N- (2- (4-morphc-1 in-1-yl) -ethyl) -N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl- 2 -indolinone<br>
(352)	3-Z-[1-(4-(N-(ethylaminocarbonylmethyl)-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(353)	3-Z- [1- (4- (N-,"(diethylaminocarbonylmethyl) -N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(354)	3-Z-[1-(4-(N-(pyrrolidin-1-yl-carbonylmethyl)-N-methyl-sulphonyl-amino)-anilino)-1-phenyl-methylene] -6-<br>
methoxycarbonyl-2 -indolinone<br>
(355)	3-Z-[1-(4-(N-(piperidin-1-yl-carbonylmethyl)-N-methyl-<br>
sulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
(356)	3-Z-[1-(4-(N-(piperazin-1-yl-carbonylmethyl)-N-methyl-<br>
sulphonyl-amino)-anilino)-1-phenyl-methylene] -6-<br>
methoxycarbonyl-2 -indolinone<br>
(357)	3-Z-[1-(4-(N-((morpholin-4-yl)-carbonylmethyl)-N-methyl-<br>
sulphonyl-amino)-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone<br>
(358)	3-Z-[1-(4-(2-dimethylamino-ethoxy)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2 -indolinone<br>
(359)	3-Z-[1-(4-(3-dimethylamino-propoxy)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(360)	3-Z-[1-(4-(aminocarbonylmethyl)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone<br><br><br>
(361)	3-Z- [1-(4-(2-aminocarbonyl-ethyl)-anilino)-1-phenyl-<br>
methylene]-6-methoxycarbonyl-2-indolinone<br>
(362)	3-Z- [1-(4-(pyridin-2-yl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(363)	3-Z-[1-(4-(pyridine-3-yl)-anilino)-1-phenyl-methylene]-6 -methoxycarbonyl-2,- indolinone<br>
(364)	3-Z- [1-(4((N-phenethyl-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(365)	3-Z- [1-(4-(N-acetyl-N-methyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone<br>
(366)	3-Z- [1-(4-(N-ethylcarbonyl-N-(dimethylaminocarbonyl-methyl)-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(367)	3-Z- [1-(4-(N-methyl-N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -iridolinone<br>
(368)	3-Z- [1-(4-carboxymethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(369)	3-Z- [1-(4-carbamoylmethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(370)	3-Z- [1-(4-dimethylcarbamoylmethyl-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(371)	3-Z-[1-(4-tetrazol-5-yl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(372)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
(373)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-ethylidene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
(374)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-propylidene]-6-methoxycarbonyl-2-indolinone<br>
(375)	3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-butylidene]-6-methoxycarbonyl-2 -indolinone<br>
(376)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-methylene]-6-methoxycarbonyl-2-indolinone<br>
(377)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-ethylidene]-6-methoxycarbonyl-2-indolinone<br>
(378)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-propylidene]-6-methoxycarbonyl-2-indolinone<br>
(379)	3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-butylidene]-6-methoxycarbonyl-2-indolinone<br>
(380)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-methylene]-6-methoxycarbonyl-2-indolinone<br>
(381)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-ethylidene]-6-methoxycarbonyl-2-indolinone<br>
(382)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-propylidene]-6-methoxycarbonyl-2-indolinone<br>
(383)	3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-butylidene]-6-methoxycarbonyl-2-indolinone<br><br><br><br>
(384)	3-Z- [1-(4-tetrazol-5-yl-anilino)-methylene]-6-methoxy¬carbonyl - 2 -indolinone<br>
(385)	3-Z- [1-(4-tetrazol-5-yl-anilino)-ethylidene]-6-methoxy¬carbonyl -2 -indolinone<br><br>
(386)	3-Z- [1-(4-tetrazol-5-yl-anilino)-propylidene]-6-methoxy¬carbonyl -2 -indolinone<br>
(387)	3-Z-[1-(4-tetrazol-5-yl-anilino)-butylidene]-6-methoxy¬carbonyl -2 -indolinone<br>
(388)	3-Z-[1-(4-carboxy-anilino)-methylene] -6-methoxycarbonyl -2-indolinone<br>
(389)	3-Z-[1-(4-carboxy-anilino)-ethylidene] -6-methoxycarbonyl-2 -indolinone<br>
(390)	3-Z-[1-(4-carboxy-anilino)-propylidene]-6-methoxy¬carbonyl - 2 - indolinone<br>
(391)	3-Z-[1-(4-carboxy-anilino)-butylidene]-6-methoxycarbonyl-2 -indolinone<br>
(392)	3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)-1-<br>
methyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(3 93) 3-Z-[l-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(394) 3-Z- [1-(4-((benzo(1,3)dioxol-5-yl-methyl)-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(395)	3-Z-[1-(4-(N-phenethyl-N-methyl-aminomethyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(396)	3-Z-[1-(4-(N-(3,4-dimethoxy-benzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(397)	3-Z-[1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl)-anilino)-l-methyl-m£thylene]-6-methoxycarbonyl-2-indolinone<br>
(398)	3-Z-[1-(4-(N-(4-methylbenzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(399)	3-Z-[1-(4-(N-(4-fluoro-benzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(400)	3-Z-[1-(4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(401)	3-Z-[1-(4-(N-(3-dimethylamino-propionyl)-N-dimethylaminocarbonylmethyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(402)	3-Z-[1-(4-(N-(4-dimethylamino-butyryl)-N-dimethylaminocarbonylmethyl-amino)-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(403)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-(2-dimethylamino-ethylsulphonyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(404)	3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-(3-dimethylamino-propylsulphonyl)-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(405)	3-Z-[1-(4-((2-hydroxy-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(406)	3-Z- [1-(4-((2-methoxy-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(407)	3-Z-[1-(4-((2-dimethylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(408)	3-Z-[1-(4-((3-dimethylamino-propyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(409)	3-Z-[1-(4-((N-tert.butoxycarbonyl-2-amino-ethyl)-amino-methyl) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(410)	3-Z-[1-(4-((N-tert.butoxycarbonyl-3-amino-propyl)-amino-methyl) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indol.inone<br>
(411)	3-Z-[1-(4-((2-amino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(412)	3-Z-[1-(4-((3-amino-propyl)-amino-methyl)-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(413)	3-Z-[1-(4-((2-acetylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(414)	3-Z- [1-(4-((3-acetylamino-propyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(415)	3-Z-[1-(4-((2-methylsulphonylamino-ethyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(416)	3-Z- [1-(4-((3-methylsulphonylamino-propyl)-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(417)	3-Z- [1-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-N-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(418)	3-Z- [1- (4- (N-,(2-amino-ethyl) -N-methyl-amino-methyl) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(419)	3-Z-[1-(4-(N-(2-acetylamino-ethyl)-N-methyl-amino-methyl) -anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(420)	3-Z- [1-(4-(N-(2-methylsulphonylamino-ethyl)-N-methyl-amino-methyl) -anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(421)	3-Z- [1-(4-(carboxymethyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(422)	3-Z-[1-(4-(ethoxycarbonylmethyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(423)	3-Z-[1-(4-(carbamoylmethyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
(424)	3-Z-[1-(4-(dimethylcarbamoyl-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(425)	3-Z-[1-(4-(methylcarbamoyl-methyl-amino-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br><br>
(426)	3-2- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-amino-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(427)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-nitro-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(428)	3-Z-[1-(4-(N-plmethylaminomethylcarbonyl-N-methyl-amino)-3-acetylamino-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(429)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methylsulphonylamino-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(430)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-cyano-anilino)-l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(431)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-hydroxy-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
(432)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methoxy-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(433)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-ethoxycarbonyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(434)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-<br>
amino)-3-carboxy-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br><br><br>
(435)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-carbamoyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(436)	3-2-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-chloro-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(437)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-fluoro-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(438)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-bromo-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(439)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-methyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(44 0) 3-Z-[l-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-3-trifluoromethyl-anilino)-1-phenyl-methylene]-6-methoxycarbony1-2 -indolinone<br>
(441)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-<br>
amino)-3,5-dibromo-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
(442)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-<br>
amino)-3,5-dichloro-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2 -indolinone<br>
(443)	3-Z- [1- (4- (dimethylaminomethyll.-3-amino-anilino) -1-<br>
phenyl-methylene]-6-methoxycarbony1-2 -indolinone<br><br><br>
(444)	3-Z-[1-(4-(dimethylaminomethyl)-3-nitro-anilino)-1-<br>
phenyl-methylene]- 6-methoxycarbonyl-2-indolinone<br>
(445)	3-Z-[1-(4-(dimethylaminomethyl)-3-acetylamino-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(446)	3-Z-[1-(4-(dimethylaminomethyl)-3-methylsulphonylamino-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(447)	3-Z-[1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
(448)	3-Z-[1-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-1-pheny1-methylene]-6-methoxycarbonyl-2-indolinone<br>
(449)	3-Z-[1-(4-(dimethylaminomethyl)-3-methoxy-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(450)	3-Z-[1-(4-(dimethylaminomethyl)-3-ethoxycarbonyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(451)	3-Z-[l-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
(452)	3-Z-[1-(4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(453)	3-Z-[1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(454)	3-Z-[1-(4-(dimethylaminomethyl)-3-fluoro-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(455)	3-Z-[1-(4-(dimethylaminomethyl)-3-bromo-anilino)-1-phenyl-methylene]-6-methoxycarbonyl- 2-indolinone<br><br><br>
(456)	3-Z-[1-(4-(dimethylaminomethyl)-3-methyl-anilino)-1-<br>
phenyl-methylene]-6-methoxycarbonyl- 2-indolinone<br>
(457)	3-Z-[1-(4-(dimethylaminomethyl)-3-trifluoromethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(458)	3-Z-[1-(4-dimethylaminomethyl-3,5-dibromo-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(459)	3-Z-[1-(4-(dimethylaminomethyl) -3 , 5-dichloro-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br><br>
(460)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene] -6-[(2-hydroxy-ethoxy)-carbonyl] -2-indolinone<br>
(461)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene] -6- [ (ethoxycarbonyl-methoxy) -carbonyl] -2-indolinone<br>
(462)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene] -6-[(carboxy-methoxy)-carbonyl]-2-indolinone<br>
(463)	3-Z-[1-(4-(dimethylaminomethyl) -anilino)-1-phenyl-methylene] -6-[(carbamoyl-methoxy)-carbonyl] -2-indolinone<br><br>
(464)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene] -6-[(2-hydroxy-ethoxy) -carbonyl]-2-indolinone<br>
(465)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(ethoxycarbonyl-methoxy) -carbonyl]-2-indolinone<br>
(466)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6- [ (carboxy-methoxy) -carbonyl]-2-indolinone<br><br><br>
(467)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(carbamoyl-methoxy)-carbonyl]" - 2 - indolinone<br>
(468)	3-Z- [1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(2-methoxy-ethoxy)-carbonyl]-2-indolinone<br>
(469)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(2-dimethylamino-ethoxy)-carbonyl]-2-indolinone<br>
(470)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-<br>
amino)-anilino)-1-phenyl-methylene]-6-[(2-(N-<br>
tert.butoxycarbonyl-amino)-ethoxy)-carbonyl]-2-indolinone<br>
(471)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(2-amino-ethoxy)-carbonyl]-2-indolinone<br>
(472)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-[(2,2,2-trifluoroethoxy)-carbonyl]-2-indolinone<br>
(473)	3-Z-[1-(4-(N-((4-methyl-piperazin-l-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br>
(474)	3-Z-[1-(4-(N-(imidazo-1-yl-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(475)	3-Z- [1-(4-(N-(phthalimido-2-yl-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(476)	3-Z-[1-(4-(N-aminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(477)	3-Z-[1-(4-(N-acetylaminomethylcarbonyl-N-methyl-amino)-<br>
anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(478)	3-Z-[1-(4-(N-methylsulphonylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 - i ndo 1 i none      „"<br>
(479)	3-Z-[1-(4-(N-((N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(480)	3-Z-[1-(4-(N-((N-(2-dimethylaminoethyl)-N-methyl-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-<br>
6-methoxycarbonyl-2 -indolinone<br>
(481)	3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(482)	3-Z-[1-(4-tert.butoxycarbonylmethyl-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone<br>
(483)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino)-methylene]-6-methoxycarbonyl-2-indolinone<br>
(484)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino)-ethylidene]-6-methoxycarbonyl-2-indolinone<br>
(485)	3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino)-propylidene]-6-methoxycarbonyl-2-indolinone<br>
(486)	3-Z-[l-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino)-butylidene]-6-methoxycarbonyl-2-indolinone<br><br><br>
(487)	3-Z-[1-(4-(dimethylaminomethyl)-anilino)-methylene]-6-methoxycarbonyl-2-indolinone<br>
(488)	3-Z- [1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6-methoxycarbonyl- 2 -indolinone<br>
(489)	3-Z- [1-(4-(dimethylaminomethyl)-anilino)-propylidene]-6-methoxycarbonyl-2 -indolinone<br>
(490)	3-Z- [1-(4-(dimethylaminomethyl)-anilino)-butylidene]-6-methoxycarbonyl-2 -indolinone<br>
(491)	3-Z- [1-(4-tert.butyloxycarbonyl-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2 -indolinone<br>
(492)	3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br><br>
(493)	3-Z- [1- (4-(N-(3-dimethylamino-propyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone<br>
(494)	3-Z- [1-(4-(N-methyl-acetylamino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(495)	3-Z- [1-(4-(imidazol-4-yl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2 -indolinone<br>
(496)	3-Z- [1-(4-((N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-<br>
2-indolinone<br>
(497)	3-Z- [1-(4-(N-benzyl-N-methyl-amino-methyl)-anilino)-1-<br>
methyl-methylene]-6-carbamoyl-2-indolinone<br><br>
(498)	3-Z-[l-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone<br>
(499)	3-Z-[1-(4-((benzo(1,3)dioxol-5-yl-methyl)-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-carbamoyl~2-indolinone<br>
(500)	3-Z-[1-(4-(N-phenethyl-N-methyl-amino-methyl)-anilino)-<br>
1-methyl-methylene]- 6-carbamoyl-2 -indolinone<br>
l<br>
(501)	3-Z-[1-(4-(N-(3,4-dimethoxy-benzyl)-N-methyl-amino-<br>
methyl)-anilino)-1-methyl-methylene]-6-carbamoyl-2-indolinone<br>
(502)	3-Z-[1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl)-<br>
anilino)-1-methyl-methylene]-6-carbamoyl-2-indolinone<br>
(503)	3-Z-[1-(4-(N-(4-methyl-benzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-carbamoyl-2-indolinone<br>
(504)	3-Z-[1-(4-(N-(4-fluoro-benzyl)-N-methyl-amino-methyl)-anilino)-1-methyl-methylene]-6-carbamoyl-2-indolinone<br>
(505)	3-Z-[1-(4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)-anilino) -1-methyl-methylene]-6-carbamoyl-2-indolinone<br>
(506)	3-Z- [1- (4-( (N- (2-methoxy-ethyl)-N-methyl-amino)-methyl)-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br>
(507)	3-Z-[1-(4-(dimethylaminomethyl)-anilino) -1-phenyl-methylene]-6- [ (2-amino-ethoxy)-carbonyl]-2-indolinone<br>
(508)	3-Z-[1-(4-((N-(3-methylsulfonylamino-propyl)-N-methyl-amino)-methyl)-anilino)-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone<br><br><br>
Example 13<br>
Dry ampoule containing 75 mg of active substance per 10 ml<br>
Composition:<br>
Active substance	75.0 mg<br>
Mannitol	50.0 mg<br>
water for injections	ad 10.0 ml<br>
Preparation:<br>
Active substance and mannitol are dissolved in water.  After packaging the solution is freeze-dried.  To produce the solution ready for use, the product is dissolved in water for injections.<br>
Example 14<br>
Dry ampoule containing 35 mg of active substance per 2 ml<br>
Composition:<br>
Active substance	35.0 mg<br>
Mannitol	100.0 mg<br>
water for injections	ad 2.0 ml<br>
Preparation:<br>
Active substance and mannitol are dissolved in water. After<br>
packaging, the solution is freeze-dried.<br>
To produce the solution ready for use, the product is dissolved in water for injections.<br><br><br>
Example 15<br>
Tablet containing 50 mg of active substance<br>
Composition:<br>
(1)	Active substance	50.0 mg<br>
(2)	Lactose       																											98.0 mg<br>
(3)	Maize starch	50.0 mg<br>
(4)	Polyvinylpyrrolidone	15.0 mg<br>
(5)	Magnesium stearate		 2 . 0 mg<br>
215.0 mg<br>
Preparation:<br>
(1), (2) and (3) are mixed together and granulated with an aqueous solution of (4). (5) is added to the dried granulated material. From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side. Diameter of the tablets: 9 mm.<br>
Example 16<br>
Tablet containing 350 mg of active substance<br>
Composition:<br>
(1)	Active substance	350.0 mg<br>
(2)	Lactose	136.0 mg<br>
(3)	Maize starch	80.0 mg<br>
(4)	Polyvinylpyrrolidone	30.0 mg<br>
(5)	Magnesium stearate	4.0 mg<br>
600.0 mg<br>
Preparation:<br>
(1), (2) and (3) are mixed together and granulated with an aqueous solution of (4). (5) is added to the dried granulated material.  From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side. Diameter of the tablets: 12 mm.<br>
Example 17<br>
Capsules containing 50 mg of active substance Composition:<br>
(1)	Active substance	50.0 mg<br>
(2)	Dried maize starch	58.0 mg<br>
(3)	Powdered lactose	50.0 mg<br>
(4)	Magnesium stearate	2.0 mg<br>
160.0 mg<br>
Preparation:<br>
(1) is triturated with (3).  This trituration is added to the mixture of (2) and (4) with vigorous mixing.<br>
This powder mixture is packed into size 3 hard gelatine capsules in a capsule filling machine.<br>
Example 18<br>
Capsules containing 350 mg of active substance<br><br><br>
Composition:<br>
(1)	Active substance	350.0 mg<br>
(2)	Dried maize starch	46.0 mg<br>
(3)	Powdered lactose	3 0.0 mg<br>
(4)	Magnesium stearate	4.0 mg<br>
4 3 0.0 mg<br>
Preparation:<br>
(1) is triturated with (3).  This trituration is added to the mixture of (2) and (4) with vigorous mixing.<br>
This powder mixture is packed into size 0 hard gelatine capsules in a capsule filling machine.<br>
Example 19<br>
Suppositories containing 100 mg of active substance<br>
1 suppository contains:<br>
Active substance	100.0 mg<br>
Polyethyleneglycol (M.W. 1500) 600.0 mg Polyethyleneglycol (M.W. 6000) 460.0 mg Polyethylenesorbitan monostearate   840.0 mg<br>
2,000.0 mg<br>
Preparation:<br>
The polyethyleneglycol is melted together with polyethylene sorbitan monostearate. At 40°C the ground active substance is homogeneously dispersed in the melt. It is cooled to 38°C and poured into slightly chilled suppository moulds.<br><br>
We claim:<br>
1.       Indolinones of general formula I<br><br><br>
(I),<br><br>
wherein<br>
X denotes an oxygen atom,<br>
R1 denotes a hydrogen atom,<br>
R2 denotes a carboxy group, a straight-chain or branched C1-4-alk-<br>
oxycarbonyl group,<br>
a straight-chain or branched C1-3-alkoxy-carbonyl group, which is<br>
terminally substituted in the alkyl moiety by a phenyl group,<br>
a  straight-chain or branched C2-3-alkoxy-carbonyl  group which is<br>
terminally   substituted   in   the   alkyl   moiety   by   a   C1-3-alkoxy—or<br>
di-(C1-3-alkyl)-amino group,<br>
an       aminocarbonyl       or       methylaminocarbonyl       group,       an<br>
ethylaminocarbonyl group optionally substituted in the 2 position of<br>
the ethyl group by a hydroxy group or, if R4 does not denote an<br>
aminosulphonyl-phenyl     or     N-(C1-5-alkyl)-C1-3-alkylaminocarbonyl-<br>
phenyl   group,   it  may  also   denote  a  di-(C1-2-alkyl)-aminocarbonyl<br>
group,<br>
R3  denotes a C1-4-alkyl  group or a phenyl group  which  may be<br>
substituted    by    a    fluorine,    chlorine    or    bromine    atom,    by    a<br>
trifluoromethyl, C1-3-alkyl, hydroxy or C1-3-alkoxy group,<br>
R4 denotes a C5-6-cycloalkyl group,<br><br>
wherein the methylene group in position 4 of the cyclohexyl group may<br>
be substituted by an amino group or replaced by a -N(C1-3-alkyl)<br>
group,<br>
a phenyl group, a phenyl group disubstituted by C1-3-alkyl, C1-3-alkoxy<br>
or nitro groups, wherein the substituents may be identical or different,<br>
or<br>
a phenyl group substituted by the group R6, which may additionally be substituted by a chlorine or bromine atom or by an amino or nitro group, wherein<br>
R6 denotes a fluorine, chlorine or bromine atom,<br>
a C1-3-alkyl, C1-3-alkoxy, nitro, or amino or C5-6-cycloalkyl group,<br>
an imidazolyl or tetrazolyl group bound via a carbon atom, wherein the<br>
abovementioned heteroaromatic groups in the carbon skeleton may be<br>
substituted by a C1-3-alkyl group or a hydrogen atom bound to a<br>
nitrogen atom may be replaced by a C1-3-alkyl or phenyl-C1-3-alkyl<br>
group,<br>
the group of formula<br><br>
a carboxy, C1-4-alkoxycarbonyl or C5-7-cycloalkyl-carbonyl group,<br>
a 5 or 6-membered cycloalkyleneimino group, wherein<br>
the methylene group in position 4 of the piperidino group may be<br>
replaced by an -NH group,<br>
an unbranched C1-3-alkyl group terminally substituted by the group R7,<br>
wherein<br>
R7 denotes a C5-7-cycloalkyl group,<br>
wherein in a 5 or 6-membered cycloalkyl group a -(CH2)2 group may be<br>
replaced by a -CO-NH group, a -(CH2)3 group may be replaced by an -<br>
NH-CO-NH- or a -(CH2)4 group may be replaced by an -NH-CO-NH-CO<br><br>
group, whilst in each case a hydrogen atom bound to a nitrogen atom<br>
may be replaced by a C1-3-alkyl group,<br>
a phenyl or pyridinyl group or a pyrrolyl, imidazolyl or triazolyl group<br>
bound via a carbon or nitrogen atom, wherein the abovementioned<br>
heteroaromatic groups in the carbon skeleton may be substituted by a<br>
C1-3-alkyl group,<br>
a hydroxy group,<br>
an amino, C1-6-alkylamino, di-(C1-6-alkyl)-amino, henyl-C1-3-alkylamino<br>
or N-(C1-3-alkyl)-phenyl-C1-3-alkylamino group,<br>
a     co-hydroxy-C2-3-alkyl-amino,     di-(to-hydroxy-C2-3-alkyl)-amino      or<br>
di-(co-(C1-3-alkoxy)-C2-3-alkyl)-amino group,<br>
a C1-3-alkylcarbonylamino-C2-3-alkyl-N-(C1-3-alkyl)-aniino group,<br>
a C1-3-alkylsulphonylamino group,<br>
a N-(C1-3-alkyl)-hydroxycarbonyl-C1-3-alkyl-amino group,<br>
a guanidino group wherein a hydrogen atom may be replaced by a<br>
C1-3-alkyl group,<br>
a group of formula<br>
-N(R8)-CO-(CH2)n -R9    (II), wherein R8 denotes a hydrogen atom or a C1-3-alkyl group,<br>
n denotes one of the numbers 0 or 1  and<br>
R9 denotes an amino, C1-3-alkylamino, di-(C1-3-alkyl)-amino or C1-3-alkoxy group, a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C1-3-alkyl) or -N(C1-3-alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R9 may also denote a hydrogen atom,<br>
a group of formula<br>
-N(R10)-(CH2)m-(CO)0-Rn      (III),<br>
wherein<br>
R10 denotes a C1-3-alkyl group,<br>
m denotes one of the numbers 1, 2 or 3,<br><br><br>
o denotes the number 1 or, if m is one of the numbers 2 or 3, o may<br>
also denote the number 0 and<br>
R11    denotes    an    amino,     C1-3-alkylamino,     di-(C1-3-alkyl)-amino,<br>
C1-4-alkoxy or methoxy-C1-3-alkoxy group or a 5-  or 6-membered<br>
cycloalkyleneimino group, wherein the methylene group in position 4<br>
of the piperidino group may be replaced by an -NH, -N(C1-3-alkyl) or<br>
-N(C1-3-alkyl-carbonyl) group,<br>
an   azetidino,    pyrrolidino,    piperidino,    2,6-dimethyl-piperidino—or<br>
azepino group, wherein<br>
the methylene group in position 3 of the pyrrolidino group may be<br>
substituted by a hydroxy group,<br>
the methylene group in position 4 of the piperidino group may be<br>
substituted by a hydroxy or hydroxy-C1-3-alkyl group or<br>
may be replaced by an oxygen or sulphur atom,  by a sulphinyl,<br>
sulphonyl, -N(C1-3-alkyl) or -N(benzoyl) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the<br>
pyrrolidino or piperazino group may be replaced by a carbonyl group,<br>
or Re denotes a straight-chain C1-3-alkyl group which is terminally<br>
substituted by a carboxy or C1-3-alkoxy-carbonyl group, a group of<br>
formula<br>
-N(R12)-CO-(CH2)p-R13     (IV),<br>
wherein<br>
R12 denotes a C1-3-alkyl or phenyl-C1-3-alkyl group,<br>
p denotes one of the numbers 1 or 2 and<br>
R13 denotes C1-4-alkylamino, di-(C1-4-alkyl)-amino, N-(C1-3-alkyl)-benzylamino, di-(2-methoxy-ethyl)-amino, or aminocarbonyl-methyl-N-(methyl)-amino group,<br>
a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and<br>
optionally substituted by a C1-3-alkyl group,<br>
a pyrrolidino, piperidino, morpholino or a piperazino group optionally<br>
substituted in the 4 position by a C1-3-alkyl, phenyl-C1-3-alkyl or<br>
C1-4-alkoxycarbonyl group or, if p denotes the number 1 or 2, it may<br>
also denote a hydrogen atom, a group of formula-N(R14)-(CH2)q-(CO)r-R15      (V),<br>
wherein<br>
R14    denotes    a    hydrogen    atom,    a    C1-4-alkyl,    phenylcarbonyl,<br>
phenyl-C1-3-alkylcarbonyl,	furyl-carbonyl,	pyridinyl-carbonyl,<br>
C1-4-alkylsulphonyl,   phenylsulphonyl   or   phenyl-C1-3-alkylsulphonyl group,<br>
q denotes one of the numbers 1, 2 or 3,<br>
r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and<br>
R15   denotes   an   amino,   C1-4-alkylamino,   di-(C1-4-alkyl)-amino,   or N-(Ci-4-alkyl)-benzylamino group, or a group of formula<br>
-N(R16)-S02-R17     (VI),<br>
wherein<br>
R16 denotes a C1-3-alkyl group optionally terminally substituted by a<br>
cyano, trifluoromethyl-carbonylamino group and<br>
R17 denotes a C1-3-alkyl group,<br>
wherein all the single-bonded phenyl groups contained in the groups mentioned under Re may be substituted by a methoxy group and<br>
R5 denotes a hydrogen atom,<br>
wherein   a   hydrogen   atom   bound   to   a   nitrogen   atom   in   the<br>
abovementioned    groups    may    be    replaced    by    an    acetyl    or<br>
tert.butoxycarbonyl group,<br>
the carboxy groups contained in the abovementioned groups may also<br>
be present in the form of the tert.butoxycarbonyl precursor group,<br>
the tautomers, the diastereomers, the enantiomers, the mixtures such<br>
as herein described and the salts such as herein described.<br>
2.       Indolinones of general formula I as claimed in claim 1, wherein<br>
X denotes an oxygen atom,<br>
R1 and R5 each denote a hydrogen atom,<br>
R2   denotes  a  methoxycarbonyl,   ethoxycarbonyl   or  aminocarbonyl<br>
group,<br>
R3 denotes a phenyl group and<br><br>
R4 denotes a phenyl group monosubstituted by the group Re, wherein<br>
Re denotes an N-methyl-imidazol-2-yl group,<br>
an unbranched C1-3-alkyl group which is terminally substituted by a<br>
C1-4-alkylamino,	di-(C1-4-alkyl)-amino,	piperidino	or<br>
2,6-dimethyl-piperidino group, a group of formula<br>
-N(R12)-CO-(CH2)p-R13      (IV),<br>
wherein<br>
R12 denotes a C1-3-alkyl group,<br>
p denotes one of the numbers 1 or 2 and<br>
R13 denotes a di-(C1-3-alkyl) -amino group,  or a group of formula<br>
-N(R14)-(CH2)q-(CO)r-R15      (V),<br>
wherein<br>
R14 denotes a C1-3-alkyl-carbonyl or C1-3-alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3,<br>
r denotes the number 1 or, if q is one of the numbers 2 or 3, r may<br>
also denote the number 0 and<br>
R15   denotes   a   di-(C1-3-alkyl)-amino   group,    the   tautomers,    the<br>
diastereomers,    the   enantiomers,   the   mixtures   such   as   herein<br>
described and the salts such as herein described.<br>
3.       The following substituted indolinones of general formula I as claimed in claim 1:<br>
(a)	3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl- 2 -indolinone,<br>
(b)	3-Z-[(l-(4-(piperidin-l-yl-methyl)-anilino)-l-phenyl-methylene]-6-carbamoyl-2-indolinone,<br>
(c)	3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-l-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(d)	3-Z- [ 1 - (4- (dimethylaminomethyl) -anilino)-1 -phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(e)	3-Z-[l-(4-((2,6-dimethyl-piperidin- l-yl)-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br><br>
(f)	3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(g)	3-Z-[l-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(h)      3-Z-[ 1 -(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-<br>
anilino)-1 -phenyl-methylene]-6-ethoxycarbonyl-2-indolinone,<br>
(i)       3-Z-[l-(4-(dimethylaminomethyl)-anilino)-l-phenyl-methylene]-<br>
6-methoxycarbonyl-2-indolinone,<br>
(j)       3-Z-[l-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino)-<br>
anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(k)      3-Z-[l-(4-ethylaminomethyl-anilino)-l-phenyl-methylene]-6-<br>
methoxycarbonyl- 2 -indolinone,<br>
(1)       3-Z-[l-(4-(l-methyl-imidazol-2-yl)-anilino)-l-phenyl-methylene]-<br>
6-met±io3tycarbonyl-2 -indolinone,<br>
(m)     3-Z-[ 1 -(4-(N-dimethylaminomethylcarbonyl-N-methyl-aniino)-<br>
anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone&gt;<br>
(n)      3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-<br>
anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(o)      3-Z-[ l-(4-(N-(3-dimethylamino-propyl)-N-methylsulphonyl-ami-<br>
no)-anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(p)      3-Z-[ 1 -(4-(N-dimethylaminocarbonylmethyl-N-methylsulphonyl-<br>
amino)-anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(q)       3-Z-[ l-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-<br>
amino)-anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone,<br>
(r)        3-Z-[ 1 -(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-anilino)-1 -<br>
phenyl-methylene]-6-methoxycarbonyl-2-indolinone and<br>
(s)       3-Z-[ l-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-6-<br>
methoxycarbonyl-2-indolinone,<br>
4.       Process for preparing the compounds as claimed in claims 1 to<br>
3, wherein<br>
a)       a compound of general formula<br><br><br>
wherein<br>
X and R3 are defined as in claims 1 to 3,<br>
R2 has the meanings given for R2 in claims 1 to 3,<br>
Ris denotes a hydrogen atom or a protecting group for the nitrogen<br>
atom of the lactam group, wherein one of the groups R2 and R18 may<br>
also denote a bond to a solid phase optionally formed via a spacer and<br>
the other one of the groups R2 and R18 has the abovementioned<br>
meanings, and Z1 denotes a halogen atom, a hydroxy, alkoxy or aryl-<br>
alkoxy group, is reacted with an amine of general formula<br><br>
wherein<br>
R4 and R5 are defined as in claims  1  to 3, and subsequently, if<br>
required, any protecting group used for the nitrogen atom of the<br>
lactam group is cleaved or a compound thus obtained is cleaved from<br>
a solid phase, or<br>
b)       in order to prepare a compound of general formula I wherein<br>
R2 has the meanings given in claims 1 to 3, with the exception of the<br>
carboxy group, a compound of general formula<br><br><br>
wherein<br>
R1 and R3 to R5 are defined as in claims 1 to 3, or a reactive derivative<br>
thereof, is reacted with a compound of general formula<br>
H - R19       (X), wherein<br>
R19 denotes a C1-6-alkanol, a C4-7-cycloalkanol or an aromatic alcohol, a C1-6-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C1-3-alkoxy-carbonyl, aminocarbonyl, C1-3-alkylamino-carbonyl or di-(C1-3-alkyl)-aminocarbonyl group, a C2-6-alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C1-3-alkoxy, amino, C1-3-alkylamino or di-(C1-3-alkyl)-amino group,<br>
an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1-3-alkoxy group or a di-(C1-2-alkyl)-amino group, or<br>
c)        in order to prepare a compound of general formula I, wherein R4<br>
denotes a C1-4-alkyl group substituted by the group R7, wherein<br>
R7     denotes     an     amino,     C1-7-alkylamino,     di-(C1-7-alkyl)-amino,<br>
phenylamino,      N-phenyl-C1-3-alkyl-amino,      phenyl-C1-3-alkylamino,<br>
N-(C1-3-alkyl)-phenyl-C1-3-alkylamino    or   di-(phenyl-C1-3-alkyl)-amino<br>
group,<br>
a co-hydroxy-C2-3-alkyl-amino, N-(C1-3-alkyl)-co-hydroxy-C2-3-alkyl-amino,<br>
di-(co-hydroxy-C2-3-alkyl)-amino,  di-(co-(C1-3-alkoxy)-C2-3-alkyl)-amino or<br>
N-(dioxolan-2-yl)-C1-3-alkyl-amino group,<br>
a	C1-3-alkylcarbonylamino-C2-3-alkyl-amino	or<br>
C1-3-alkylcarbonylamino-C2-3-alkyl-N-(C1-3-alkyl)-amino group,<br><br>
a    C1-3-alkylsulphonylamino,    N-(C1-3-alkyl)-C1-3-alkylsulphonylamino,<br>
C1-3-alkylsulphonylamino-C2-3-alkyl-amino	or<br>
C1-3-alkylsulphonylamino-C2-3-alkyl-N-(C1-3-alkyl)-amino group, a group of formula<br>
-N(R10)-(CH2)m-(CO)o-R11      (III),<br>
wherein<br>
R10 denotes a hydrogen atom, a C1-3-alkyl group, a C1-3-alkylcarbonyl,<br>
arylcarbonyl,	phenyl-C1-3-alkylcarbonyl,	C1-3-alkylsulphonyl,<br>
arylsulphonyl or phenyl-C1-3-alkylsulphonyl group,<br>
m denotes one of the numbers 1, 2, 3 or 4,<br>
o denotes the number 1 and<br>
R11     denotes    an    amino,     C1-4-alkylamino,     di-(C1-4-alkyl)-amino,<br>
phenylamino,	N-(C1-4-alkyl)-phenylamino,	benzylamino,<br>
N-(C1-4-alkyl)-benzylamino,     C1-4-alkoxy    or    C1-3-alkoxy-C1-3-alkoxy<br>
group,     a    di-(C1-4-alkyl)-amino-C1-3-alkylamino     group     optionally<br>
substituted in the  1 position by a C1-3-alkyl group, or a 4- to 7-<br>
membered cycloalkyleneimino group, wherein the cycloalkylene moiety<br>
may be fused to a phenyl ring or in each case the methylene group in<br>
the 4 position of a 6- or 7-membered cycloalkyleneimino group may be<br>
replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl,<br>
-NH, -N(C1-3-alkyl), -N(phenyl), -N(C1-3-alkyl-carbonyl) or -N(benzoyl)<br>
group,<br>
a	C4-7-cycloalkylamino,	C4-7-cycloalkyl-C1-3-alkylamino	or <br>
C4-7-cycloalkenylamino group wherein position  1 of the ring is not<br>
involved in the double bond and wherein the abovementioned groups<br>
may each additionally be substituted at the amino-nitrogen atom by a<br>
C5-7-cycloalkyl, C2-4-alkenyl or C1-4-alkyl group,<br>
or a 4- to 7-membered cycloalkyleneimino group, wherein<br>
the cycloalkylene moiety may be fused to a phenyl group or to an<br>
oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group<br>
optionally substituted by a fluorine, chlorine, bromine or iodine atom,<br>
by a nitro, C1-3-alkyl, C1-3-alkoxy or amino group, and/or<br>
one or two hydrogen atoms may each be replaced by a C1-3-alkyl,<br>
C5-7-cycloalkyl or phenyl group and/or  the methylene group in the 3 position of a 5-membered<br>
cycloalkyleneimino group may be substituted by a hydroxy, hy-<br>
droxy-C1-3-alkyl, C1-3-alkoxy or C1-3-alkoxy-C1-3-alkyl group,<br>
in each case the methylene group in the 3 or 4 position of a 6- or 7-<br>
membered cycloalkyleneimino group may be substituted by a hydroxy,<br>
hydroxy-C1-3-alkyl,	C1-3-alkoxy,	C1-3-alkoxy-C1-3-alkyl,<br>
C1-4-alkoxycarbonyl,	aminocarbonyl,	C1-3-alkylaminocarbonyl,<br>
di-(C1-3-alkyl)-aminocarbonyl, phenyl-C1-3-alkylamino or N-(C1-3-alkyl)-phenyl-C1-3-alkylamino group or<br>
may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C1-3-alkyl-), -N(phenyl), -N(phenyl-C1-3-alkyl-), -N(C1-3-alkyl-carbonyl-), -N(C1-3-alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C1-3-alkyl-carbonyl-) group,<br>
wherein a methylene group linked to an imino-nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a 5- to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino-nitrogen atom may each be replaced by a carbonyl group,<br>
a compound of general formula<br><br>
wherein<br>
R3, R5 and X are defined as in claims 1 to 3,<br>
R2 has the meanings given for R2 in claims 1 to 3,<br>
also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups R2 and R18 has the abovementioned meanings, A denotes a Ci-4-alkyl group and Z2 denotes a leaving group, is reacted with an amine of general formula<br>
H—R7,	(XII),<br>
wherein<br>
R7 has the meanings given for R7 hereinbefore, and subsequently, if<br>
necessary, any protecting group used for the nitrogen atom of the<br>
lactam group is cleaved, or a compound thus obtained is cleaved from<br>
a solid phase, and<br>
subsequently,   if desired,   a compound  of general  formula  I  thus<br>
obtained which contains an alkoxycarbonyl group is converted by<br>
hydrolysis into a corresponding carboxy compound, or<br>
a compound of general formula I thus obtained which contains an<br>
amino or alkylamino group is converted by reductive alkylation into a<br>
corresponding alkylamino or dialkylamino compound, or<br>
a compound of general formula I thus obtained which contains an<br>
amino or alkylamino group is converted by acylation or sulphonation<br>
into a corresponding acyl or sulphonyl compound or<br>
a compound of general formula I thus obtained which contains a<br>
carboxy group  is converted by esterification or amidation into  a<br>
corresponding ester or aminocarbonyl compound or<br>
a compound of general formula I thus obtained which contains a<br>
cycloalkyleneimino group wherein a methylene group is replaced by a<br>
sulphur atom is converted by oxidation into a corresponding sulphinyl<br>
or sulphonyl compound, or   a compound of general formula I thus obtained which contains a nitro<br>
group   is   converted   by   reduction   into   a   corresponding   amino<br>
compound, or  a compound of general formula I thus obtained wherein R4 denotes a<br>
phenyl group substituted by an amino, alkylamino, aminoalkyl or  N-alkyl-amino group is converted, by reaction with a corresponding  cyanate, isocyanate or carbamoyl halide, into a corresponding ureacompound of general formula I <br>
Ri8 denotes a hydrogen atom or a protecting group for the nitrogen<br>
atom of the lactam group, wherein one of the groups R2 and R18 may<br><br>
a compound of general formula I thus obtained wherein R4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group is converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I, or if necessary any protecting group used during the reactions to protect reactive groups is cleaved or subsequently, if desired, a compound of general formula I thus obtained is resolved into the stereoisomers thereof or<br>
a compound of general formula I thus obtained is converted into the salts thereof, particularly, for pharmaceutical use, into the physiologically acceptable salts thereof with an inorganic or organic acid or base.<br>
Dated this 26th day of April, 2007.<br>
(SHUKADEV KHURAIJAM)<br>
OF REMFRY &amp; SAGAR<br>
ATTORNEY )FOR THE APPLICANTS</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1jYW5jZWxsZWQgcGFnZXMoMjUtMDYtMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-cancelled pages(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1jbGFpbXMoZ3JhbnRlZCktKDI1LTA2LTIwMDcpLmRvYw==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-claims(granted)-(25-06-2007).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1jbGFpbXMoZ3JhbnRlZCktKDI1LTA2LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-claims(granted)-(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1jb3JyZXNwb25kZW5jZSgyMy0wOC0yMDA3KS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-correspondence(23-08-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1jb3JyZXNwb25kZW5jZShpcG8pLSgyMy0wOC0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-correspondence(ipo)-(23-08-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDEoMjYtMDMtMjAwMikucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 1(26-03-2002).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDEzKDA1LTA1LTIwMDMpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 13(05-05-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDE4KDMwLTExLTIwMDUpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 18(30-11-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDFhKDI1LTA2LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 1a(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDIoZ3JhbnRlZCktKDI1LTA2LTIwMDcpLmRvYw==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 2(granted)-(25-06-2007).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDIoZ3JhbnRlZCktKDI1LTA2LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 2(granted)-(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDMoMjUtMDYtMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 3(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDMoMjYtMDMtMjAwMikucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 3(26-03-2002).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtIDUoMjUtMDYtMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form 5(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtLXBjdC1pcGVhLTQwOSgyNi0wMy0yMDAyKS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form-pct-ipea-409(26-03-2002).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1mb3JtLXBjdC1pc2EtMjEwKDI2LTAzLTIwMDIpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-form-pct-isa-210(26-03-2002).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1wZXRpdGlvbiB1bmRlciBydWxlIDEzNygyNS0wNi0yMDA3KS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-petition under rule 137(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1wZXRpdGlvbiB1bmRlciBydWxlIDEzOCgyNS0wNi0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-petition under rule 138(25-06-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1wb3dlciBvZiBhdXRob3JpdHkoMjUtMDYtMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-power of authority(25-06-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMzYyLW11bS1wb3dlciBvZiBhdXRob3JpdHkoMjYtMDMtMjAwMikucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-362-mum-power of authority(26-03-2002).pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="210414-image-processing-apparatus.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="210417-an-anaerobic-microbial-process-for-deinking-of-news-paper-waste.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>210415</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>IN/PCT/2002/00362/MUM</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>44/2007</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>02-Nov-2007</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>03-Oct-2007</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>26-Mar-2002</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>55216 INGELHEIM AM RHEIN</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>ARMIN HECKEL</td>
											<td>GESCHWISTER-SCHOLL-STRASSE 71, D-88400 BIBERCH</td>
										</tr>
										<tr>
											<td>2</td>
											<td>GERALD JURGEN ROTH</td>
											<td>AKAZEIENWEG 47, D-88400 BIBETRCH</td>
										</tr>
										<tr>
											<td>3</td>
											<td>RAINER WALTER</td>
											<td>PROBSTRASSE 3, D-88400 BIBERCH</td>
										</tr>
										<tr>
											<td>4</td>
											<td>JACOBUS VAN MEEL</td>
											<td>WEISSES KREUZ GASSE 61, A-2340 MODLING</td>
										</tr>
										<tr>
											<td>5</td>
											<td>NORBERT REDEMANN</td>
											<td>KOHLESRAIN 48, D-88400 BIBERCH</td>
										</tr>
										<tr>
											<td>6</td>
											<td>ULRIKE TONTSCH-GRUNT</td>
											<td>OETKERWEG 23, A-2500 BADEN</td>
										</tr>
										<tr>
											<td>7</td>
											<td>WALTER SPEVAK</td>
											<td>LEOBERNDORFERSTRASSE 36, A-2105 OBERROHRBACH</td>
										</tr>
										<tr>
											<td>8</td>
											<td>FRANK HILBERG</td>
											<td>PILGRAMGASSE 18/22, A-1050 WIEN</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D209/34</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP00/09867</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2000-10-09</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>19949208.5</td>
									<td>1999-10-13</td>
								    <td>Germany</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/210415-indolinones-of-general-formula-i by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 04:04:56 GMT -->
</html>
